<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Non‐pharmacological care for opioid withdrawal in newborns - Pahl, A - 2020 | Cochrane Library</title> <meta content="Non‐pharmacological care for opioid withdrawal in newborns - Pahl, A - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013217.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Non‐pharmacological care for opioid withdrawal in newborns - Pahl, A - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013217.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013217.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Non‐pharmacological care for opioid withdrawal in newborns" name="citation_title"/> <meta content="Adrienne Pahl" name="citation_author"/> <meta content="University of Vermont Medical Center" name="citation_author_institution"/> <meta content="adrienne.pahl@uvmhealth.org" name="citation_author_email"/> <meta content="Leslie Young" name="citation_author"/> <meta content="Larner College of Medicine at the University of Vermont" name="citation_author_institution"/> <meta content="Madge E Buus-Frank" name="citation_author"/> <meta content="Lenora Marcellus" name="citation_author"/> <meta content="University of Victoria" name="citation_author_institution"/> <meta content="Roger Soll" name="citation_author"/> <meta content="Larner College of Medicine at the University of Vermont" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD013217.pub2" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/12/21" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013217.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013217.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013217.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Beds; Breast Feeding; Environment Design; Hypnotics and Sedatives [therapeutic use]; Infant Equipment; Intensive Care Units, Neonatal [statistics &amp; numerical data]; *Length of Stay; Narcotics [*adverse effects]; Neonatal Abstinence Syndrome [drug therapy, *therapy]; Nurseries, Infant; Opiate Substitution Treatment [methods]; Patient Positioning [methods]; Prone Position; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013217.pub2&amp;doi=10.1002/14651858.CD013217.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="JmNqPX1V";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013217\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013217\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","ko","ms","ja","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013217.pub2",title:"Non\\u2010pharmacological care for opioid withdrawal in newborns",firstPublishedDate:"Dec 21, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=JmNqPX1V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013217.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013217.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013217.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013217.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013217.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013217.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013217.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013217.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013217.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013217.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8816 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013217.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-sec-0114"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-sec-0017"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-sec-0018"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-sec-0108"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/appendices#CD013217-sec-0119"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/supinfo/CD013217StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/supinfo/CD013217StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Non‐pharmacological care for opioid withdrawal in newborns</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/information#CD013217-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Adrienne Pahl</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/information#CD013217-cr-0005">Leslie Young</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/information#CD013217-cr-0006">Madge E Buus-Frank</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/information#CD013217-cr-0007">Lenora Marcellus</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013217.pub2/information#CD013217-cr-0008">Roger Soll</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/information/en#CD013217-sec-0159">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 21 December 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013217.pub2">https://doi.org/10.1002/14651858.CD013217.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013217-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013217-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013217-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013217-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013217-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013217-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013217-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013217-abs-0001" lang="en"> <section id="CD013217-sec-0001"> <h3 class="title" id="CD013217-sec-0001">Background</h3> <p>The prevalence of substance use, both prescribed and non‐prescribed, is increasing in many areas of the world. Substance use by women of childbearing age contributes to increasing rates of neonatal abstinence syndrome (NAS). Neonatal opioid withdrawal syndrome (NOWS) is a newer term describing the subset of NAS related to opioid exposure. Non‐pharmacological care is the first‐line treatment for substance withdrawal in newborns. Despite the widespread use of non‐pharmacological care to mitigate symptoms of NAS, there is not an established definition of, and standard for, non‐pharmacological care practices in this population. Evaluation of safety and efficacy of non‐pharmacological practices could provide clear guidance for clinical practice. </p> </section> <section id="CD013217-sec-0002"> <h3 class="title" id="CD013217-sec-0002">Objectives</h3> <p>To evaluate the safety and efficacy of non‐pharmacological treatment of infants at risk for, or having symptoms consistent with, opioid withdrawal on the length of hospitalization and use of pharmacological treatment for symptom management. </p> <p><b>Comparison 1:</b> in infants at risk for, or having early symptoms consistent with, opioid withdrawal, does non‐pharmacological treatment reduce the length of hospitalization and use of pharmacological treatment? </p> <p><b>Comparison 2:</b> in infants receiving pharmacological treatment for symptoms consistent with opioid withdrawal, does concurrent non‐pharmacological treatment reduce duration of pharmacological treatment, maximum and cumulative doses of opioid medication, and length of hospitalization? </p> </section> <section id="CD013217-sec-0003"> <h3 class="title" id="CD013217-sec-0003">Search methods</h3> <p>We used the standard search strategy of Cochrane Neonatal to search CENTRAL (2019, Issue 10); Ovid MEDLINE; and CINAHL on 11 October 2019. We also searched clinical trials databases and the reference lists of retrieved articles for randomized controlled trials (RCTs), quasi‐RCTs, and cluster trials. </p> </section> <section id="CD013217-sec-0004"> <h3 class="title" id="CD013217-sec-0004">Selection criteria</h3> <p>We included trials comparing single or bundled non‐pharmacological interventions to no non‐pharmacological treatment or different single or bundled non‐pharmacological interventions. We assessed non‐pharmacological interventions independently and in combination based on sufficient similarity in population, intervention, and comparison groups studied. We categorized non‐pharmacological interventions as: modifying environmental stimulation, feeding practices, and support of the mother‐infant dyad. We presented non‐randomized studies identified in the search process narratively. </p> </section> <section id="CD013217-sec-0005"> <h3 class="title" id="CD013217-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane. We used the GRADE approach to assess the certainty of evidence. Primary outcomes in infants at risk for, or having early symptoms consistent with, opioid withdrawal included length of hospitalization and pharmacological treatment with one or more doses of opioid or sedative medication. Primary outcomes in infants receiving opioid treatment for symptoms consistent with opioid withdrawal included length of hospitalization, length of pharmacological treatment with opioid or sedative medication, and maximum and cumulative doses of opioid medication. </p> </section> <section id="CD013217-sec-0006"> <h3 class="title" id="CD013217-sec-0006">Main results</h3> <p>We identified six RCTs (353 infants) in which infants at risk for, or having symptoms consistent with, opioid withdrawal participated between 1975 and 2018. We identified no RCTs in which infants receiving opioid treatment for symptoms consistent with opioid withdrawal participated. The certainty of evidence for all outcomes was very low to low. We also identified and excluded 34 non‐randomized studies published between 2005 and 2018, including 29 in which infants at risk for, or having symptoms consistent with, opioid withdrawal participated and five in which infants receiving opioid treatment for symptoms consistent with opioid withdrawal participated. We identified seven preregistered interventional clinical trials that may qualify for inclusion at review update when complete. </p> <p>Of the six RCTs, four studies assessed modifying environmental stimulation in the form of a mechanical rocking bed, prone positioning, non‐oscillating waterbed, or a low‐stimulation nursery; one study assessed feeding practices (comparing 24 kcal/oz to 20 kcal/oz formula); and one study assessed support of the maternal‐infant dyad (tailored breastfeeding support). </p> <p>There was no evidence of a difference in length of hospitalization in the one study that assessed modifying environmental stimulation (mean difference [MD) –1 day, 95% confidence interval [CI) –2.82 to 0.82; 30 infants; very low‐certainty evidence) and the one study of support of the maternal‐infant dyad (MD –8.9 days, 95% CI –19.84 to 2.04; 14 infants; very low‐certainty evidence). No studies of feeding practices evaluated the length of hospitalization. </p> <p>There was no evidence of a difference in use of pharmacological treatment in three studies of modifying environmental stimulation (typical risk ratio [RR) 1.00, 95% CI 0.86 to 1.16; 92 infants; low‐certainty evidence), one study of feeding practices (RR 0.92, 95% CI 0.63 to 1.33; 49 infants; very low‐certainty evidence), and one study of support of the maternal‐infant dyad (RR 0.50, 95% CI 0.13 to 1.90; 14 infants; very low‐certainty evidence). </p> <p>Reported secondary outcomes included neonatal intensive care unit (NICU) admission, days to regain birth weight, and weight nadir. One study of support of the maternal‐infant dyad reported NICU admission (RR 0.50, 95% CI 0.13 to 1.90; 14 infants; very low‐certainty evidence). One study of feeding practices reported days to regain birth weight (MD 1.10 days, 95% CI 2.76 to 0.56; 46 infants; very low‐certainty evidence). One study that assessed modifying environmental stimulation reported weight nadir (MD –0.28, 95% CI –1.15 to 0.59; 194 infants; very low‐certainty evidence) and one study of feeding practices reported weight nadir (MD –0.8, 95% CI –2.24 to 0.64; 46 infants; very low‐certainty evidence). </p> </section> <section id="CD013217-sec-0007"> <h3 class="title" id="CD013217-sec-0007">Authors' conclusions</h3> <p>We are uncertain whether non‐pharmacological care for opioid withdrawal in newborns affects important clinical outcomes including length of hospitalization and use of pharmacological treatment based on the six included studies. The outcomes identified for this review were of very low‐ to low‐certainty evidence. Combined analysis was limited by heterogeneity in study design and intervention definitions as well as the number of studies. Many prespecified outcomes were not reported. Although caregivers are encouraged by experts to optimize non‐pharmacological care for opioid withdrawal in newborns prior to initiating pharmacological care, we do not have sufficient evidence to inform specific clinical practices. Larger well‐designed studies are needed to determine the effect of non‐pharmacological care for opioid withdrawal in newborns. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013217-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013217-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013217-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013217-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013217-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD013217-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013217-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013217-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013217-abs-0014">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD013217-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013217-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013217-abs-0002" lang="en"> <h3>Non‐pharmacological care for opioid withdrawal in newborns</h3> <p><b>Review question</b> </p> <p>Do one or more specific non‐pharmacological (treatments other than medicines) care practices benefit newborns with opioid withdrawal after birth? </p> <p><b>Background</b> </p> <p>Newborns of mothers who take opioids during pregnancy often experience symptoms of withdrawal after delivery, such as high‐pitched cry, tremors, and high tone. Non‐pharmacological care is the first treatment for symptoms of withdrawal. If symptoms worsen despite non‐pharmacological care, a medication such as morphine, methadone, or buprenorphine is the second treatment to reduce symptoms. Though non‐pharmacological care is the first approach to symptom management, it is not the same at every hospital. We wanted to discover whether one or more non‐pharmacological care practices benefit newborns with opioid withdrawal after birth. </p> <p><b>Study characteristics</b> </p> <p>We looked at randomized controlled trials (RCTs; clinical studies where people are randomly put into one of two or more treatment groups) of opioid‐exposed newborns treated with one or more non‐pharmacological care practice. Non‐pharmacological care practices include changes to the environment to reduce stimulation or provide soothing, changes to feeding frequency or type, changes that increase maternal care of the newborn or maternal wellness, and multiple changes such as occur in a new site or system of care. Search is up to date as of October 2019. </p> <p><b>Key results</b> </p> <p>This review included six RCTs that enrolled 353 opioid‐exposed newborns. The studies were published between 1975 and 2018. We also identified seven ongoing studies that may qualify for inclusion at review update when complete. </p> <p>Of the six RCTs, four assessed changes to the environment to reduce stimulation or provide soothing. These studies examined the effect of a mechanical rocking bed, prone positioning (lying on tummy), non‐oscillating waterbed, and a low‐stimulation nursery. We are uncertain whether modifying environmental stimulation is associated with length of hospitalization based on one study with 30 infants. Modifying environmental stimulation may be associated with little or no difference in use of pharmacological treatment based on three studies with 92 infants. We are uncertain whether modifying environmental stimulation is associated with weight nadir (lowest weight recorded during birth hospitalization) based on one study with 194 infants. </p> <p>One study assessed a change to the feeding type comparing higher‐calorie formula to standard‐calorie formula. We are uncertain whether feeding practices are associated with use of medicines, days to regain birth weight, or weight nadir based on one study with 46 infants. </p> <p>One study assessed changes to support the mother with tailored breastfeeding support. We are uncertain whether support of the mother‐infant dyad is associated with length of hospitalization, use of medicines, or neonatal intensive care unit admission based on one study with 14 infants. </p> <p>Many potential important effects were not reported, and others were not reported in all studies. </p> <p><b>Quality of evidence</b> </p> <p>We are uncertain whether one or more specific non‐pharmacological care practices benefit newborns with opioid withdrawal after birth. The quality of evidence for all outcomes is very low to low and provides limited information to inform individual non‐pharmacological care practices or combinations of non‐pharmacological care practices. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013217-sec-0114" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013217-sec-0114"></div> <h3 class="title" id="CD013217-sec-0115">Implications for practice</h3> <section id="CD013217-sec-0115"> <p>Although non‐pharmacological care for opioid withdrawal in newborns has biologic plausibility, is low cost, and has potentially low risk of harm, limited evidence informs specific practices. We found six randomized controlled trials (RCTs) that provide very low‐ to low‐certainty evidence for all reported outcomes. Based on this evidence, it is difficult to definitively state an association of specific interventions with outcomes. Given the limited evidence to guide practice, other factors, such as the risk associated with the interventions or the cost to implement the intervention, may guide practitioners to determine optimal non‐pharmacological care practices for their setting while awaiting further evidence. For example, prone positioning is associated with measurable risk of infant death and is not a recommended position for safe sleep in infants (<a href="./references#CD013217-bbs2-0109" title="MoonRY , Task Force on Sudden Infant Death Syndrome. SIDS and other sleep-related infant deaths: evidence base for 2016 updated recommendations for a safe infant sleeping environment. Pediatrics2016;138(5):e20162940. [DOI: 10.1542/peds.2016-2940]">Moon 2016</a>). It is notable that there is often a greater difference in outcomes between sites than there is between comparison groups within a study, suggesting that there are many unmeasured variables that impact care. These may include variability in quality and quantity of non‐pharmacological interventions. We do not have sufficient evidence to guide clinical practice about the use of non‐pharmacological care for opioid withdrawal in newborns. </p> </section> <h3 class="title" id="CD013217-sec-0116">Implications for research</h3> <section id="CD013217-sec-0116"> <p>Well‐designed appropriately powered studies are needed to determine the effect of non‐pharmacological care for opioid withdrawal in newborns. Studies should use clear and consistent definitions to reduce heterogeneity across sites and studies. To assess heterogeneity in population, it is important to record details about perinatal exposures and maternal medical history, particularly psychiatric history. Strategies to ensure representative enrollment of this vulnerable population are also important to ensure generalizability of studies. Clear definition and categorization of non‐pharmacological care practices is important in the framework of future studies. Better definition of timing and duration or 'dose' of non‐pharmacological interventions, cointerventions, and research outcomes will allow meaningful interpretation of interventions in a systematic review and meta‐analysis. Cointerventions may include other non‐pharmacological interventions, pharmacological interventions, and site of care among other interventions. Use of a core outcome set such as that proposed by <a href="./references#CD013217-bbs2-0088" title="KellyL , ShanF , MacVicarS , CzaplinkskiE , MoulsdaleW , SimpsonS , et al. A core outcome set for neonatal opioid withdrawal syndrome. Pediatrics2020;146(1):e20200018. [DOI: ﻿10.1542/peds.2020-0018] [PMID: 32493710]">Kelly 2020</a> could facilitate study of meaningful outcomes. Standardized definitions of outcome measures will facilitate meaningful combination of studies in systematic review and meta‐analysis. Future studies should consistently assess both important short‐term outcomes and longer‐term outcomes such as maternal mood and bonding, long‐term neurodevelopment, and social outcomes such as custody status. </p> <p>The body of literature identified for this systematic review consists of few RCTs and a larger body of non‐randomized study. This is likely partially due to the practical challenges in designing randomized or blinded studies of point‐of‐care practices. Many practices, such as breastfeeding and rooming in, are difficult to randomize and impossible to blind. Others, such as systematic support of the maternal‐infant dyad, consist of cultural changes that will affect care of all patients in a care setting and may require broader community wide interventions. These cultural changes range from hospital practices such as staff ratios and site of care to deeper social issues such as stigma, racism, and poverty. Well‐designed larger studies to determine the most efficacious non‐pharmacological care practices will likely require creative design, such as a stepped wedge cluster randomized trial. To accomplish these important research goals, resources are needed to study point‐of‐care non‐pharmacological interventions and the effects of hospital practices such as site of care, staff ratios, and casualization of the workforce. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013217-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013217-sec-0008"></div> <div class="table" id="CD013217-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Non‐pharmacological treatment compared to placebo for infants at risk for, or having early symptoms consistent with, opioid withdrawal</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Non‐pharmacological treatment compared to placebo for infants at risk for, or having early symptoms consistent with, opioid withdrawal</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> infants at risk for, or having early symptoms consistent with, opioid withdrawal </p> <p><b>Setting:</b> newborn or neonatal unit, USA and UK </p> <p><b>Intervention:</b> non‐pharmacological treatment </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with non‐pharmacological treatment</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Primary outcome measures</i> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Length of hospitalization (days)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Modifying environmental stimulation</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean was 11.5 days (SD 3.4)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 1 lower</b><br/>(2.82 lower to 0.82 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Feeding practices</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Support of the mother‐infant dyad</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean was 19.4 days (SD 13)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 8.9 lower</b><br/>(19.84 lower to 2.04 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Pharmacological treatment with</b> ≥ 1<b>doses of opioid or sedative medication</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>– <i>Modifying environmental stimulation</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.00</b><br/>(0.86 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>92<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>844 per 1000</p> <p>(533 to 1000)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>851 per 1000<br/>(533 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>– <i>Feeding practices</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.92</b><br/>(0.63 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>49<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>727 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>667 per 1000</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>– <i>Support of the mother‐infant dyad</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.50</b><br/>(0.13 to 1.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>571 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1000</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Secondary outcome measures**</i> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>NICU admission</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>– <i>Support of the mother‐infant dyad</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.50</b><br/>(0.13 to 1.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>571 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1000</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Days to regain birth</b> <b>weight</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Feeding practices</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean was 14.7 days (SD 2.84)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.1 lower</b><br/>(2.76 lower to 0.56 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>e</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Weight nadir (% weight loss)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Modifying environmental stimulation</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean was 5.5% weight loss</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.28 lower</b><br/>(1.15 lower to 0.59 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>f</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Feeding practices</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean was 9.4% weight loss</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.8 lower</b><br/>(2.24 lower to 0.64 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p>**Only interventions that reported on secondary outcomes are included in the 'Summary of findings' table. </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>NICU:</b> neonatal intensive care unit; <b>RCT:</b> randomized controlled trial; <b>SD:</b> standard deviation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded three levels for very serious concerns about risk of bias (due to unblinded study, concern for performance, detection, and attrition bias) and serious concern for imprecision (due to wide CIs).<br/><sup>b</sup>Downgraded three levels for very serious concerns about risk of bias (due to unblinded study, concern for performance, detection, and attrition bias) and very serious concern for imprecision (due to very wide CIs).<br/><sup>c</sup>Downgraded two levels for very serious concerns about risk of bias (due to unblinded study, concern for performance, detection, and attrition bias).<br/><sup>d</sup>Downgraded three levels for very serious concerns about risk of bias (due to concern for attrition and reporting bias), serious concern about imprecision (due to wide CIs), and plausible confounding that would reduce demonstrated effect.<br/><sup>e</sup>Downgraded three levels for very serious concerns about risk of bias (due to concern for attrition and reporting bias), very serious concern about imprecision (due to very wide CIs), and plausible confounding that would reduce demonstrated effect.<br/><sup>f</sup>Downgraded three levels for very serious concerns about risk of bias (due to unblinded study, concern for performance and detection bias) and serious concern for imprecision (due to wide CIs). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013217-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013217-sec-0009"></div> <p>Substance use, both prescribed and non‐prescribed, is an international public health concern. Prevalence is increasing in many areas of the world. Substance use by women of childbearing age contributes to increasing neonatal abstinence syndrome (NAS). Although mothers may have multiple substance exposures, opioid exposure constitutes the majority of cases described historically as NAS (<a href="./references#CD013217-bbs2-0080" title="HudakM , TanR , Committee on Drugs, Committee on Fetus and Newborn, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics2012;129(2):e540-60. [DOI: 10.1542/peds.2011-3212] [PMID: 22291123]">Hudak 2012</a>). Neonatal opioid withdrawal syndrome (NOWS) is a newer term describing the subset of NAS related to opioid exposure (<a href="./references#CD013217-bbs2-0088" title="KellyL , ShanF , MacVicarS , CzaplinkskiE , MoulsdaleW , SimpsonS , et al. A core outcome set for neonatal opioid withdrawal syndrome. Pediatrics2020;146(1):e20200018. [DOI: ﻿10.1542/peds.2020-0018] [PMID: 32493710]">Kelly 2020</a>). For the purposes of this review, we will use the broader term of NAS to include the broader definition used in much of the literature. </p> <p>Incidence of NAS varies by location, and rising rates are not universal. The incidence of NAS in Australia and England is 2.7 per 1000 hospital births and stable (<a href="./references#CD013217-bbs2-0063" title="DaviesH , GilbertR , JohnsonK , PetersenI , NazarethI , O'DonnellM , et al. Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia, and Ontario, Canada. Archives of Disease in Childhood. Fetal and Neonatal Edition2016;101(1):F26-30. [DOI: 10.1136/archdischild-2015-308948] [PMID: 26290479]">Davies 2016</a>). The incidence of NAS in the USA and Canada is rising. Incidence increased four‐fold in the USA between 2003 and 2012 to 5.8 per 1000 hospital births, then rose further to 7.0 per 1000 hospital births in 2016 (<a href="./references#CD013217-bbs2-0061" title="CorrT , HollenbeakC . The economic burden of neonatal abstinence syndrome in the United States. Addiction2017;112(9):1590-9. [DOI: 10.1111/add.13842] [PMID: 28612362]">Corr 2017</a>; <a href="./references#CD013217-bbs2-0077" title="Healthcare Cost and Utilization Project. HCUP Fast Stats, 2019. hcup-us.ahrq.gov/news/announcements/faststats092019update.jsp (accessed prior to 1 December 2020).">HCUP 2019</a>; <a href="./references#CD013217-bbs2-0121" title="PatrickSW , DavisMM , LehmanCU , CooperWO . Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009–2012. Journal of Perinatology2015;35(8):650-5. [DOI: 10.1038/jp.2015.36] [PMID: 25927272]">Patrick 2015a</a>). Incidence of NAS in Canada rose 21% between 2013 and 2017 to 5.2 per 1000 hospital births (<a href="./references#CD013217-bbs2-0059" title="Canadian Institute for Health Information. Opioid-related harms in Canada, 2018. cihi.ca/sites/default/files/document/opioid-related-harms-report-2018-en-web.pdf (assessed prior to 1 December 2020).">CIHI 2018</a>). There is also regional variability within countries. In New South Wales, Australia, incidence of NAS was 3.18 per 1000 hospital births in 2011 (<a href="./references#CD013217-bbs2-0140" title="UebelH , WrightIM , BurnsL , HilderL , BajukB , BreenC , et al. Epidemiological evidence for a decreasing incidence of neonatal abstinence syndrome, 2000–11. Paediatric and Perinatal Epidemiology2016;30(3):267-73. [DOI: 10.1111/ppe.12282] [PMID: 26849178]">Uebel 2016</a>). Within the USA, there is a wide range in incidence of NAS, ranging from 0.7 to 33.4 per 1000 hospital births (<a href="./references#CD013217-bbs2-0089" title="KoJY , PatrickSW , TongVT , PatelR , LindJN , BarfieldWD . Incidence of neonatal abstinence syndrome – 28 states, 1999–2013. Morbidity and Mortality Weekly Report2016;65(31):799-802. [DOI: 10.15585/mmwr.mm6531a2] [PMID: 27513154]">Ko 2016</a>). In 23 USA hospitals, NAS affected a range from less than 1% to 18% of neonatal encounters (<a href="./references#CD013217-bbs2-0106" title="MillirenCE , GuptaM , GrahamDA , MelvinP , JorinaM , OzonoffA . Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use, and costs across pediatric hospitals in the United States, 2013 to 2016. Hospital Pediatrics2018;8(1):15-20. [DOI: 10.1542/hpeds.2017-0077] [PMID: 29263122]">Milliren 2018</a>). Genetic, socioeconomic, racial, and local factors including legislation, culture, and medical practices contribute to the variability (<a href="./references#CD013217-bbs2-0096" title="LiMD , BurmeisterM . New insights into the genetics of addiction. Nature Reviews. Genetics2009;10(4):225-31. [DOI: 10.1038/nrg2536] [PMID: 19238175]">Li 2009</a>). Substance use affects all socioeconomic and racial groups, but is disproportionately reported in women of color and low socioeconomic status (<a href="./references#CD013217-bbs2-0118" title="PaltrowLM , FlavinJ . Arrests of and forced interventions on pregnant women in the United States, 1973–2005: implications for women's legal status and public health. Journal of Health Politics, Policy and Law2013;38(2):299-343. [DOI: 10.1215/03616878-1966324] [PMID: 23262772]">Paltrow 2013</a>). Incidence of NAS is 14.4 per 1000 hospital births in the subgroup of low‐income USA infants with public insurance (<a href="./references#CD013217-bbs2-0146" title="WinkelmanT , VillapianoN , KozhimannilK , DavisM , PatrickS . Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004–2014. Pediatrics2018;141(4):e20173520. [DOI: 10.1542/peds.2017-3520] [PMID: 29572288]">Winkelman 2018</a>). Punitive state legislation policies are also associated with higher incidence of NAS (<a href="./references#CD013217-bbs2-0065" title="FahertyL , KranzA , Russell-FritchJ , PatrickS , CantorJ , SteinB . Association of punitive and reporting state policies related to substance use in pregnancy with rates of neonatal abstinence syndrome. JAMA Network Open2019;2(11):e1914078. [DOI: ﻿10.1001/jamanetworkopen.2019.14078] [PMID: 31722022]">Faherty 2019</a>). Under‐recognition and variable use of diagnostic codes may also affect the measured incidence of NAS (<a href="./references#CD013217-bbs2-0055" title="BurnsL , MattickRP . Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug and Alcohol Review2007;26(5):487-92. [DOI: 10.1080/09595230701494416] [PMID: 17701511]">Burns 2007</a>; <a href="./references#CD013217-bbs2-0069" title="GoyalS , SaundersKC , MooreCS , FilloK , KoJ , ManningS , et al. Identification of substance-exposed newborns and neonatal abstinence syndrome using ICD-10-CM – 15 Hospitals, Massachusetts, 2017. Morbidity and Mortality Weekly Report2020;69(29):951-5. [DOI: 10.15585/mmwr.mm6929a2] [PMID: 32701936]">Goyal 2020</a>). </p> <p>Care for infants with NAS in the neonatal period, and later in childhood, place demands on the medical system, social welfare system, educational system, and society at large. In 2013, infants with NAS occupied 4% of neonatal intensive care unit (NICU) beds in the USA, an increase from 0.6% in only nine years (<a href="./references#CD013217-bbs2-0138" title="ToliaVN , PatrickSW , BennettMM , MurthyK , SousaJ , SmithPB , et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. New England Journal of Medicine2015;372(22):2118-26. [DOI: 10.1056/NEJMsa1500439] [PMID: 25913111]">Tolia 2015</a>). Over 95% of these patients are withdrawing from prenatal exposure (<a href="./references#CD013217-bbs2-0120" title="PatrickSW , SchumacherRE , BenneyworthBD , KransEE , McAllisterJM , DavisMM . Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA2012;307(18):1934-40. [DOI: 10.1001/jama.2012.3951] [PMID: 22546608]">Patrick 2012</a>). Infants with NAS are at increased risk of morbidity or mortality in the neonatal period (<a href="./references#CD013217-bbs2-0099" title="LisonkovaS , RichterL , TingJ , MuracaG , MehrabadiA , Mitchell-FosterS , et al. Neonatal abstinence syndrome and associated neonatal and maternal mortality and morbidity. Pediatrics2019;144(2):e20183664. [DOI: ﻿10.1542/peds.2018-3664] [PMID: 31300529]">Lisonkova 2019</a>; <a href="./references#CD013217-bbs2-0120" title="PatrickSW , SchumacherRE , BenneyworthBD , KransEE , McAllisterJM , DavisMM . Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA2012;307(18):1934-40. [DOI: 10.1001/jama.2012.3951] [PMID: 22546608]">Patrick 2012</a>). Parental substance use is associated with increased child welfare involvement (<a href="./references#CD013217-bbs2-0112" title="O'DonnellM , NassarN , LeonardH , HaganR , MathewsR , PattersonY , et al. Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement. Pediatrics2009;123(4):e614-21. [DOI: ﻿10.1542/peds.2008-2888] [PMID: 19336352]">O'Donnell 2009</a>; <a href="./references#CD013217-bbs2-0123" title="PatrickSW , FrankRG , McNeerE , SteinBD . Improving the child welfare system to respond to the needs of substance-exposed infants. Hospital Pediatrics2019;9(8):651-4. [DOI: ﻿10.1542/hpeds.2019-0106] [PMID: 31300463]">Patrick 2019</a>). Later in childhood, children with a history of NAS have an increased risk of rehospitalization (<a href="./references#CD013217-bbs2-0139" title="UebelH , WrightIM , BurnsL , HilderL , BajukB , BreenC , et al. Reasons for rehospitalization in children who had neonatal abstinence syndrome. Pediatrics2015;136(4):e811-20. [DOI: ﻿10.1542/peds.2014-2767] [PMID: 26371197]">Uebel 2015</a>). Non‐randomized studies demonstrate poorer cognitive and behavioral outcomes through childhood and into high school (<a href="./references#CD013217-bbs2-0094" title="LeeS , BoraS , AustinN , WestermanA , HerndersonJ . Neurodevelopmental outcomes of children born to opioid-dependent mothers: a systematic review and meta-analysis. Academic Pediatrics2020;20(3):308-18. [DOI: ﻿10.1016/j.acap.2019.11.005] [PMID: 31734383]">Lee 2020</a>; <a href="./references#CD013217-bbs2-0147" title="YeohSL , EastwoodJ , WrightIM , MortonR , MelhuishE , WardM , et al. Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis. JAMA Network Open2019;2(7):e197025. [DOI: ﻿10.1001/jamanetworkopen.2019.7025] [PMID: 31298718]">Yeoh 2019</a>). Importantly, many of these associations are based on non‐randomized studies with both recognized and unrecognized complex confounding factors (<a href="./references#CD013217-bbs2-0093" title="LarsonJ , GrahamD , SingerL , BeckwithA , TerplanM , DavisJ , et al. Cognitive and behavioral impact on children exposed to opioids during pregnancy. Pediatrics2019;144(2):e20190514. [DOI: ﻿10.1542/peds.2019-0514] [PMID: 31320466 ]">Larson 2019</a>). Further study is needed to distinguish causation related to opioid exposure versus other social, environmental, or biological factors. </p> <section id="CD013217-sec-0010"> <h3 class="title" id="CD013217-sec-0010">Description of the condition</h3> <p>The contemporary definition of NAS is broad, and includes symptoms associated with prenatal exposure to many substances, both prescribed and non‐prescribed. Symptoms related to withdrawal from opioids, such as methadone, buprenorphine, heroin, oxycodone, and other prescribed and non‐prescribed opioids, may also be described as NOWS. Opioid withdrawal is a unique subset of NAS characterized by common symptomatology and is more likely to respond to postnatal treatment with opioids (<a href="./references#CD013217-bbs2-0080" title="HudakM , TanR , Committee on Drugs, Committee on Fetus and Newborn, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics2012;129(2):e540-60. [DOI: 10.1542/peds.2011-3212] [PMID: 22291123]">Hudak 2012</a>). Polysubstance use is common among opioid users and is associated with more severe NAS (<a href="./references#CD013217-bbs2-0142" title="WachmanEM , WardenAH , ThomasZ , Thomas-LewisJA , ShresthaH , NikitaFN , et al. Impact of psychiatric medication co-exposure on neonatal abstinence syndrome severity. Drug and Alcohol Dependence2018;192:45-50. [DOI: ﻿10.1016/j.drugalcdep.2018.07.024] [PMID: ﻿30205307]">Wachman 2018a</a>). Non‐opioid substance exposures may be associated with NAS due to ongoing toxic effects of exposure (e.g. cocaine) or due to withdrawal following birth (e.g. benzodiazepines). Substances associated with NAS include benzodiazepines, selective serotonin reuptake inhibitors (SSRIs), and tobacco, among other substances. While exposure may occur in isolation or in combination with other substances, most documented NAS is at least partly due to opioids (<a href="./references#CD013217-bbs2-0080" title="HudakM , TanR , Committee on Drugs, Committee on Fetus and Newborn, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics2012;129(2):e540-60. [DOI: 10.1542/peds.2011-3212] [PMID: 22291123]">Hudak 2012</a>). </p> <p>Infants express varied signs of withdrawal from opioids and other substances following birth. Symptoms are those of dysregulated autonomic, gastrointestinal, and central nervous systems. The most severe manifestations of withdrawal may include seizures, which are likely rare, and severe weight loss. Symptoms of opioid withdrawal peak in the first week of life due to cessation of opioid transfer through the placenta. Infants need medical monitoring and treatment during this period. Symptoms are more severe with maternal methadone maintenance, smoking, and polysubstance exposure (<a href="./references#CD013217-bbs2-0054" title="BroglyS , SaiaK , WalleyA , DuH , SebastianiP . Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis. American Journal of Epidemiology2014;180(7):673-86. [DOI: 10.1093/aje/kwu190] [PMID: 25150272]">Brogly 2014</a>; <a href="./references#CD013217-bbs2-0122" title="PatrickSW , DudleyJ , MartinPR , HarrellFE , WarrenMD , HartmannKE , et al. Prescription opioid epidemic and infant outcomes. Pediatrics2015;135(5):842-50. [DOI: 10.1542/peds.2014-3299] [PMID: 25869370]">Patrick 2015b</a>; <a href="./references#CD013217-bbs2-0142" title="WachmanEM , WardenAH , ThomasZ , Thomas-LewisJA , ShresthaH , NikitaFN , et al. Impact of psychiatric medication co-exposure on neonatal abstinence syndrome severity. Drug and Alcohol Dependence2018;192:45-50. [DOI: ﻿10.1016/j.drugalcdep.2018.07.024] [PMID: ﻿30205307]">Wachman 2018a</a>). Symptoms are less severe in preterm infants; this may be related to a different physiologic response to opioids or a different manifestation of withdrawal in the preterm population (<a href="./references#CD013217-bbs2-0095" title="LemonL , NaimiA , CaritisS , PlattR , VenkataramananR , BodnarL . The role of preterm birth in the association between opioid maintenance therapy and neonatal abstinence syndrome. Paediatric and Perinatal Epidemiology2018;32(2):213-22. [DOI: 10.1111/ppe.12443] [PMID: 29372750]">Lemon 2018</a>). </p> <p>The American Academy of Pediatrics recommends standardized assessment of symptom severity (<a href="./references#CD013217-bbs2-0080" title="HudakM , TanR , Committee on Drugs, Committee on Fetus and Newborn, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics2012;129(2):e540-60. [DOI: 10.1542/peds.2011-3212] [PMID: 22291123]">Hudak 2012</a>). Published standardized withdrawal assessment tools include the Finnegan Neonatal Abstinence Scoring Tool (score range 0 to 62) (<a href="./references#CD013217-bbs2-0067" title="FinneganLP , Connaughton JF Jr, KronRE , EmichJP . Neonatal abstinence syndrome: assessment and management. Addictive Diseases1975;2(1-2):141-58. [PMID: 1163358]">Finnegan 1975</a>), Lipsitz Neonatal Drug Withdrawal Scoring System (score range 0 to 20) (<a href="./references#CD013217-bbs2-0098" title="LipsitzPJ . A proposed narcotic withdrawal score for use with newborn infants: a pragmatic evaluation of its efficacy. Clinical Pediatrics1975;14(6):592-4. [DOI: 10.1177/000992287501400613] [PMID: 1126108]">Lipsitz 1975</a>), Neonatal Narcotic Withdrawal Index (score range 0 to 14) (<a href="./references#CD013217-bbs2-0074" title="GreenM , SuffetF . The Neonatal Narcotic Withdrawal Index: a device for the improvement of care in the abstinence syndrome. American Journal of Drug and Alcohol Abuse1981;8(2):203-13. [DOI: 10.3109/00952998108999125] [PMID: 7331976]">Green 1981</a>), Neonatal Withdrawal Inventory (score range 0 to 19) (<a href="./references#CD013217-bbs2-0148" title="ZahorodnyW , RomC , WhitneyW , GiddensS , SamuelM , MaichukG , et al. The neonatal withdrawal inventory: a simplified score of newborn withdrawal. Journal of Developmental and Behavioral Pediatrics1998;19(2):89-93. [DOI: 1097/00004703-199804000-00005] [PMID: 9584937]">Zahorodny 1998</a>), and Maternal Opioid Treatment: Human Experimental Research (MOTHER) NAS scale (score range 0 to 42) (<a href="./references#CD013217-bbs2-0083" title="JonesHE , KaltenbackK , HeilSH , StineS , CoyleM , ArriaA , et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine2010;363(24):2320-31. [DOI: 10.1056/NEJMoa1005359] [PMID: 21142534]">Jones 2010</a>). Several recent efforts have been made to simplify scoring. Examples include Finnegan Neonatal Abstinence Syndrome Scale – Short Form (score range 0 to 16) (<a href="./references#CD013217-bbs2-0102" title="MaguireD , ClineGJ , ParnellL , Tai C-Y. Validation of the Finnegan neonatal abstinence syndrome tool – short form. Advances in Neonatal Care2013;13(6):430-7. [DOI: 10.1097/ANC.0000000000000033] [PMID: 24300963]">Maguire 2013</a>), MOTHER NAS Short Form (score range not reported) (<a href="./references#CD013217-bbs2-0084" title="JonesHE , SeashoreC , JohnsonE , HortonE , O'GradyKE , AndringaK . Measurement of neonatal abstinence syndrome: evaluation of short forms. Journal of Opioid Management2016;12(1):19-23. [DOI: 10.5055/jom.2016.0308] [PMID: 26908300]">Jones 2016a</a>), simplified Finnegan Neonatal Abstinence Scoring System (score range 0 to 23) (<a href="./references#CD013217-bbs2-0068" title="Gomez PomarE , FinneganLP , DevlinL , BadaH , ConcinaVA , IboniaKT , et al. Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA. BMJ Open2017;7(9):e016176. [DOI: ﻿10.1136/bmjopen-2017-016176] [PMID: 28963285]">Gomez Pomar 2017</a>), a new scoring system for NAS (score range 0 to 27) (<a href="./references#CD013217-bbs2-0090" title="KocherlakotaP , QianE , PatelVC , MandruC , VilarRE , AlpanG , et al. A new scoring system for the assessment of neonatal abstinence syndrome. American Journal of Perinatology2020;37(3):333-40. [DOI: ﻿10.1055/s-0039-3400310] [PMID: 31777045]">Kocherlakota 2020</a>), and the eight‐item simplified Finnegan Neonatal Abstinence Scoring System (score range 0 to 8) (<a href="./references#CD013217-bbs2-0064" title="DevlinL , BreezeJ , TerrinN , Gomez PomarE , BadaH , FinneganLP , et al. Association of a simplified Finnegan Neonatal Abstinence Scoring Tool with the need for pharmacologic treatment for neonatal abstinence syndrome. JAMA Network Open2020;3(4):e202275. [DOI: ﻿10.1001/jamanetworkopen.2020.2275] [PMID: 32267513]">Devlin 2020</a>). Each tool assesses a combination of symptoms of opioid or non‐opioid withdrawal; however, most tools were designed in a time when single drug use was common, primarily heroin. Most hospitals use a version of the Finnegan Neonatal Abstinence Scoring Tool (<a href="./references#CD013217-bbs2-0105" title="MehtaA , ForbesK , KuppalaV . Neonatal abstinence syndrome management from prenatal counseling to postdischarge follow-up care: results of a national survey. Hospital Pediatrics2013;3(4):317-23. [DOI: 10.1542/hpeds.2012-0079] [PMID: 24435188]">Mehta 2013</a>; <a href="./references#CD013217-bbs2-0128" title="SarkarS , DonnSM . Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. Journal of Perinatology2006;26(1):15-7. [DOI: 10.1038/sj.jp.7211427] [PMID: 16355103]">Sarkar 2006</a>; <a href="./references#CD013217-bbs2-0134" title="SnowdenJN , AkshathaA , AnnettRD , CrawfordMM , DasA , DevlinLA , et al. The ACT NOW clinical practice survey: gaps in the care of infants with neonatal opioid withdrawal syndrome. Hospital Pediatrics2019;9(8):585-92. [DOI: ﻿10.1542/hpeds.2019-0089] [PMID: 31324654]">Snowden 2019</a>); however, the pharmacological treatment threshold is not validated and the tool has poor psychometric properties and poor internal consistency (<a href="./references#CD013217-bbs2-0085" title="JonesH , SeashoreC , JohnsonE , HortonE , O'GradyK , AndringaK , et al. Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale. American Journal on Addictions2016;25(5):370-3. [DOI: 10.1111/ajad.12388] [PMID: 27287965]">Jones 2016b</a>). Newer approaches in the USA shift from reliance on a threshold score to initiate pharmacological treatment to an approach based on a care pathway. One example focuses on early modulation of symptoms with a standard non‐pharmacological care bundle including family involvement and a more nuanced evaluation of critical functional symptoms including the infant's ability to eat, sleep, and be consoled (<a href="./references#CD013217-bbs2-0075" title="GrossmanM , LipshawM , OsbornR , BerkwittA . A novel approach to assessing infants with neonatal abstinence syndrome. Hospital Pediatrics2018;8(1):1-6. [DOI: 10.1542/hpeds.2017-0128] [PMID: 29263121]">Grossman 2018</a>; <a href="./references#CD013217-bbs2-0143" title="WachmanEM , GrossmanM , SchiffDM , PhilippBL , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: 10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018b</a>). </p> <p>The first‐line treatment for NAS is non‐pharmacological care (<a href="./references#CD013217-bbs2-0080" title="HudakM , TanR , Committee on Drugs, Committee on Fetus and Newborn, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics2012;129(2):e540-60. [DOI: 10.1542/peds.2011-3212] [PMID: 22291123]">Hudak 2012</a>; <a href="./references#CD013217-bbs2-0103" title="MangatAK , SchmolzerGM , KraftWK . Pharmacological and non-pharmacological treatments for the neonatal abstinence syndrome (NAS). Seminars in Fetal and Neonatal Medicine2019;24(2):133-41. [DOI: ﻿10.1016/j.siny.2019.01.009] [PMID: 30745219]">Mangat 2019</a>). Severe symptoms despite maximal non‐pharmacological treatment mark a threshold for pharmacological treatment. Though norms exist, scores are often subjective, and treatment thresholds established based on historical norms are not validated. Pharmacological treatments that reduce withdrawal symptoms include opioid or sedative medications, or both. Morphine is the most common opioid treatment; methadone and buprenorphine are also used (<a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>; <a href="./references#CD013217-bbs2-0134" title="SnowdenJN , AkshathaA , AnnettRD , CrawfordMM , DasA , DevlinLA , et al. The ACT NOW clinical practice survey: gaps in the care of infants with neonatal opioid withdrawal syndrome. Hospital Pediatrics2019;9(8):585-92. [DOI: ﻿10.1542/hpeds.2019-0089] [PMID: 31324654]">Snowden 2019</a>). Adjunctive therapies may include phenobarbital and clonidine to address polysubstance exposure. Long‐term developmental impact of pharmacological treatment is unclear. Immediate adverse effects of pharmacological treatment include respiratory depression and sedation. Most hospitals care for infants receiving sedating medications on a cardiac monitor in the intensive care unit (ICU) (<a href="./references#CD013217-bbs2-0106" title="MillirenCE , GuptaM , GrahamDA , MelvinP , JorinaM , OzonoffA . Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use, and costs across pediatric hospitals in the United States, 2013 to 2016. Hospital Pediatrics2018;8(1):15-20. [DOI: 10.1542/hpeds.2017-0077] [PMID: 29263122]">Milliren 2018</a>). Unfortunately, ICU care separates infants from caregivers and often is a high stimulus environment. This interferes with bonding, caregiver self‐efficacy, and full non‐pharmacological treatment, potentially affecting severity of NAS symptoms. </p> <p>The approach to care for infants with NAS has wide variation (<a href="./references#CD013217-bbs2-0051" title="BogenD , WhalenB , KairL , ViningM , KingB . Wide variation found in care of opioid-exposed newborns. Academic Pediatrics2017;17(4):374-80. [DOI: 10.1016/j.acap.2016.10.003] [PMID: 27889436]">Bogen 2017</a>; <a href="./references#CD013217-bbs2-0105" title="MehtaA , ForbesK , KuppalaV . Neonatal abstinence syndrome management from prenatal counseling to postdischarge follow-up care: results of a national survey. Hospital Pediatrics2013;3(4):317-23. [DOI: 10.1542/hpeds.2012-0079] [PMID: 24435188]">Mehta 2013</a>; <a href="./references#CD013217-bbs2-0113" title="O'GradyMJ , HopewellJ , WhiteMJ . Management of neonatal abstinence syndrome: a national survey and review of practice. Archives of Disease in Childhood. Fetal and Neonatal Edition2009;94(4):F249-52. [DOI: 10.1136/adc.2008.152769] [PMID: 19174414]">O'Grady 2009</a>; <a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>; <a href="./references#CD013217-bbs2-0128" title="SarkarS , DonnSM . Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. Journal of Perinatology2006;26(1):15-7. [DOI: 10.1038/sj.jp.7211427] [PMID: 16355103]">Sarkar 2006</a>; <a href="./references#CD013217-bbs2-0134" title="SnowdenJN , AkshathaA , AnnettRD , CrawfordMM , DasA , DevlinLA , et al. The ACT NOW clinical practice survey: gaps in the care of infants with neonatal opioid withdrawal syndrome. Hospital Pediatrics2019;9(8):585-92. [DOI: ﻿10.1542/hpeds.2019-0089] [PMID: 31324654]">Snowden 2019</a>). Surveys show differences in prenatal counseling, written policies, staff training, threshold for pharmacological treatment, weaning protocols, breastfeeding support, and location of care, among other aspects of care (<a href="./references#CD013217-bbs2-0051" title="BogenD , WhalenB , KairL , ViningM , KingB . Wide variation found in care of opioid-exposed newborns. Academic Pediatrics2017;17(4):374-80. [DOI: 10.1016/j.acap.2016.10.003] [PMID: 27889436]">Bogen 2017</a>; <a href="./references#CD013217-bbs2-0105" title="MehtaA , ForbesK , KuppalaV . Neonatal abstinence syndrome management from prenatal counseling to postdischarge follow-up care: results of a national survey. Hospital Pediatrics2013;3(4):317-23. [DOI: 10.1542/hpeds.2012-0079] [PMID: 24435188]">Mehta 2013</a>; <a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>; <a href="./references#CD013217-bbs2-0134" title="SnowdenJN , AkshathaA , AnnettRD , CrawfordMM , DasA , DevlinLA , et al. The ACT NOW clinical practice survey: gaps in the care of infants with neonatal opioid withdrawal syndrome. Hospital Pediatrics2019;9(8):585-92. [DOI: ﻿10.1542/hpeds.2019-0089] [PMID: 31324654]">Snowden 2019</a>). Most hospitals use a standardized withdrawal assessment tool; however, hospitals have differing treatment protocols. Almost half lack a written policy for management of opioid‐exposed newborns (<a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>; <a href="./references#CD013217-bbs2-0128" title="SarkarS , DonnSM . Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. Journal of Perinatology2006;26(1):15-7. [DOI: 10.1038/sj.jp.7211427] [PMID: 16355103]">Sarkar 2006</a>). There is no clear standard for non‐pharmacological care or pharmacological treatment thresholds (<a href="./references#CD013217-bbs2-0105" title="MehtaA , ForbesK , KuppalaV . Neonatal abstinence syndrome management from prenatal counseling to postdischarge follow-up care: results of a national survey. Hospital Pediatrics2013;3(4):317-23. [DOI: 10.1542/hpeds.2012-0079] [PMID: 24435188]">Mehta 2013</a>). Non‐pharmacological treatment and pharmacological treatment thresholds are not well studied and likely vary between centers. Most importantly, efforts to standardize hospital policies are associated with improved outcomes (<a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>). </p> <p>Outcomes such as pharmacological treatment rate and length of hospital stay also vary widely. The percent of infants who receive pharmacological therapy ranges from 13% to 90% (<a href="./references#CD013217-bbs2-0106" title="MillirenCE , GuptaM , GrahamDA , MelvinP , JorinaM , OzonoffA . Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use, and costs across pediatric hospitals in the United States, 2013 to 2016. Hospital Pediatrics2018;8(1):15-20. [DOI: 10.1542/hpeds.2017-0077] [PMID: 29263122]">Milliren 2018</a>). The mean length of stay at some centers in the USA is as low as 5.9 days, while the national mean is 16.9 days (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0121" title="PatrickSW , DavisMM , LehmanCU , CooperWO . Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009–2012. Journal of Perinatology2015;35(8):650-5. [DOI: 10.1038/jp.2015.36] [PMID: 25927272]">Patrick 2015a</a>). </p> <p>Variations in diagnosis and management of NAS represent an important opportunity to improve care. Multicenter quality improvement collaboratives in the USA show that increased standardization of care can reduce length of hospital stay (<a href="./references#CD013217-bbs2-0076" title="HallE , WexelblattS , CrowleyM , GrowJ , JasinL , KlebanoffM , et al, OCHNAS Consortium. Implementation of a neonatal abstinence syndrome weaning protocol: a multicenter cohort study. Pediatrics2015;136(4):e803. [DOI: 10.1542/peds.2015-1141] [PMID: 26371196]">Hall 2015</a>; <a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>). Emerging evidence suggests that standardization of non‐pharmacological care also reduces length of hospital stay and use of pharmacological treatment (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0143" title="WachmanEM , GrossmanM , SchiffDM , PhilippBL , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: 10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018b</a>). </p> </section> <section id="CD013217-sec-0011"> <h3 class="title" id="CD013217-sec-0011">Description of the intervention</h3> <p>Non‐pharmacological treatments focus on minimizing dysregulation and maximizing infant functioning. Treatments are heterogeneous interventions within three main categories of care: </p> <p> <ol id="CD013217-list-0001"> <li> <p>modifying environmental stimulation;</p> </li> <li> <p>feeding practices; and</p> </li> <li> <p>support of the mother‐infant dyad.</p> </li> </ol> </p> <p>Interventions may occur alone, or in combination with other non‐pharmacological and pharmacological treatments. The 'dose' of non‐pharmacological intervention is difficult to assess, and may be related to timing, intensity, quality, consistency, and adequacy of interventions among other features. </p> <section id="CD013217-sec-0012"> <h4 class="title">Modifying environmental stimulation</h4> <p>Treatments addressing environmental stimulation reduce negative stimuli and promote positive experiences. Gentle handling and maintaining a low‐light, quiet environment reduce negative stimulation. Infant containment or swaddling, bedding choice including vibrating beds, and infant positioning may also soothe infants. Positive experiences may include non‐nutritive sucking and bathing. Aromatherapy, music therapy, massage, and acupuncture/acupressure are therapies that may also calm infants through stimulation. </p> </section> <section id="CD013217-sec-0013"> <h4 class="title">Feeding practices</h4> <p>Disorganized feeding and weight loss are common in infants withdrawing from opioids. In general, breast milk and breastfeeding reduce withdrawal symptoms (<a href="./references#CD013217-bbs2-0081" title="Academy of Breastfeeding Medicine Protocol Committee, JanssonLM . ABM clinical protocol #21: guidelines for breastfeeding and the drug-dependent woman. Breastfeeding Medicine2009;4(4):225-8. [DOI: 10.1089/bfm.2009.9987] [PMID: 19835481]">Jansson 2009</a>). Small, frequent feedings and infant‐led feeding are often helpful in improving the transfer of food. Higher‐calorie feedings or tube feedings may reduce weight loss and improve satiety in these infants. Non‐maternal or maternal breast milk or low‐lactose formula may reduce gas and feeding discomfort. </p> </section> <section id="CD013217-sec-0014"> <h4 class="title">Support of the mother‐infant dyad</h4> <p>Treatments also address the health and support of the mother‐infant dyad as a unit (<a href="./references#CD013217-bbs2-0091" title="KransEE , CampopianoM , ClevelandLM , GoodmanD , KildayD , KendigS , et al. National partnership for maternal safety: consensus bundle on obstetric care for women with opioid use disorder. Obstetrics and Gynecology2019;134(2):365-75. [DOI: 10.1097/AOG.0000000000003381] [PMID: 31306323]">Krans 2019</a>; <a href="./references#CD013217-bbs2-0141" title="VelezM , JanssonLM . The opioid dependent mother and newborn dyad: non-pharmacologic care. Journal of Addiction Medicine2008;2(3):113-20. [DOI: 10.1097/ADM.0b013e31817e6105] [PMID: 19727440]">Velez 2009</a>). Parental presence alone is an important aspect of non‐pharmacological care (<a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a>). Rooming in (where the baby's crib is kept by the side of the mother's bed) and skin‐to‐skin care promote mother‐infant bonding and infant regulation. Direct parental support promotes parental well‐being. Well caregivers are better able to recognize and respond to infant cues. Parental supports enhance comfort and plan for respite. Examples include 'cuddler' programs (where cuddling the baby is maximized) and designated spaces in the hospital to promote parent comfort. Staff contribute to parental well‐being by using trauma‐informed care principles. A comprehensive biopsychosocial needs assessment may also improve parental well‐being and prompt referral for comprehensive integrated care (<a href="./references#CD013217-bbs2-0091" title="KransEE , CampopianoM , ClevelandLM , GoodmanD , KildayD , KendigS , et al. National partnership for maternal safety: consensus bundle on obstetric care for women with opioid use disorder. Obstetrics and Gynecology2019;134(2):365-75. [DOI: 10.1097/AOG.0000000000003381] [PMID: 31306323]">Krans 2019</a>). Needs may include addiction, social, mental health, legal, and custody supports. </p> </section> </section> <section id="CD013217-sec-0015"> <h3 class="title" id="CD013217-sec-0015">How the intervention might work</h3> <p>Many non‐pharmacological practices improve autonomic regulation for infants and could mitigate the autonomic dysregulation noted in infants with NAS. </p> <p>Environmental changes and feeding practices, individually and in combination, can affect physiologic parameters in infants. Facilitated tucking by holding the infant in a gently flexed position lowers stress‐related behaviors and vital sign changes in infants (<a href="./references#CD013217-bbs2-0097" title="LiawJ , YangL , WangK , ChenC , ChangY , YinT . Non-nutritive sucking and facilitated tucking relieve preterm infant pain during heel-stick procedures: a prospective, randomised controlled crossover trial. International Journal of Nursing Studies2012;49(3):300-9. [DOI: 10.1016/j.ijnurstu.2011.09.017] [PMID: 22001561]">Liaw 2012</a>). Human touch through massage improves weight gain, growth, and sleep in infants (<a href="./references#CD013217-bbs2-0086" title="JuneauA , AitaM , HeonM . Review and critical analysis of massage studies for term and preterm infants. Neonatal Network2015;34(3):165-77. [DOI: 10.1891/0730-0832.34.3.165] [PMID: 26802392]">Juneau 2015</a>). Non‐nutritive sucking and acupressure are associated with reduced infant pain response (<a href="./references#CD013217-bbs2-0058" title="ChenK , LindreaK , Quah-SmithI , DalyM , SchindlerT , OeiJ . Magnetic noninvasive acupuncture for infant comfort (MAGNIFIC) – a single-blinded randomised controlled pilot trial. Acta Paediatrica2017;106(11):1780-6. [DOI: 10.1111/apa.14002] [PMID: 28741805]">Chen 2017</a>; <a href="./references#CD013217-bbs2-0124" title="PinelliJ , SymingtonA , CiliskaD . Nonnutritive sucking in high-risk infants: benign intervention or legitimate therapy?Journal of Obstetric, Gynecologic, and Neonatal Nursing2002;31(5):582-91. [DOI: 10.1111/j.1552-6909.2002.tb00084.x] [PMID: 12353738]">Pinelli 2002</a>). Breastfeeding and breast milk odor are each associated with reduced infant pain response (<a href="./references#CD013217-bbs2-0056" title="CarbajalR , VeerapenS , CoudercS , JugieM , VilleY . Analgesic effect of breast feeding in term neonates: randomised controlled trial. BMJ (Clinical Research Ed.)2003;326(7379):13. [DOI: 10.1136/bmj.326.7379.13] [PMID: 12511452]">Carbajal 2003</a>; <a href="./references#CD013217-bbs2-0073" title="GrayL , MillerL , PhilippB , BlassE . Breastfeeding is analgesic in healthy newborns. Pediatrics2002;109(4):590-3. [DOI: 10.1542/peds.109.4.590] [PMID: 11927701]">Gray 2002</a>; <a href="./references#CD013217-bbs2-0149" title="ZhangS , SuF , LiJ , ChenW . The analgesic effects of maternal milk odor on newborns: a meta-analysis. Breastfeeding Medicine2018;13(5):327-34. [DOI: 10.1089/bfm.2017.0226] [PMID: 29733222]">Zhang 2018</a>). Breastfeeding, especially combined with maternal holding, is associated with widespread cortical activity distinct from that of glucose exposure alone (<a href="./references#CD013217-bbs2-0050" title="BembichS , ContG , CausinE , PaviottiG , MarzariP , DemariniS . Infant analgesia with a combination of breast milk, glucose, or maternal holding. Pediatrics2018;142(3):e20173416. [DOI: 10.1542/peds.2017-3416] [PMID: 30166366]">Bembich 2018</a>). </p> <p>Maternal interaction and presence have many unique benefits for the infant, likely related to complex and multifactorial sensory stimuli involved in interactions within the mother‐infant dyad. Skin‐to‐skin contact between caregiver and infant (also termed 'kangaroo care') is associated with a reduced infant pain response (<a href="./references#CD013217-bbs2-0072" title="GrayL , Watt L Blass E. Skin-to-skin contact is analgesic in healthy newborns. Pediatrics2000;105(1):e14. [DOI: 10.1542/peds.105.1.e14] [PMID: 10617751]">Gray 2000</a>; <a href="./references#CD013217-bbs2-0082" title="JohnstonC , Campbell-YeoM , DisherT , BenoitB , FernandesA , StreinerD , et al. Skin-to-skin care for procedural pain in neonates. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: CD008435. [DOI: 10.1002/14651858.CD008435.pub3]">Johnston 2017</a>; <a href="./references#CD013217-bbs2-0119" title="PanditaA , PanghalA , GuptaG , VermaA , PillaiA , SinghA , et al. Is kangaroo mother care effective in alleviating vaccination associated pain in early infantile period? A RCT. Early Human Development2018;127:69-73. [DOI: 10.1016/j.earlhumdev.2018.10.001] [PMID: 30321774]">Pandita 2018</a>; <a href="./references#CD013217-bbs2-0131" title="ShahPS , HerbozoC , AliwalasLL , ShahVS . Breastfeeding or breast milk for procedural pain in neonates. Cochrane Database of Systematic Reviews2012, Issue 12. Art. No: CD004950. [DOI: 10.1002/14651858.CD004950.pub3]">Shah 2012</a>). Mother's presence and tactile contact improve visual attention in term infants (<a href="./references#CD013217-bbs2-0048" title="ArditiH , FeldmanR , EidelmanA . Effects of human contact and vagal regulation on pain reactivity and visual attention in newborns. Developmental Psychobiology2006;48(7):561-73. [DOI: 10.1002/dev.20150] [PMID: 17016840]">Arditi 2006</a>). Maternal well‐being and functioning appear to affect infant regulation. Sensitive maternal caregiving as measured by the Emotional Availability Scales is associated with lower infant cortisol and improved infant regulation (<a href="./references#CD013217-bbs2-0087" title="KaplanL , EvansL , MonkC . Effects of mothers' prenatal psychiatric status and postnatal caregiving on infant biobehavioral regulation: can prenatal programming be modified?Early Human Development2008;84(4):249-56. [DOI: 10.1016/j.earlhumdev.2007.06.004] [PMID: 17761394]">Kaplan 2008</a>). Relationships between parents, specifically the levels of avoidance and dyadic adjustment, are associated with infant vagal tone (<a href="./references#CD013217-bbs2-0071" title="GrahamA , AblowJ , MeaselleJ . Interparental relationship dynamics and cardiac vagal functioning in infancy. Infant Behavior &amp; Development2010;33(4):530-44. [DOI: 10.1016/j.infbeh.2010.07.005] [PMID: 20727595]">Graham 2010</a>). </p> <p>This literature suggests that non‐pharmacological measures affect autonomic functioning and are likely to attenuate withdrawal symptoms due to dysregulation in NAS. </p> </section> <section id="CD013217-sec-0016"> <h3 class="title" id="CD013217-sec-0016">Why it is important to do this review</h3> <p>Other Cochrane Reviews address the evidence for, and comparative effectiveness of, pharmacological treatments including opiates, sedatives, and naloxone treatments for opioid‐exposed newborns (<a href="./references#CD013217-bbs2-0107" title="Moe-ByrneT , BrownJ , McGuireW . Naloxone for opioid-exposed newborn infants. Cochrane Database of Systematic Reviews2018, Issue 10. Art. No: CD003483. [DOI: 10.1002/14651858.CD003483.pub3]">Moe‐Byrne 2018</a>; <a href="./references#CD013217-bbs2-0115" title="OsbornD , JefferyH , ColeM . Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database of Systematic Reviews2010, Issue 10. Art. No: CD002059. [DOI: 10.1002/14651858.CD002059.pub3]">Osborn 2010a</a>; <a href="./references#CD013217-bbs2-0116" title="OsbornD , JefferyH , ColeM . Sedatives for opiate withdrawal in newborn infants. Cochrane Database of Systematic Reviews2010, Issue 10. Art. No: CD002053. [DOI: 10.1002/14651858.CD002053.pub3]">Osborn 2010b</a>). The reviews conclude that initial pharmacological treatment of neonatal opioid withdrawal should be an opiate. Opiates reduce the time to regain birth weight but increase the length of hospital stay. Adding a sedative may further reduce symptoms. Given the methodologic limitations of the included studies, further firm recommendations are not made. </p> <p>Non‐pharmacological interventions are not assessed or controlled in most studies focused on pharmacological treatments for NAS. The use and 'dose' of non‐pharmacological care may be an important confounder in these studies. Standardized non‐pharmacological care may improve care outcomes (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0143" title="WachmanEM , GrossmanM , SchiffDM , PhilippBL , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: 10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018b</a>). Evidence for non‐pharmacological interventions will guide future efforts to improve care. This review evaluated the current literature and gaps in research regarding non‐pharmacological care. Acupuncture and acupressure will be addressed in a separate Cochrane Review, and was not included in this review. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013217-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013217-sec-0017"></div> <p>To evaluate the safety and efficacy of non‐pharmacological treatment of infants at risk for, or having symptoms consistent with, opioid withdrawal on the length of hospitalization and use of pharmacological treatment for symptom management. </p> <p><b>Comparison 1:</b> in infants at risk for, or having early symptoms consistent with, opioid withdrawal, does non‐pharmacological treatment reduce the length of hospitalization and use of pharmacological treatment? </p> <p><b>Comparison 2:</b> in infants receiving pharmacological treatment for symptoms consistent with opioid withdrawal, does concurrent non‐pharmacological treatment reduce duration of pharmacological treatment, maximum and cumulative doses of opioid medication, and length of hospitalization? </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013217-sec-0018" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013217-sec-0018"></div> <section id="CD013217-sec-0019"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013217-sec-0020"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs), quasi‐RCTs, and cluster trials in our formal analysis (see <a href="#CD013217-sec-0039">Selection of studies</a>). We excluded cross‐over trials. </p> </section> <section id="CD013217-sec-0021"> <h4 class="title">Types of participants</h4> <section id="CD013217-sec-0022"> <h5 class="title">Inclusion criteria</h5> <section id="CD013217-sec-0023"> <h6 class="title">Comparison 1</h6> <p>Term (37 weeks' gestation or greater) and late preterm infants (34 weeks' gestation to 37 weeks' gestation) with known or suspected prenatal opioid exposure or having opioid withdrawal in the first seven days of life. </p> </section> <section id="CD013217-sec-0024"> <h6 class="title">Comparison 2</h6> <p>Term (37 weeks' gestation or greater) and late preterm infants (34 weeks' gestation to 37 weeks' gestation) on opioid treatment for opioid withdrawal in the first 28 days of life. </p> <p>Opioid withdrawal may have been defined by the presence of symptoms consistent with opioid withdrawal or an elevated score on a standardized withdrawal assessment tool. </p> <p>Symptoms consistent with opioid withdrawal are those of dysregulated autonomic, gastrointestinal, and central nervous systems. Symptoms included, but were not limited to: increased crying, irritability, inability to sleep, tremors, increased tone, myoclonic jerks, fever, sweating, rapid breathing, labored breathing, sneezing, yawning, unco‐ordinated feeding, excessive sucking, vomiting, loose stools, and excessive weight loss. </p> <p>Scores are often used to quantify the symptoms and provide information to guide pharmacological treatment. Elevated scores on standardized withdrawal assessment tools include Finnegan Neonatal Abstinence Scoring Tool score above 8 (<a href="./references#CD013217-bbs2-0067" title="FinneganLP , Connaughton JF Jr, KronRE , EmichJP . Neonatal abstinence syndrome: assessment and management. Addictive Diseases1975;2(1-2):141-58. [PMID: 1163358]">Finnegan 1975</a>), Lipsitz Neonatal Drug Withdrawal Scoring System score above 4 (<a href="./references#CD013217-bbs2-0098" title="LipsitzPJ . A proposed narcotic withdrawal score for use with newborn infants: a pragmatic evaluation of its efficacy. Clinical Pediatrics1975;14(6):592-4. [DOI: 10.1177/000992287501400613] [PMID: 1126108]">Lipsitz 1975</a>), Neonatal Narcotic Withdrawal Index score above 5 (<a href="./references#CD013217-bbs2-0074" title="GreenM , SuffetF . The Neonatal Narcotic Withdrawal Index: a device for the improvement of care in the abstinence syndrome. American Journal of Drug and Alcohol Abuse1981;8(2):203-13. [DOI: 10.3109/00952998108999125] [PMID: 7331976]">Green 1981</a>), Neonatal Withdrawal Inventory score above 8 (<a href="./references#CD013217-bbs2-0148" title="ZahorodnyW , RomC , WhitneyW , GiddensS , SamuelM , MaichukG , et al. The neonatal withdrawal inventory: a simplified score of newborn withdrawal. Journal of Developmental and Behavioral Pediatrics1998;19(2):89-93. [DOI: 1097/00004703-199804000-00005] [PMID: 9584937]">Zahorodny 1998</a>), MOTHER NAS score above 9 (<a href="./references#CD013217-bbs2-0083" title="JonesHE , KaltenbackK , HeilSH , StineS , CoyleM , ArriaA , et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine2010;363(24):2320-31. [DOI: 10.1056/NEJMoa1005359] [PMID: 21142534]">Jones 2010</a>), Finnegan Neonatal Abstinence Syndrome Scale – Short Form score above 8 (<a href="./references#CD013217-bbs2-0102" title="MaguireD , ClineGJ , ParnellL , Tai C-Y. Validation of the Finnegan neonatal abstinence syndrome tool – short form. Advances in Neonatal Care2013;13(6):430-7. [DOI: 10.1097/ANC.0000000000000033] [PMID: 24300963]">Maguire 2013</a>), or a score exceeding the stated threshold on any novel validated assessment tool. </p> </section> </section> <section id="CD013217-sec-0025"> <h5 class="title">Exclusion criteria</h5> <p> <ol id="CD013217-list-0002"> <li> <p>Preterm infants less than 34 weeks' gestation.</p> </li> <li> <p>Critically ill term and late preterm infants (greater than 34 weeks' gestation) with medical comorbidities unrelated to opioid withdrawal. Medical comorbidities included but were not limited to the need for mechanical ventilation (positive pressure ventilation), culture‐confirmed infection, necrotizing enterocolitis, major congenital anomaly, and status postmajor surgical intervention. </p> </li> </ol> </p> </section> </section> <section id="CD013217-sec-0026"> <h4 class="title">Types of interventions</h4> <section id="CD013217-sec-0027"> <h5 class="title">Comparison 1</h5> <p>Trials comparing single or bundled non‐pharmacological interventions to no non‐pharmacological treatment or different single or bundled non‐pharmacological interventions in infants at risk for, or having early symptoms consistent with, opioid withdrawal as defined above. </p> </section> <section id="CD013217-sec-0028"> <h5 class="title">Comparison 2</h5> <p>Trials comparing single or bundled non‐pharmacological interventions to no non‐pharmacological treatment or different single or bundled non‐pharmacological interventions in infants receiving opioid treatment for symptoms consistent with opioid withdrawal as defined above. </p> <p><b>Non‐pharmacological care is a heterogeneous group of interventions addressing three aspects of care, as follows.</b> </p> <p> <ol id="CD013217-list-0003"> <li> <p><b>Modifying environmental stimulation:</b> adjustments of environmental stimulation include low light, low noise, clustered care, containment or swaddling, bedding type, positioning, non‐nutritive sucking, bathing, aromatherapy, music therapy, and massage. </p> </li> <li> <p><b>Feeding practices:</b> feeding modifications include infant‐led feeding, high caloric feedings, tube feedings, maternal breast milk feedings, non‐maternal breast milk feedings, low‐lactose formula, and breastfeeding. </p> </li> <li> <p><b>Support of the mother‐infant dyad:</b> treatments focused on the mother‐infant dyad include parental presence, rooming in, skin‐to‐skin or 'kangaroo care,' parental respite or 'cuddler' programs, trauma‐informed care, social work support, mental health support, treatment program support, and legal support. </p> </li> </ol> </p> <p><b>Bundled non‐pharmacological interventions:</b> multiple non‐pharmacological interventions delivered in combination. </p> <p>We assessed non‐pharmacological interventions independently and in combination based on sufficient similarity in population, intervention, and comparison groups studied. </p> </section> </section> <section id="CD013217-sec-0029"> <h4 class="title">Types of outcome measures</h4> <section id="CD013217-sec-0030"> <h5 class="title">Primary outcomes</h5> <section id="CD013217-sec-0031"> <h6 class="title">Comparison 1</h6> <p> <ol id="CD013217-list-0004"> <li> <p>Length of hospitalization (days).</p> </li> <li> <p>Pharmacological treatment with one or more doses of opioid or sedative medication.</p> </li> </ol> </p> </section> <section id="CD013217-sec-0032"> <h6 class="title">Comparison 2</h6> <p> <ol id="CD013217-list-0005"> <li> <p>Length of hospitalization (days).</p> </li> <li> <p>Length of pharmacological treatment with opioid or sedative medication (days).</p> </li> <li> <p>Maximum and cumulative dose of opioid medication (milligrams/kilogram and morphine milligram equivalents). </p> </li> </ol> </p> </section> </section> <section id="CD013217-sec-0033"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD013217-list-0006"> <li> <p>Peak NAS score in first 72 hours of life as measured by a standardized withdrawal assessment tool. Tools included the Finnegan Neonatal Abstinence Scoring Tool (score range 0 to 62) (<a href="./references#CD013217-bbs2-0067" title="FinneganLP , Connaughton JF Jr, KronRE , EmichJP . Neonatal abstinence syndrome: assessment and management. Addictive Diseases1975;2(1-2):141-58. [PMID: 1163358]">Finnegan 1975</a>), Lipsitz Neonatal Drug Withdrawal Scoring System (score range 0 to 20) (<a href="./references#CD013217-bbs2-0098" title="LipsitzPJ . A proposed narcotic withdrawal score for use with newborn infants: a pragmatic evaluation of its efficacy. Clinical Pediatrics1975;14(6):592-4. [DOI: 10.1177/000992287501400613] [PMID: 1126108]">Lipsitz 1975</a>), Neonatal Narcotic Withdrawal Index (score range 0 to 14) (<a href="./references#CD013217-bbs2-0074" title="GreenM , SuffetF . The Neonatal Narcotic Withdrawal Index: a device for the improvement of care in the abstinence syndrome. American Journal of Drug and Alcohol Abuse1981;8(2):203-13. [DOI: 10.3109/00952998108999125] [PMID: 7331976]">Green 1981</a>), Neonatal Withdrawal Inventory (score range 0 to 19) (<a href="./references#CD013217-bbs2-0148" title="ZahorodnyW , RomC , WhitneyW , GiddensS , SamuelM , MaichukG , et al. The neonatal withdrawal inventory: a simplified score of newborn withdrawal. Journal of Developmental and Behavioral Pediatrics1998;19(2):89-93. [DOI: 1097/00004703-199804000-00005] [PMID: 9584937]">Zahorodny 1998</a>), MOTHER NAS scale (score range 0 to 42) (<a href="./references#CD013217-bbs2-0083" title="JonesHE , KaltenbackK , HeilSH , StineS , CoyleM , ArriaA , et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine2010;363(24):2320-31. [DOI: 10.1056/NEJMoa1005359] [PMID: 21142534]">Jones 2010</a>), or Finnegan Neonatal Abstinence Syndrome Scale – Short Form (score range 0 to 16) (<a href="./references#CD013217-bbs2-0102" title="MaguireD , ClineGJ , ParnellL , Tai C-Y. Validation of the Finnegan neonatal abstinence syndrome tool – short form. Advances in Neonatal Care2013;13(6):430-7. [DOI: 10.1097/ANC.0000000000000033] [PMID: 24300963]">Maguire 2013</a>). Separate assessments were made for each score (Comparison 1 only). </p> </li> <li> <p>NICU admission (Comparison 1 only).</p> </li> <li> <p>Length of NICU stay (days).</p> </li> <li> <p>Physical growth: weight:</p> <ol id="CD013217-list-0007"> <li> <p>days to regain birth weight;</p> </li> <li> <p>growth during study period and hospital stay (grams/day); growth velocity (grams/kg/day or change in z‐score); </p> </li> <li> <p>weight nadir (percent weight loss) (<a href="./references#CD013217-bbs2-0066" title="FentonTR , ChanHT , MadhuA , GriffinIJ , HoyosA , ZieglerEE , et al. Preterm infant growth velocity calculations: a systematic review. Pediatrics2017;139(3):e20162045. [DOI: 10.1542/peds.2016-2045] [PMID: 28246339]">Fenton 2017</a>). </p> </li> </ol> </li> <li> <p>Neonatal seizures (any seizures, clinical seizures, electroencephalogram [EEG]‐confirmed seizures; seizure treated with anticonvulsant therapy). </p> </li> <li> <p>Neonatal and infant all‐cause mortality.</p> </li> <li> <p>Cerebral palsy (clinical cerebral palsy diagnosed if the child had a non‐progressive motor impairment characterized by abnormal muscle tone and decreased range or control of movements). If data were available, we determined the level of gross motor function using the Gross Motor Function Classification System (<a href="./references#CD013217-bbs2-0117" title="PalisanoR , RosenbaumP , WalterS , RussellD , WoodE , GaluppiB . Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine and Child Neurology1997;39(4):214-23. [DOI: 10.1111/j.1469-8749.1997.tb07414.x] [PMID: 9183258]">Palisano 1997</a>). </p> </li> <li> <p>Neurodevelopmental outcome at approximately two years' corrected age (acceptable range 18 months to 28 months) including: cerebral palsy, significant mental developmental delay (Bayley Scales of Infant Development Mental Developmental Index less than 70 or Griffith 2 standard deviations [SD] below mean) (<a href="./references#CD013217-bbs2-0049" title="BayleyN . Bayley Scales of Infant Development-II. San Antonio (TX): Psychological Corporation, 1993.">Bayley 1993</a>; <a href="./references#CD013217-bbs2-0057" title="ChaudharyT , WalchE , HeroldB , MetzeB , LejeuneA , BurkhardtF , et al. Predictive and concurrent validity of standardized neurodevelopmental examinations by the Griffiths scales and Bayley Scales of Infant Development II. Klinische Padiatrie2013;225(1):8-12. [DOI: 10.1055/s-0032-1331169] [PMID: 23235928]">Chaudhary 2013</a>), legal blindness (less than 20/200 visual acuity), and hearing deficit (aided or less than 60 dB on audiometric testing). The composite outcome 'neurodevelopmental impairment' was defined as having any one of the aforementioned deficits (modified from definitions of moderate‐to‐severe developmental delay) (<a href="./references#CD013217-bbs2-0129" title="SchmidtB , RobertsRS , DavisP , DoyleLW , BarringtonKJ , OhlssonA , et al, Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. New England Journal of Medicine2007;357(19):1893-902. [DOI: 10.1056/NEJMoa073679] [PMID: 17989382]">Schmidt 2007</a>). </p> </li> <li> <p>Complications of therapy: apnea, need for positive pressure ventilation, need for oxygen, somnolence. </p> </li> <li> <p>Measures of maternal mood and bonding including Edinburgh Postpartum Depression Scale (<a href="./references#CD013217-bbs2-0062" title="CoxJ , HoldenJ , SagovskyR . Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry1987;150(6):782-6. [DOI: 10.1192/bjp.150.6.782] [PMID: 3651732]">Cox 1987</a>), Patient Health Questionnaire (2 or 9) (<a href="./references#CD013217-bbs2-0092" title="KroenkeK , SpitzerR , WilliamsJ . The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine2001;16(9):606-13. [DOI: 10.1046/j.1525-1497.2001.016009606.x] [PMID: 11556941]">Kroenke 2001</a>; <a href="./references#CD013217-bbs2-0145" title="WhooleyMA , AvinsAL , MirandaJ , BrownerWS . Case-finding instruments for depression. Two questions are as good as many. Journal of General Internal Medicine1997;12(7):439-45. [DOI: 10.1046/j.1525-1497.1997.00076.x] [PMID: 9229283]">Whooley 1997</a>), Maternal Attachment Inventory (<a href="./references#CD013217-bbs2-0110" title="MullerME . A questionnaire to measure mother-to-infant attachment. Journal of Nursing Measurement1994;2(2):129-41. [PMID: 7780768]">Muller 1994</a>), Maternal Postpartum Attachment Scale (<a href="./references#CD013217-bbs2-0060" title="CondonJ , CorkindaleCJ . The assessment of parent-to-infant attachment: development of a self-report questionnaire instrument. Journal of Reproductive and Infant Psychology1998;16(1):57-76. [DOI: 10.1080/02646839808404558]">Condon 1998</a>), Mother‐Infant Bonding Scale (<a href="./references#CD013217-bbs2-0137" title="TaylorA , AtkinsR , KumarR , AdamsD , GloverV . A new mother-to-infant bonding scale: links with early maternal mood. Archives of Women's Mental Health2005;8(1):45-51. [DOI: 10.1007/s00737-005-0074-z] [PMID: 15868385]">Taylor 2005</a>), or Postpartum Bonding Questionnaire (<a href="./references#CD013217-bbs2-0053" title="BrockingtonI , FraserC , WilsonD . The Postpartum Bonding Questionnaire: a validation. Archives of Women's Mental Health2006;9(5):233-42. [DOI: 10.1007/s00737-006-0132-1] [PMID: 16673041]">Brockington 2006</a>). Separate comparisons were made for each score. </p> </li> <li> <p>Custody status at discharge.</p> </li> <li> <p>Cost of care: including economic analyses of the impact of care practices including total hospitalization cost or charges per patient. </p> </li> </ol> </p> <section id="CD013217-sec-0034"> <h6 class="title">Post hoc</h6> <p>Peak NAS score in first 72 hours of life definition expanded to include either a 'peak' score at any time or a score in the first 72 hours as measured by a standardized withdrawal assessment tool as described above (Comparison 1 only). </p> <p>We added a secondary outcome, cost of care, to include economic analyses of the impact of care practices including total hospitalization cost or charges per patient. </p> </section> </section> </section> </section> <section id="CD013217-sec-0035"> <h3 class="title">Search methods for identification of studies</h3> <p>We used the criteria and standard methods of Cochrane and Cochrane Neonatal (see the Cochrane Neonatal search strategy for specialized register [<a href="http://neonatal.cochrane.org/resources-review-authors" target="_blank">neonatal.cochrane.org/resources-review-authors</a>]). We searched for errata or retractions from included studies published in full text on PubMed (<a href="http://www.ncbi.nlm.nih.gov/pubmed" target="_blank">www.ncbi.nlm.nih.gov/pubmed</a>), and reported the date this was done in the review. </p> <section id="CD013217-sec-0036"> <h4 class="title">Electronic searches</h4> <p>We conducted a comprehensive search including: Cochrane Central Register of Controlled Trials (CENTRAL 2019, Issue 10) in the Cochrane Library; Ovid MEDLINE(R) and Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Daily and Versions(R) (1946 to 11 October 2019); and CINAHL (1981 to 11 October 2019). We included the search strategies for each database in <a href="./appendices#CD013217-sec-0120">Appendix 1</a>. We applied no language restrictions. </p> <p>We searched clinical trial registries for ongoing or recently completed trials. We searched the World Health Organization's International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en/" target="_blank">www.who.int/ictrp/search/en/</a>), and the US National Library of Medicine's ClinicalTrials.gov (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>), via Cochrane CENTRAL. Additionally, we searched the ISRCTN <a href="http://www.isrctn.com/" target="_blank">Registry</a> for any unique trials not found through the Cochrane CENTRAL search. </p> <p>The search strategies for the protocol are in <a href="./appendices#CD013217-sec-0125">Appendix 2</a> (<a href="./references#CD013217-bbs2-0150" title="PahlA , YoungL , Buus‐FrankME , MarcellusL , SollR . Non-pharmacological care for opioid withdrawal in newborns. Cochrane Database of Systematic Reviews2018, Issue 12. Art. No: CD013217. [DOI: 10.1002/14651858.CD013217]">Pahl 2018</a>). </p> </section> <section id="CD013217-sec-0037"> <h4 class="title">Searching other resources</h4> <p>We also searched the reference lists of all identified articles for relevant articles not located in the primary search. </p> </section> </section> <section id="CD013217-sec-0038"> <h3 class="title" id="CD013217-sec-0038">Data collection and analysis</h3> <p>We collected information regarding the method of randomization, blinding, intervention, stratification, and whether the trial was single or multicenter for each included study. We noted information regarding trial participants including gestational age criteria, birth weight criteria, and other inclusion or exclusion criteria. We analyzed the clinical outcomes listed above in <a href="#CD013217-sec-0029">Types of outcome measures</a>. </p> <section id="CD013217-sec-0039"> <h4 class="title">Selection of studies</h4> <p>We included all RCTs, quasi‐RCTs, and cluster trials fulfilling our inclusion criteria. Both superiority trials and non‐inferiority trials were eligible for inclusion. All review authors reviewed the results of the search and separately selected studies for inclusion. We resolved any disagreements by discussion. </p> <p>We recorded the selection process in sufficient detail to complete a PRISMA flow diagram (<a href="#CD013217-fig-0001">Figure 1</a>), and <a href="./references#CD013217-sec-0166" title="">Characteristics of excluded studies</a> table (<a href="./references#CD013217-bbs2-0108" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology2009;62(10):1006-12. [DOI: 1016/j.jclinepi.2009.06.005] [PMID: 19631508]">Moher 2009</a>). </p> <div class="figure" id="CD013217-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013217-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>We excluded non‐randomized studies and presented these studies narratively in <a href="./appendices#CD013217-sec-0130">Appendix 3</a>. </p> </section> <section id="CD013217-sec-0040"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (AP and RS) extracted, assessed, and coded all data for each study, using a form designed specifically for this review. We replaced any standard error of the mean by the corresponding SD. We resolved any disagreements by discussion. For each study, one review author (AP) entered final data into Review Manager 5 (<a href="./references#CD013217-bbs2-0126" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, Cochrane, 2020.">Review Manager 2020</a>), which a second review author (RS) checked. All review authors reviewed the protocol, analysis, and draft manuscript. </p> </section> <section id="CD013217-sec-0041"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (AP and RS) independently assessed the risk of bias (low, high, or unclear) of all included RCTs using the Cochrane 'Risk of bias' tool for the following domains (<a href="./references#CD013217-bbs2-0078" title="HigginsJP , AltmanDG , Sterne JA: on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> <p> <ol id="CD013217-list-0008"> <li> <p>Sequence generation (selection bias).</p> </li> <li> <p>Allocation concealment (selection bias).</p> </li> <li> <p>Blinding of participants and personnel (performance bias).</p> </li> <li> <p>Blinding of outcome assessment (detection bias).</p> </li> <li> <p>Incomplete outcome data (attrition bias).</p> </li> <li> <p>Selective reporting (reporting bias).</p> </li> <li> <p>Any other bias.</p> </li> </ol> </p> <p>We resolved any disagreements by discussion or by consulting a third review author. See <a href="./appendices#CD013217-sec-0149">Appendix 4</a> for a more detailed description of risk of bias for each domain. </p> </section> <section id="CD013217-sec-0042"> <h4 class="title">Measures of treatment effect</h4> <p>We performed the statistical analyses using Review Manager 5 (<a href="./references#CD013217-bbs2-0126" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, Cochrane, 2020.">Review Manager 2020</a>). We analyzed categorical data using risk ratio (RR) and risk difference (RD). We reported 95% confidence intervals (CIs) for all outcomes. For statistically significant outcomes, we calculated the number needed to treat for an additional beneficial outcome (NNTB) or number needed to treat for an additional harmful outcome (NNTH). We calculated mean differences (MDs) between treatment groups where outcomes were measured in the same way and standardized mean differences (SMDs) where outcomes were measured using different scales for continuous data. </p> </section> <section id="CD013217-sec-0043"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the participating infant in individually randomized trials, and an infant was considered only once in the analysis. The participating neonatal unit or section of a neonatal unit or hospital was the unit of analysis in cluster‐RCTs. While we identified no cluster RCTs, we planned to analyze them using an estimate of the intracluster correlation coefficient (ICC) derived from the trial (if possible), or from a similar trial or from a study with a similar population as described in Section 23.1.4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013217-bbs2-0079" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). If we had used ICCs from a similar trial, or from a study with a similar population, we planned to report this and conduct a sensitivity analysis to investigate the effect of variation in the ICC. We identified no cluster trials and performed no sensitivity analysis. </p> <p>If we identified both cluster‐RCTs and individually randomized trials, we would only combine the results from both if there was little heterogeneity between the study designs, and the interaction between the effect of the intervention and the choice of randomization unit was considered unlikely. </p> <p>We acknowledged any possible heterogeneity in the randomization unit and performed a sensitivity analysis to investigate possible effects of the randomization unit. </p> </section> <section id="CD013217-sec-0044"> <h4 class="title">Dealing with missing data</h4> <p>Where feasible, we carried out analysis on an intention‐to‐treat basis for all outcomes. Whenever possible, we analyzed all participants in the treatment group to which they were randomized, regardless of the actual treatment received. If we identified important missing data (in the outcomes) or unclear data, we requested the missing data by contacting the original investigators. We made explicit the assumptions of any methods used to deal with missing data. The search identified few studies for each intervention; therefore, sensitivity analyses were not performed. We addressed the potential impact of missing data on the findings of the review in the <a href="#CD013217-sec-0108">Discussion</a> section of the review. </p> </section> <section id="CD013217-sec-0045"> <h4 class="title">Assessment of heterogeneity</h4> <p>We estimated the treatment effects of individual trials and examined heterogeneity among trials by inspecting the forest plots and quantifying the impact of heterogeneity using the I² statistic. We graded the degree of heterogeneity as: less than 25%, no heterogeneity; 25% to 49%, low heterogeneity; 50% to 75%, moderate heterogeneity; more than 75%, substantial heterogeneity. If we noted statistical heterogeneity (I² greater than 50%), we explored the possible causes (e.g. differences in study quality, participants, intervention regimens, or outcome assessments). </p> </section> <section id="CD013217-sec-0046"> <h4 class="title">Assessment of reporting biases</h4> <p>We conducted a comprehensive search for eligible studies and were alert for duplication of data. If we had identified 10 or more trials for meta‐analysis, we planned to assess possible publication bias by inspection of a funnel plot. If we uncovered reporting bias that could, in the opinion of the review authors, introduce serious bias, we planned to conduct a sensitivity analysis to determine the effect of including and excluding these studies in the analysis. </p> </section> <section id="CD013217-sec-0047"> <h4 class="title">Data synthesis</h4> <p>If we identified multiple studies that we considered to be sufficiently similar, we performed meta‐analysis using Review Manager 5 (<a href="./references#CD013217-bbs2-0126" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, Cochrane, 2020.">Review Manager 2020</a>). We determined study similarity based on concordance of population, intervention or combination of interventions, and comparison group. For categorical outcomes, we calculated the typical estimates of RR and RD, each with its 95% CI; for continuous outcomes, we calculated the MD or SMD, each with its 95% CI. We used a fixed‐effect model to combine data where it was reasonable to assume that studies were estimating the same underlying treatment effect. If we judged meta‐analysis to be inappropriate, we analyzed and interpreted individual trials separately. If there was evidence of clinical heterogeneity, we tried to explain this based on the different study characteristics and subgroup analyses. </p> </section> <section id="CD013217-sec-0048"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD013217-sec-0049"> <h5 class="title">Planned subgroup analyses</h5> <p> <ol id="CD013217-list-0009"> <li> <p>Gestational age (late preterm [34 weeks' gestation to 37 weeks' gestation], term (37 weeks' gestation or greater]). </p> </li> <li> <p>Birth weight (less than 2500 g or 2500 g or greater).</p> </li> <li> <p>Type of non‐pharmacological intervention:</p> <ol id="CD013217-list-0010"> <li> <p>environmental stimulation: adjustments of environmental stimulation include low light, low noise, clustered care, containment or swaddling, bedding type, positioning, non‐nutritive sucking, bathing, aromatherapy, music therapy, and massage; </p> </li> <li> <p>feeding practices: feeding modifications include infant‐led feeding, high‐caloric feedings, tube feedings, maternal breast milk feedings, non‐maternal breast milk feedings, low‐lactose formula, and breastfeeding; </p> </li> <li> <p>support of the mother‐infant dyad: treatments focused on the mother‐infant dyad included parental presence, rooming in, skin‐to‐skin or 'kangaroo care,' parental respite or 'cuddler' programs, trauma‐informed care, social work support, mental health support, treatment program support, and legal support. </p> </li> </ol> </li> <li> <p>Prenatal opioid exposure: polysubstance use, single substance (opioid) use, prescribed opioid, non‐prescribed opioid, not known. </p> </li> <li> <p>Other prenatal substance exposures:</p> <ol id="CD013217-list-0011"> <li> <p>nicotine exposure: nicotine use, no nicotine use;</p> </li> <li> <p>alcohol exposure (based on maternal history or evidence of fetal alcohol spectrum disorder); </p> </li> <li> <p>SSRI exposure.</p> </li> </ol> </li> <li> <p>Maternal social situation (custody status, homelessness, employment status, public insurance, ethnicity, involvement of birth father, marital status, family support). </p> </li> </ol> </p> <p>We did not attempt to perform the subgroup analyses proposed due to insufficient similarity in population, intervention, and comparison groups studied. Few studies were identified for each non‐pharmacological intervention with significant differences between studies. </p> </section> </section> <section id="CD013217-sec-0050"> <h4 class="title">Sensitivity analysis</h4> <p>We identified few studies for each intervention and did not conduct sensitivity analysis.</p> </section> <section id="CD013217-sec-0051"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used the GRADE approach, as outlined in the GRADE Handbook (<a href="./references#CD013217-bbs2-0130" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>), to assess the certainty of evidence for the following (clinically relevant) outcomes for comparison one. </p> <section id="CD013217-sec-0052"> <h5 class="title">Comparison 1</h5> <p> <ol id="CD013217-list-0012"> <li> <p>Length of hospitalization (days).</p> </li> <li> <p>Pharmacological treatment with opioid or sedative medication.</p> </li> <li> <p>Peak NAS score in first 72 hours of life.</p> </li> <li> <p>NICU admission.</p> </li> <li> <p>Neonatal seizures requiring anticonvulsant therapy.</p> </li> <li> <p>Neurodevelopmental outcome at approximately two years' corrected age (cerebral palsy, developmental delay [Bayley or Griffith assessment more than two SD below mean] or intellectual impairment (intelligence quotient [IQ] more than two SD below mean), blindness (vision less than 6/60 in both eyes), sensorineural deafness requiring amplification. </p> </li> <li> <p>Measures of maternal mood and bonding including Edinburgh Postpartum Depression Scale, Patient Health Questionnaire (2 or 9), Maternal Attachment Inventory, Maternal Postpartum Attachment Scale, Mother‐Infant Bonding Scale, or Postpartum Bonding Questionnaire (<a href="./references#CD013217-bbs2-0053" title="BrockingtonI , FraserC , WilsonD . The Postpartum Bonding Questionnaire: a validation. Archives of Women's Mental Health2006;9(5):233-42. [DOI: 10.1007/s00737-006-0132-1] [PMID: 16673041]">Brockington 2006</a>; <a href="./references#CD013217-bbs2-0060" title="CondonJ , CorkindaleCJ . The assessment of parent-to-infant attachment: development of a self-report questionnaire instrument. Journal of Reproductive and Infant Psychology1998;16(1):57-76. [DOI: 10.1080/02646839808404558]">Condon 1998</a>; <a href="./references#CD013217-bbs2-0062" title="CoxJ , HoldenJ , SagovskyR . Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry1987;150(6):782-6. [DOI: 10.1192/bjp.150.6.782] [PMID: 3651732]">Cox 1987</a>; <a href="./references#CD013217-bbs2-0092" title="KroenkeK , SpitzerR , WilliamsJ . The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine2001;16(9):606-13. [DOI: 10.1046/j.1525-1497.2001.016009606.x] [PMID: 11556941]">Kroenke 2001</a>; <a href="./references#CD013217-bbs2-0110" title="MullerME . A questionnaire to measure mother-to-infant attachment. Journal of Nursing Measurement1994;2(2):129-41. [PMID: 7780768]">Muller 1994</a>; <a href="./references#CD013217-bbs2-0137" title="TaylorA , AtkinsR , KumarR , AdamsD , GloverV . A new mother-to-infant bonding scale: links with early maternal mood. Archives of Women's Mental Health2005;8(1):45-51. [DOI: 10.1007/s00737-005-0074-z] [PMID: 15868385]">Taylor 2005</a>; <a href="./references#CD013217-bbs2-0145" title="WhooleyMA , AvinsAL , MirandaJ , BrownerWS . Case-finding instruments for depression. Two questions are as good as many. Journal of General Internal Medicine1997;12(7):439-45. [DOI: 10.1046/j.1525-1497.1997.00076.x] [PMID: 9229283]">Whooley 1997</a>) </p> </li> </ol> </p> <p>We planned to assess the certainty of evidence for the following (clinically relevant) outcomes for comparison two. </p> </section> <section id="CD013217-sec-0053"> <h5 class="title">Comparison 2</h5> <p> <ol id="CD013217-list-0013"> <li> <p>Length of hospitalization (days).</p> </li> <li> <p>Length of pharmacological treatment with opioid or sedative medication (days).</p> </li> <li> <p>Maximum and cumulative dose of opioid medication (morphine milligram equivalents).</p> </li> <li> <p>Length of NICU stay.</p> </li> <li> <p>Neonatal seizures requiring anticonvulsant therapy.</p> </li> <li> <p>Neurodevelopmental outcome at approximately two years' corrected age (cerebral palsy, developmental delay [Bayley or Griffith assessment more than two SD below mean] or intellectual impairment [IQ] more than two SD below mean), blindness (vision less than 6/60 in both eyes), sensorineural deafness requiring amplification. </p> </li> <li> <p>Measures of maternal mood and bonding including Edinburgh Postpartum Depression Scale, Patient Health Questionnaire (2 or 9), Maternal Attachment Inventory, Maternal Postpartum Attachment Scale, Mother‐Infant Bonding Scale, or Postpartum Bonding Questionnaire (<a href="./references#CD013217-bbs2-0053" title="BrockingtonI , FraserC , WilsonD . The Postpartum Bonding Questionnaire: a validation. Archives of Women's Mental Health2006;9(5):233-42. [DOI: 10.1007/s00737-006-0132-1] [PMID: 16673041]">Brockington 2006</a>; <a href="./references#CD013217-bbs2-0060" title="CondonJ , CorkindaleCJ . The assessment of parent-to-infant attachment: development of a self-report questionnaire instrument. Journal of Reproductive and Infant Psychology1998;16(1):57-76. [DOI: 10.1080/02646839808404558]">Condon 1998</a>; <a href="./references#CD013217-bbs2-0062" title="CoxJ , HoldenJ , SagovskyR . Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry1987;150(6):782-6. [DOI: 10.1192/bjp.150.6.782] [PMID: 3651732]">Cox 1987</a>; <a href="./references#CD013217-bbs2-0092" title="KroenkeK , SpitzerR , WilliamsJ . The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine2001;16(9):606-13. [DOI: 10.1046/j.1525-1497.2001.016009606.x] [PMID: 11556941]">Kroenke 2001</a>; <a href="./references#CD013217-bbs2-0110" title="MullerME . A questionnaire to measure mother-to-infant attachment. Journal of Nursing Measurement1994;2(2):129-41. [PMID: 7780768]">Muller 1994</a>; <a href="./references#CD013217-bbs2-0137" title="TaylorA , AtkinsR , KumarR , AdamsD , GloverV . A new mother-to-infant bonding scale: links with early maternal mood. Archives of Women's Mental Health2005;8(1):45-51. [DOI: 10.1007/s00737-005-0074-z] [PMID: 15868385]">Taylor 2005</a>; <a href="./references#CD013217-bbs2-0145" title="WhooleyMA , AvinsAL , MirandaJ , BrownerWS . Case-finding instruments for depression. Two questions are as good as many. Journal of General Internal Medicine1997;12(7):439-45. [DOI: 10.1046/j.1525-1497.1997.00076.x] [PMID: 9229283]">Whooley 1997</a>). </p> </li> </ol> </p> <p>Two review authors (AP and RS) independently assessed the certainty of the evidence for each of the outcomes listed above. We considered evidence from RCTs as high certainty, downgrading the evidence one level for serious (or two levels for very serious) limitations based upon the following: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates, and presence of publication bias. </p> <p>We used <a href="./references#CD013217-bbs2-0070" title="GRADEpro GDT. Version accessed 2 February 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.">GRADEpro GDT</a> to create <a href="./full#CD013217-tbl-0001">summary of findings Table 1</a> to report the certainty of the evidence for comparison one. </p> <p>The GRADE approach results in an assessment of the certainty of a body of evidence as one of four grades. </p> <p> <ol id="CD013217-list-0014"> <li> <p>High certainty: further research is very unlikely to change our confidence in the estimate of effect. </p> </li> <li> <p>Moderate certainty: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> </li> <li> <p>Low certainty: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </li> <li> <p>Very low certainty: we are very uncertain about the estimate.</p> </li> </ol> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013217-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013217-sec-0054"></div> <section id="CD013217-sec-0055"> <h3 class="title">Description of studies</h3> <section id="CD013217-sec-0056"> <h4 class="title">Included studies</h4> <p>The search identified six RCTs evaluating non‐pharmacological care for opioid withdrawal published between 1975 and 2018 (<a href="./references#CD013217-sec-0165" title="">Characteristics of included studies</a> table). Four studies compared modifications of environmental stimulation (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>; <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>), one study compared feeding practices (<a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a>), and one study compared interventions targeting support of the mother‐infant dyad (<a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a>). Two studies were RCTs due to use of computer‐generated randomization (<a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a>; <a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a>), one was classified as a quasi‐RCT due to randomization by hospital record number (<a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>), and three reported randomization of study participants without further details about the methods and may represent RCTs or quasi‐RCTs (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>). The search identified no cluster trials. </p> </section> <section id="CD013217-sec-0057"> <h4 class="title">Excluded studies</h4> <p>The search identified 34 non‐randomized studies published between 2005 and 2018 comparing single or bundled non‐pharmacological interventions to no non‐pharmacological treatment or different single or bundled non‐pharmacological interventions for opioid withdrawal in newborns (see <a href="./references#CD013217-sec-0166" title="">Characteristics of excluded studies</a> table; <a href="#CD013217-tbl-0002">Table 1</a>; <a href="#CD013217-tbl-0003">Table 2</a>; <a href="#CD013217-tbl-0004">Table 3</a>; <a href="#CD013217-tbl-0005">Table 4</a>; and <a href="./appendices#CD013217-sec-0130">Appendix 3</a>). </p> <div class="table" id="CD013217-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Excluded studies of modifying environmental stimulation</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Details</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0033" title="RadziewiczRM , Wright-EsberS , ZupancicJ , GargiuloD , WoodallP . Safety of reiki therapy for newborns at risk for neonatal abstinence syndrome. Holistic Nursing Practice2018;32(2):63-70. [DOI: 10.1097/HNP.0000000000000251] [PMID: 29315084]">Radziewicz 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 newborns at risk for withdrawal in a newborn nursery</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newborn nursery (Ohio, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Each subject received one thirty‐minute treatment of Reiki in a private room."</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0015"> <li> <p>Slight decrease in heart rate and withdrawal scores following treatment</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0040" title="ZuzarteI , IndicP , BartonB , PaydarfarD , BednarekF , Bloch-SalisburyE . Vibrotactile stimulation: a nonpharmacological intervention for opioid exposed newborns. PloS One2017;12(4):e0175981. [DOI: ﻿10.1371/journal.pone.0175981] [PMID: 28426726]">Zuzarte 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective cohort (within‐subjects)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 opioid‐exposed newborns (&gt; 37 weeks' gestation) treated pharmacologically for NAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neonatal intensive care unit and newborn nursery (Massachusetts, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "A specially‐constructed mattress delivered low‐level SVS (30–60Hz, 10–12μm RMS [root‐mean‐square]), alternated in 30‐min intervals between continuous vibration (ON) and no vibration (OFF) over a 6–8 hr session." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0016"> <li> <p>35% reduction in movement activity with SVS</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>NAS: neonatal abstinence syndrome; SVS: stochastic vibrotactile stimulation.</p> </div> </div> <div class="table" id="CD013217-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Excluded studies of feeding practices</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Details</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>190 consecutive drug‐dependent mother‐infant pairs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1998–2004</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward with mother unless medical or social contraindications (New South Wales, Australia) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Predominant feed on day 5 of life: ≤ 2 feeds daily of formula (85 infants) or &gt; 2 feeds daily of formula (105 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≤ 2 feeds daily of formula vs &gt; 2 feeds daily of formula</p> <p> <ol id="CD013217-list-0017"> <li> <p>Shorter length of hospitalization (mean: 14.7 days, SD 14.9 vs 19.1 days, SD 15.0; P = 0.049) </p> </li> <li> <p>Significant decrease in need for treatment (52.9% vs 79.0%; P &lt; 0.001)</p> </li> <li> <p>Non‐significant decrease in treatment duration (mean: 85.4 days, SD 71.7 vs 108.2 days, SD 81.8; P = 0.185) </p> </li> <li> <p>Non‐significant decrease in maximum dose of morphine (mean: 0.57 mg/kg/day, SD 0.22 vs 0.59 mg/kg/day, SD 0.22; P = 0.526) </p> </li> <li> <p>Fewer infants in foster care (9.4% vs 29.5%; P = 0.001)</p> </li> <li> <p>Fewer infants designated; quote: "child at risk" (31.8% vs 68.6%; P &lt; 0.001)</p> </li> <li> <p>Lower mean Finnegan scores (numeric values not provided in text)</p> </li> <li> <p>Later median time to withdrawal (10 days vs 3 days; P &lt; 0.001)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More heroin, non‐opioid, and polydrug use in formula group</p> <p>Emailed authors to clarify data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0010" title="ArlettazR , KashiwagiM , Das-KunduS , FauchèreJC , LangA , BucherHU . Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstetricia et Gynecologica Scandinavica2005;84(2):145-50. [DOI: ﻿10.1111/j.0001-6349.2005.00510.x] [PMID: 15683374]">Arlettaz 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 infants of women enrolled in a methadone maintenance program</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1996–2001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified, 77% transferred to the neonatal unit for medical reasons or pharmacological treatment (Switzerland) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infants who received more than half of total amount of milk during hospital stay as human milk (27 infants) vs infants who received less than half (59 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Twenty‐six percent of breast‐fed babies (7/27) and 78% of formula‐fed babies (42/54) developed NAS (P &lt; 0.01)." </p> <p>Pharmacological treatment rate and custody not reported by feeding status</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0012" title="DrydenC , YoungD , CampbellN , MactierH . Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. Archives of Disease in Childhood. Fetal and Neonatal Edition2012;97(3):F214-6. [DOI: ﻿10.1136/adc.2009.178723] [PMID: 20656717]DrydenC , YoungD , HepburnM , MactierH . Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG2009;116(5):665-71. [DOI: 10.1111/j.1471-0528.2008.02073.x] [PMID: 19220239]">Dryden 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>450 singleton pregnancies of drug misusing women prescribed substitute methadone for pregnancy </p> <p>354 term substitute methadone‐exposed infants included in subgroup published in 2012</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2004 to December 2006</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward with mother unless any specific indication for admission to the neonatal unit (UK) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received maternal breast milk ≥ 72 hours (99 infants) vs formula fed or received maternal breast milk &lt; 72 hours (351 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received maternal breast milk ≥ 72 hours vs formula fed or received maternal breast milk &lt; 72 hours </p> <p> <ol id="CD013217-list-0018"> <li> <p>Breastfeeding associated with reduced odds of requiring treatment for NAS (OR 0.55, 95% CI 0.34 to 0.88; P = 0.013) </p> </li> <li> <p>Follow‐up analysis of 354 infants with complete data (breastfed 72 infants, non‐breastfed 282 infants) showed higher median maximal weight loss in breastfed group (10.2% vs 8.5%; P = 0.003) </p> </li> <li> <p>The group of 22 exclusively breastfed infants had a median maximal weight loss of 9.3% </p> </li> <li> <p>Quote: "For infants who were not admitted to the [neonatal unit] (n=208), median age at discharge was 7 days; this did not differ between breast and formula feeders" </p> </li> <li> <p>More breastfed infants were classified as "non‐admitted" and did not require admission to the neonatal unit (52/72 [72%] vs 155/282 [55%]) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emailed authors to clarify the relationship between the 2 publications, 2009 study is the primary study as fewer infants were included in 2012 study due to missing data. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0014" title="HodgsonZG , AbrahamsRR . A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2012;34(5):475-81. [DOI: 10.1016/s1701-2163(16)35245-8] [PMID: 22555142]">Hodgson 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>295 singleton mother‐infant dyads who received care in combined care for maternal substance use in a rooming in program </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2003 to December 2006</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal; quote: "combined care nursery" with mother including those receiving pharmacotherapy (British Columbia, Canada) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed (196 infants) vs not breastfed (99 infants)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0019"> <li> <p>Significant decrease in probability of an infant receiving morphine (12% of breastfed infants vs 37% of non‐breastfed infants; OR 0.21, SD 1.43, 95% CI 0.10 to 0.42; P &lt; 0.001) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0018" title="IsemannB , Meinzen-DerrJ , AkinbiH . Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. Journal of Perinatology2011;31(1):25-9. [DOI: dx.doi.org/10.1038/jp.2010.66] [PMID: 20508596]">Isemann 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>128 infants that received pharmacotherapy for opiate withdrawal in the newborn intensive care unit (92 infants &gt; 37 weeks, 36 infants &lt; 37 weeks) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2002 to December 2007</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NICU (Ohio, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mother's breast milk ingested vs formula fed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0020"> <li> <p>Inverse correlation between the percentage of mother's breast milk ingested and length of stay (β = –0.03; P = 0.02) </p> </li> <li> <p>Median: 12.5 days, range 3–51 days for infants who ingested maternal breast milk vs 18.5 days, range 9̫–43 days for formula‐fed infant </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0019" title="JanssonLM , ChooR , VelezML , HarrowC , SchroederJR , ShakleyaDM , et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics2008;121(1):106-14. [DOI: ﻿10.1542/peds.2008-0217] [PMID: 18166563]">Jansson 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective case control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 breastfed methadone‐exposed infants and 8 matched formula‐feeding infants</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2001 to September 2005</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (Maryland, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed (8 infants) vs formula fed (8 infants)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs formula fed</p> <p> <ol id="CD013217-list-0021"> <li> <p>Decrease in use of pharmacological treatment (12.5% vs 50%; P = 0.28)</p> </li> <li> <p>Shorter time of treatment (median: 6 days, IQR not reported vs 13.5 days, IQR 10.5)</p> </li> <li> <p>Lower day 3 NAS score (median: 4.5, IQR 3.9 vs 6.8, IQR 1.2; P non‐significant)</p> </li> <li> <p>Lower peak NAS score (median: 6.5, IQR 4.5 vs 11.0, IQR 5.0; P non‐significant)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More medical comorbidities in breastfed group</p> <p>3 breastfeeding infants not included due to failure to provide complete study specimens</p> <p>1 breastfeeding infants not included due to inability to find match</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0021" title="LiuA , JuarezJ , NairA , NananR . Feeding modalities and the onset of the neonatal abstinence syndrome. Frontiers in Pediatrics2015;3:14. [DOI: ﻿10.3389/fped.2015.00014] [PMID: 25767791]">Liu 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194 methadone‐maintained mother‐infant dyads &gt; 30 weeks' gestation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2000–2006</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified; quote: "two birthing units" (New South Wales, Australia)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorized in the 1st 2 days of life as predominantly breastfed (≥ 50% of feeds, 32 infants), fed expressed breast milk (≥ 15 mL expressed breast milk and breastfed &lt; 3 times daily, 12 infants), or formula fed (≥ 50% of feeds and &lt; 15 ml/day breast milk ingestion, 150 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs fed expressed breast milk vs formula fed</p> <p> <ol id="CD013217-list-0022"> <li> <p>No difference in percent requiring treatment for NAS (72% vs 100% vs 81%; P = 0.11)</p> </li> <li> <p>No difference in maximum dose of morphine required (median: 0.5 mg/kg/day, IQR 0.5 to 0.7 vs 0.7, IQR 0.53 to 9.84 vs 0.5, IQR 0.5 to 0.7; P = 0.20) </p> </li> <li> <p>No difference in mean NAS score (5.1, SD 1.3 vs 5.7, SD 0.9 vs 5.4, SD 1.1; P = 0.47)</p> </li> <li> <p>Quote: "Breastfeeding during the first 2 days of life was associated with a delayed onset of NAS (P = .04)" </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0024" title="McQueenKA , Murphy-OikonenJ , GerlachK , MontelpareW . The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Advances in Neonatal Care2011;11(4):282-90. [DOI: ﻿10.1097/ANC.0b013e318225a30c] [PMID: 22123351]">McQueen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 term infants exposed to methadone with symptoms of NAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2007 to March 2008</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (Ontario, Canada)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfeeding (&gt; 75% breast milk, 8 infants) vs combination feeds (25% to 75% breast milk, 11 infants) vs formula fed (&lt; 25% breast milk, 9 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs combination feed vs formula fed</p> <p> <ol id="CD013217-list-0023"> <li> <p>Fewer mean NAS scores on Modified Finnegan Scoring Tool (25, SD 23.5 vs 56.2, SD 39.1 vs 95.6, SD 34.6) </p> </li> <li> <p>Lower mean NAS scores on Modified Finnegan Scoring Tool (4.9, SD 2.9 vs 6.5, SD 3.7 vs 6.9, SD 4.2) </p> </li> <li> <p>Fewer infants scored &gt; 8 (17% vs 38.8% vs 40.2%)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More regular prenatal care in the breastfed group</p> <p>Emailed with authors to clarify data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0026" title="MetzVE , ComerSD , PribasnigA , WuerzlJ , FischerG . Observational study in an outpatient clinic specializing in treating opioid dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine. Heroin Addiction and Related Clinical Problems2015;17(1):5-16. ">Metz 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>390 infants born to opioid‐dependent women undergoing comprehensive treatment during pregnancy (184 methadone, 77 buprenorphine, 129 slow‐release oral morphine) </p> <p>50 infants excluded due to incomplete data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1994 to January 2009</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (Austria)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed infants (100 infants; methadone group 48 infants, slow‐release oral morphine group 21 infants, buprenorphine group 31 infants) vs non‐breastfed infants (250 infants; methadone group 118 infants, slow‐release oral morphine group 91 infants, buprenorphine group 41 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs non‐breastfed</p> <p> <ol id="CD013217-list-0024"> <li> <p>Decreased mean modified Finnegan score in methadone group (6.52, SD 2.50 vs 7.94, SD 2.87; P = 0.004) and slow‐release oral morphine group (6.97, SD 2.77 vs 9.07, SD 3.11; P = 0.007) with no difference in buprenorphine group (4.89, SD 2.03 vs 5.77, SD 2.49; P = 0.110) </p> </li> <li> <p>Decreased peak modified Finnegan score in methadone group (mean: 12.60, SD 5.16 vs 17.00, SD 5.65; P &lt; 0.001) and slow‐release oral morphine group (mean 15.24, SD 6.66 vs 18.93, SD 5.56; P = 0.009) with no difference in buprenorphine group (mean: 11.19, SD 5.11 vs 12.29, SD 4.78; P = 0.352) </p> </li> <li> <p>Decreased total morphine dose in methadone group (mean: 4.35 mg, SD 9.03 vs 12.65 mg, SD 18.64; P &lt; 0.001) with no difference in slow‐release oral morphine group (mean: 5.23 mg, SD 7.00 vs 8.75 mg, SD 11.54; P = 0.193) and buprenorphine group (mean: 1.90 mg, SD 3.32 vs 2.77 mg, SD 5.78; P = 0.457) </p> </li> <li> <p>Decreased duration of treatment in methadone group (mean: 8.10 days, SD 12.64 vs 16.94 days, SD 16.75; P &lt; 0.001) and slow‐release oral morphine group (mean: 10.20 days, SD 12.53 vs 18.07, SD 13.67; P = 0.020) with no difference in buprenorphine group (mean: 4.74 days, SD 5.58 vs 5.76 days, SD 7.37; P = 0.524) </p> </li> <li> <p>Decreased length of stay in methadone group (mean: 17.17 days, SD 10.28 vs 29.36 days, SD 15.07; P &lt; 0.001) and slow‐release oral morphine group (mean: 19.71 days, SD 12.37 vs 31.03 days, SD 13.81; P = 0.001) with no difference in buprenorphine group (mean: 12.26 days, SD 5.35 vs 14.71 days, SD 9.60; P = 0.174) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes reported as subgroups only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0028" title="O'ConnorAB , CollettA , AltoWA , O'BrienLM . Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. Journal of Midwifery and Women's Health2013;58(4):383-8. [DOI: ﻿10.1111/jmwh.12009] [PMID: 23931660]">O'Connor 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 mother‐infant dyads in buprenorphine treatment program, infants &gt; 35 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>December 2007 to August 2012</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (Maine, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfeeding (65 infants) vs non‐breastfed infants (20 infants)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs non‐breastfed</p> <p> <ol id="CD013217-list-0025"> <li> <p>Non‐significant increase in length of hospital stay (mean: 7.08 days, SD 4.39 vs 6.60 days, SD 1.70; P = 0.35) </p> </li> <li> <p>Non‐significant decrease in peak modified Finnegan NAS score (mean: 8.83, SD 3.56 vs 9.65, SD 2.58; P = 0.17) </p> </li> <li> <p>Non‐significant decrease in pharmacological treatment (23.1% vs 30.0%; P = 0.56)</p> </li> <li> <p>Non‐significant decrease in time to first and last peak modified Finnegan NAS score (first: mean: 66.5 hours, SD 43.80 vs 73.5 hours, SD 41.82; P =.32; last: mean: 76.1 hours, SD 43.95 vs 78.3 hours, SD 38.54; P = 0.67) </p> </li> <li> <p>Decreased likelihood of higher modified Finnegan NAS scores (≥ 8: 65% vs 75%; ≥ 12: 17% vs 30%) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed infants were significantly less likely to have exposure to illicit substances in the 3rd trimester (41.4% vs 80.0%; P = 0.004) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0031" title="PrithamUA , PaulJA , HayesMJ . Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing2012;41(2):180-90. [DOI: 10.1111/j.1552-6909.2011.01330.x] [PMID: 22375882]">Pritham 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152 opioid‐dependent pregnant women in treatment (136 methadone, 16 buprenorphine) and their infants </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2005 to December 2007</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of Care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NICU (Maine, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed (17 infants, methadone group 14, buprenorphine group 3) vs both formula and breast (26 infants, methadone group 22, buprenorphine group 4) vs formula fed (105 infants, methadone group 96, buprenorphine group 9) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0026"> <li> <p>Length of stay was shorter in breastfed neonates than formula‐fed neonates or neonates that fed both formula and breast in regression model of methadone group (β = –0.176; P = 0.05) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0032" title="RadmacherP , AlexanderC , DevlinL . Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15]">Radmacher 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective cohort (historically controlled feasibility study)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 term formula‐fed infants receiving oral morphine for opioid withdrawal matched to historical controls </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2014–2017</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NICU (Kentucky, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exclusive donor milk for up to 2 weeks (12 infants) vs formula‐fed historical controls (12 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Donor milk vs formula fed</p> <p> <ol id="CD013217-list-0027"> <li> <p>No significant difference in length of stay (mean: 41 days, SD 16 vs 33 days, SD 9; P non‐significant) </p> </li> <li> <p>No significant difference in length of treatment (mean: 37 days, SD 16 vs 29 days, SD 9; P non‐significant) </p> </li> <li> <p>No significant difference in median total Finnegan Neonatal Abstinence Score (values not reported) </p> </li> <li> <p>Significant decrease in gastrointestinal subscore &gt; 2 (39% vs 61%; P = 0.001)</p> </li> <li> <p>No significant difference in return to birth weight (mean: 17 days, SD 7 vs 16 days, SD 4; P non‐significant) </p> </li> <li> <p>No significant difference in weight gain during study period (mean: 19.1 g/day, SD 13.1 vs 20.5 g/day, SD 3.0; P non‐significant) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Benzodiazepine exposure in the donor milk group but not the control group</p> <p>Significant deviation from intended intervention noted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0035" title="ShortVL , GannonM , AbatemarcoDJ . The association between breastfeeding and length of hospital stay among infants diagnosed with neonatal abstinence syndrome: a population-based study of in-hospital births. Breastfeeding Medicine2016;11(7):343-9. [DOI: ﻿10.1089/bfm.2016.0084] [PMID: 27529500]">Short 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3725 singleton in‐hospital births &gt; 35 weeks' gestation diagnosed with NAS based on discharge diagnosis codes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012–2014</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified, though mentions benefits of rooming in and 40% admission to NICU (Pennsylvania, USA) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfeeding at discharge (1576 infants) vs not breastfeeding (1968 infants) as reported on birth certificate </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0028"> <li> <p>Length of stay was 9.4% shorter in infants breastfed at discharge than infants not breastfed at discharge in regression model (β = –0.060; P = 005) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about in‐utero exposure or postnatal treatment for NAS</p> <p>Breastfed infants were more likely to have a higher birthweight and gestational age; less likely to be insured by Medicaid; and more likely to be born to mothers who completed high school, were married, had adequate prenatal care, and who did not smoke </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0037" title="WachmanEM , HayesMJ , BrownMS , PaulJ , Harvey-WilkesK , TerrinN , et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA2013;309(17):1821-7. [DOI: ﻿10.1001/jama.2013.3411]">Wachman 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 infants &gt; 36 weeks' gestation exposed to methadone or buprenorphine in utero</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>July 2011 to July 2012</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified, 5 tertiary care centers and community hospitals (Massachusetts and Maine, USA) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessed breastfeeding as a potential covariate related to NAS severity; breastfeeding (38 infants) vs no breastfeeding (48 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs non‐breastfed</p> <p> <ol id="CD013217-list-0029"> <li> <p>Shorter length of stay (mean: 15.8 days, 95% CI 11.5 to 20.1 vs 27.4 days, 95% CI 22.5 to 32.3; P &lt; 0.001) </p> </li> <li> <p>Decrease in pharmacological treatment (50% vs 77%; P = 0.009)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Objective: to determine whether single nucleotide polymorphisms in the μ‐opioid receptor (OPRM1), multiple‐drug resistance (ABCB1), and catechol‐O‐methyltransferase (COMT) genes are associated with length of hospital stay and the need for treatment of NAS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0039" title="Welle-StrandGK , SkurtveitS , JanssonLM , BakstadB , BjarkoL , RavndalE . Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatrica2013;102(11):1060-6. [DOI: ﻿10.1111/apa.12378] [PMID: 23909865]">Welle‐Strand 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>124 infants of women on opioid maintenance therapy (78 methadone, 46 muprenorphine)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1999–2003 (36 infants, retrospective), 2005–2007 (36 infants, prospective), 2007–2009 (52 infants, retrospective) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified, national cohort (Norway)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed (95 infants; methadone exposed 58, buprenorphine exposed 37) vs not breastfed (29 infants; methadone exposed 20, buprenorphine exposed 9) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs not breastfed</p> <p> <ol id="CD013217-list-0030"> <li> <p>Non‐significant decrease in NAS use of pharmacological treatment overall (overall: 57% vs 69%, not significant; methadone exposed: 53% vs 80%; P &lt; 0.05; buprenorphine exposed: 64% vs 44%; P not significant) </p> </li> <li> <p>Significant decrease in NAS treatment duration overall (overall: mean: 28.6 days, SD 19.1 vs 46.7 days, SD 26.3; P &lt; 0.05; methadone‐exposed mean: 31.0 days, SD 21.4 vs 48.9 days, SD 27.2; P &lt; 0.05; buprenorphine‐exposed mean: 25.7 days, SD 16.0 vs 38.8 days, SD 24.0; P not significant) </p> </li> <li> <p>Length of NAS treatment was shorter in breastfed infants vs not breastfed infants in regression model (overall: β = –19.7; P = 0.00; methadone exposed: β = –20.7; P = 0.00; buprenorphine exposed: β = –6.62; P = 0.59) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More preterm birth and delivery by cesarean in non‐breastfed group</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; NAS: neonatal abstinence syndrome; IQR: interquartile range; NICU: neonatal intensive care unit; OR: odds ratio; SD: standard deviation. </p> </div> </div> <div class="table" id="CD013217-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Excluded studies of support of the mother‐infant dyad</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Details</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106 infants of mothers with known heroin or methadone use during pregnancy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2001 to December 2002</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward and intensive care nursery (BC, Canada)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in infants in study hospital (32 infants) compared to historical comparisons in study hospital (38 infants) and comparisons at a neighboring hospital without rooming in (36 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in vs historical comparisons in study hospital vs neighboring hospital without rooming in </p> <p> <ol id="CD013217-list-0031"> <li> <p>Shorter length of hospital stay (mean: 11.8 days, SD 9.1 vs 23.5 days, SD 24.6 vs 25.9 days, SD 19.7) </p> </li> <li> <p>Statistically significant decrease in use of pharmacological treatment (25.0% vs 55.3% [RR 0.45, 95% CI 0.23 to 0.87] vs 52.8% [RR 0.47, 95% CI 0.24 to 0.93]) </p> </li> <li> <p>Statistically significant decrease in pharmacological treatment duration (mean: 5.9 days, SD 14.2 in study hospital vs 18.6 days, SD 23.4 vs 18.6 days, SD 20.1) </p> </li> <li> <p>Statistically significant increase in likelihood of discharge with mothers (discharged in custody of mothers: 71.9% vs 31.6% [RR 2.28, 95% CI 1.36 to 3.81] vs 42.5% [RR 1.52, 95% CI 1.01 to 2.29]) </p> </li> <li> <p>Trend toward decreased prevalence of NAS symptoms</p> </li> <li> <p>Increased prevalence of weight loss &gt; 10% in the first week of life (16.6% vs 5.2% [RR 2.96, 95% CI 0.62 to 14.28] vs 5.3% [RR 2.81, 95% CI 0.59 to 13.5]) </p> </li> <li> <p>Statistically significant decrease in admission to a level II nursery (37.5% vs 89.5% [RR 0.42, 95% CI 0.26 to 0.66] and 83.3% ]RR 0.45, 95% CI 0.28 to 0.72]) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Several baseline differences between groups and hospitals with significant difference in feeding practices between groups (62.5% of the rooming in group breastfeeding compared to 7.9% of the historical cohort and 11.1% of the concurrent cohort) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0009" title="AbrahamsRR , Mackay-DunnMH , NevmerjitskaiaV , MacraeGS , PayneSP , HodgsonZG . An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2010;32(9):866-71. [DOI: ﻿10.1016/S1701-2163(16)34659-X] [PMID: 21050520]">Abrahams 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>952 singleton infants of mothers with documented substance use</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2003 to December 2006</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal; quote: "combined care nursery" and intensive care nursery (British Columbia, Canada) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in with comprehensive education in study hospital (355 infants, term 255 infants) vs standard nursery care at all other hospitals (597 infants, term 434 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in vs standard nursery care</p> <p> <ol id="CD013217-list-0032"> <li> <p>Longer hospital length of stay (all infants: mean: 20.7 days, SD 20.5 vs 10.7 days, SD 19.4; term infants: mean 17.6 days, SD 11.3 vs 8.1 days, SD 12.6) </p> </li> <li> <p>Decreased admissions to NICU (all infants: 38.9% vs 45.0%; OR 0.68, 95% CI 0.51 to 0.92; P &lt; 0.001; term infants: 23.5% vs 38.5%; OR 47, 95% CI 0.324 to 0.67; P &lt; 0.001) </p> </li> <li> <p>Shorter NICU length of stay in term infants (all infants: mean: 5.0 days, SD 19.2 vs 5.0 days, SD 12.6; term infants: mean: 1.1 days, SD 3.1 vs 3.1 days, SD 8.3) </p> </li> <li> <p>Increased receipt of breast milk (all infants: 63.7% vs 45.4%; OR 2.11, 95% CI 1.61 to 2.77; P &lt; 0.001) </p> </li> <li> <p>No difference in breastfeeding status at discharge (all infants: 34% vs 35.1%; OR 0.953, 95% CI 0.67 to 1.35; P = 0.79) </p> </li> <li> <p>Increased discharge home with mother (69.9% vs 58.7%)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline differences between groups and hospitals. Newborns in rooming in group had increased odds of receiving breast milk during hospital stay. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0011" title="CrookK , BrandonD . Prenatal breastfeeding education: impact on infants with neonatal abstinence syndrome. Advances in Neonatal Care2017;17(4):299-305. [DOI: 10.1097/ANC.0000000000000392] [PMID: 28244941]">Crook 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort (quality improvement methodology)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 infants evaluated for NAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2014 to July 2015</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NICU, small percentage on pediatric unit if high NICU census (North Carolina, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baby friendly status</p> <p>Breastfeeding initiative (3 class curriculum)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0033"> <li> <p>Decrease in length of stay from a mean of 18.80 days, SD 14.71 to 10.41 days, SD 10.54 (P &lt; 0.001) </p> </li> <li> <p>Decrease in pharmacological treatment from 67.3% to 34.8% (P &lt; 0.001)</p> </li> <li> <p>Increase in exclusive breastfeeding from 20.0% to 31.9% (P not reported)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Infants who received more than 50% human milk had a predicted [length of stay] 2.78 days shorter than infants who received more than 50% formula during hospitalization (P = .08)." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 mother‐infant dyads in a single center rooming in cohort of infants treated pharmacologically for NAS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2015 to April 2016</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pediatric inpatient unit for pharmacological treatment (Massachusetts, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Parental presence (percent of time)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0034"> <li> <p>Maximum (100%) parental presence was associated with a 9‐day shorter length of stay (r = –0.31, 95% CI –0.48 to –0.10; P = 0.01), 8 fewer days of infant opioid therapy (r = –0.34, 95% CI –0.52 to –0.15; P = 0.001), and 1 point lower mean Finnegan score (r = –0.35, 95% CI –0.52 to –0.15; P = 0.01) </p> </li> <li> <p>Quote: "There was a 5.3 mg decrease in the total morphine equivalent dose with increased parental presence (r = –0.20; 95% CI, –0.39 to 0.02; P = .06)" </p> </li> <li> <p>Quote: "The mean NAS score when a parent was present was significantly lower compared with when a parent was not present (5.1 [95% CI, 4.9–5.3] versus 6.0 [95% CI, 5.8–6.2]; P &lt; .0001)" </p> </li> <li> <p>Quote: "Parental presence was higher for infants who were breastfed (65.2% vs 44.5%; P &lt; .001)" </p> </li> <li> <p>Quote: "Parental presence was lower for infants in Department of Children and Families (DCF) custody (36.6% vs 59.7%; P &lt; .001)" </p> </li> <li> <p>Quote: "After adjusting for breastfeeding, parental presence remained significantly associated with reduced NAS score and opioid treatment days" </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "In unadjusted analyses, any amount of breastfeeding was associated with a decreased [length of stay] (16.5 vs 21.2 days; P &lt; .01) as was clinical trial participation (15.8 vs 20.0 days; P &lt; .01). Similarly, breastfeeding and clinical trial participation were also significantly associated with decreased duration of opioid therapy and decreased total morphine equivalent dose." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 infants with NAS transferred from the maternity ward to the neonatal ward for potential pharmacological treatment </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2004–2011</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neonatal ward (Germany)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in within the neonatal ward (24 infants) vs not rooming in within the neonatal ward (53 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in vs no rooming in</p> <p> <ol id="CD013217-list-0035"> <li> <p>Shorter length of hospital stay (mean: 36.6, SD 10.2 vs 42.8, SD 15.3; P = 0.077)</p> </li> <li> <p>No difference in use of pharmacological treatment (79% vs 88.7%; P = 0.14)</p> </li> <li> <p>Shorter duration of pharmacological treatment (mean: 29.5, SD 11.5 vs 35.8, SD 15.3; P = 0.043) </p> </li> <li> <p>Lower maximum dose of opioid (mean: 132 μg/kg/day diluted tincture of opium, SD 56 vs 145 μg/kg/day diluted tincture of opium, SD 60; P = 0.84) </p> </li> <li> <p>No difference in the frequency of Finnegan Scores ≥ 12 (6.4% vs 6.3%; P = 0.98). No difference in maximum Finnegan score (19 points in both groups). </p> </li> <li> <p>Lower costs (mean EUR 10,620, SD 5306 vs EUR 14,331, SD 6028; P = 0.014)</p> </li> <li> <p>More infants discharged home with families (79.2% vs 69.8%; P = 0.046)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 2 infants were breastfed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0023" title="McKnightS , CooH , DaviesG , HolmesB , NewmanA , NewtonL , et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology2016;33(5):495-501. [DOI: ﻿10.1055/s-0035-1566295] [PMID: 26588259]NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):e555-61. [PMID: 27035006]">McKnight 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort (historical controls)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44 singleton infants &gt; 36 weeks' gestation of women taking chronic opioid therapy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>May 2012 to September 2014 (excluding June to August 2013)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pediatrics unit with transfer to NICU for pharmacological treatment (Ontario, Canada)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline (24 infants) and postimplementation (20 infants) of initial observation while rooming in with mother in a private room in the pediatrics unit. Infants transferred to the NICU if pharmacological treatment was required </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0036"> <li> <p>Shorter length of hospitalization (median: 5.0, IQR 3 vs 24.0, IQR 34; P &lt; 0.001)</p> </li> <li> <p>Reduced use of pharmacological treatment of NAS (15.0% vs 83.3%; P &lt; 0.001)</p> </li> <li> <p>No difference in duration of treatment with morphine (median: 24.0, IQR could not be calculated vs 29.5, IQR 23; P = 0.83) </p> </li> <li> <p>No difference in maximum daily dose of morphine (median: 0.48 mg/kg/day, IQR could not be calculated vs 0.48 mg/kg/day, IQR 0.48; P = 0.90) </p> </li> <li> <p>Fewer treated with adjunct pharmacotherapy (0% vs 30.0%; P = 0.54)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "While not significant, a higher proportion of infants in the rooming‐in group were breastfed exclusively or in combination with formula." </p> <p>Emailed authors to clarify data and the relationship between the 2 publications, 1 additional participant included in earlier publication (<a href="./references#CD013217-bbs2-0111" title="NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):555-61. [PMID: 27035006]">Newman 2015</a>) who was different from the usual population </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0025" title="MetzV , JagschR , EbnerN , WurzlJ , PribasnigA , AschauerC , et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology2011;26(6):412-21. [DOI: ﻿10.1002/hup.1224] [PMID: 21823171]">Metz 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114 opioid‐exposed newborns of mothers maintained on methadone (70 infants) or buprenorphine (44 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>June 2005 to December 2009</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (Austria)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participation in a randomized double‐blind double‐dummy clinical trial ("MOTHER study", 37 infants) vs standard care (77 infants) </p> <p>Clinical trial included daily maternal contact with study staff and mandatory rooming in with mother for ≥ 10 days after delivery </p> <p>Standard care neonates were treated in a separate ward and mothers were discharged when medically cleared </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical trial vs standard protocol</p> <p> <ol id="CD013217-list-0037"> <li> <p>Shorter length of stay (days) in the clinical trial group (methadone‐exposed mean: 16.74, SD 6.78 vs 29.36, SD 17.94; buprenorphine‐exposed mean: 13.67, SD 2.63 vs 13.92, SD 7.33) </p> </li> <li> <p>More infants used pharmacological treatment in the clinical trial group (76% vs 60%)</p> </li> <li> <p>Lower total medication dose in the clinical trial group (methadone‐exposed mean: 5.18 mg, SD 6.94 vs 21.61 mg, SD 26.64; buprenorphine‐exposed mean: 2.02 mg, SD 1.71 vs 4.30 mg, SD 7.30) </p> </li> <li> <p>Shorter length of pharmacological treatment in the clinical trial group (methadone‐exposed mean: 9.53 days, SD 9.14 vs 21.25 days, SD 21.22; buprenorphine‐exposed mean: 7.33 days, SD 4.46 vs 6.62 days, SD 8.07) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modified Finnegan used for clinical trial vs traditional Finnegan for standard care</p> <p>Likely fundamentally different group self‐selected for clinical trial</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94 pregnant methadone‐maintained women attending integrated care programs and their children </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1997–2009</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified for rooming in cohort, NICU (Ontario, British Columbia, and Quebec, Canada) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in approach (36 infants) vs 2 neighboring hospitals that admit infants to the neonatal intensive care unit for NAS scoring (36 and 22 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in vs hospital 1 (no rooming in) vs hospital 2 (no rooming in)</p> <p> <ol id="CD013217-list-0038"> <li> <p>Longer hospital stay (mean: 26 days, SD 16 vs 14 days, SD 15 vs 16 days, SD 14)</p> </li> <li> <p>No difference in use of pharmacological treatment (29% vs 31% vs 18%; P = 0.564)</p> </li> <li> <p>No difference in duration of NAS treatment (mean: 13 days, SD 6 vs 25 days, SD 17 vs 30 days, SD 27; P = 0.086) </p> </li> <li> <p>Decreased NICU admission (42% vs 94% vs 91%; P = 0.003)</p> </li> <li> <p>No difference in weight loss (7.4% vs 7.0% vs 8.7%; P = 0.204)</p> </li> <li> <p>No difference in days to weight gain (mean: 4.3, SD 1.9 vs 4.2, SD 2.5 vs 5.6, SD 2.8; P = 0.093) </p> </li> <li> <p>Increase in discharge with mother (41% vs 69% vs 68%; P = 0.115)</p> </li> <li> <p>No difference in breastfeeding (14% vs 17% vs 22%; P = 0.767)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Minimal difference in breastfeeding between groups.</p> <p>Significant intersite differences were found in ethnicity and marital status.</p> <p>Emailed authors to clarify data.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0034" title="SaikiT , LeeS , HannamS , GreenoughA . Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics2010;169(1):95-8. [DOI: ﻿10.1007/s00431-009-0994-0] [PMID: 19440732]">Saiki 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort (historical controls)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 infants with NAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time Period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2002–2007</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of Care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward for monitoring and pharmacological treatment and neonatal unit (UK)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline (42 infants) and postimplementation (18 infants) of a system of pharmacological treatment of the infant in the postnatal ward instead of transferring from the postnatal ward to the neonatal unit if escalating symptoms </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline vs postimplementation</p> <p> <ol id="CD013217-list-0039"> <li> <p>Shorter hospital stay (mean: 19.8 days vs 15.9 days; P = 0.012)</p> </li> <li> <p>Fewer infants required treatment (45% vs 11%; P = 0.012)</p> </li> <li> <p>Shorter duration of treatment (mean: 12.7 days vs 7.3 days; P = 0.05)</p> </li> <li> <p>No difference in discharge with mother (60% vs 67%; P = 0.264)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>466 infants receiving care for NAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2006–2014</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward for monitoring and pharmacological treatment and Neonatal unit (South Carolina, USA) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infants enrolled in the Managing Abstinence in Newborns (MAiN) intervention (110 infants) vs infants who were potentially eligible but did not receive the intervention (356 infants) </p> <p>MAiN; quote: "provides multidisciplinary, coordinated, community‐based care for infants at risk for opioid withdrawal and their families within a mother/baby unit. MAiN's three essential elements are early treatment (methadone administered within 48 hours of birth), the option to room in with the mother for the entire hospitalization, and a combined inpatient/outpatient wean." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MAiN vs no MAiN</p> <p> <ol id="CD013217-list-0040"> <li> <p>Non‐significant decrease in length of stay (median: 8 days, IQR 6 to 10 vs 9 days, IQR 4 to 18; P = 0.14) </p> </li> <li> <p>Significantly higher involvement of child protective services in the MAiN cohort (32.7% vs 23.3%; P = 0.048) </p> </li> <li> <p>All infants received level 1 care, 68.8% of comparison babies received level 2 to 3 care </p> </li> <li> <p>Lower total cost (median: USD 10,058, IQR USD 7935 to USD 11,518 vs USD 18,262, IQR USD 5816 to USD 40,922; P &lt; 0.001) </p> </li> <li> <p>'Convulsions' were reported in 1 intervention infant and no comparison infants</p> </li> <li> <p>Diagnosed with 'abnormal loss of weight' more often (3.6% vs 0.8%; P = 0.04)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference in breastfeeding between groups (43.6% vs 48.9%; P = 0.57)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; DCF: Department of Children and Families; IQR: interquartile range; MAiN: Managing Abstinence in Newborns; MOTHER: Maternal Opioid Treatment: Human Experimental Research; NAS: neonatal abstinence syndrome; NICU: neonatal intensive care unit; OR: odds ratio; r: Pearson's correlation coefficient; RR: risk ratio; SD: standard deviation. </p> </div> </div> <div class="table" id="CD013217-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Excluded studies of multiple non‐pharmacological care practices</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Details</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort (quality improvement methodology)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>287 infants diagnosed with NAS. Excluded infants not exposed to methadone and with serious comorbid conditions </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2008 to June 2016</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pediatrics unit, postnatal ward, and NICU (Connecticut, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Standardization of nonpharmacologic care coupled with an empowering message to parents, development of a novel approach to assessment, administration of morphine on an as‐needed basis, and transfer of infants directly to the inpatient unit." </p> <p>Baseline period from January 2008 to February 2010 (55 infants), intervention period (188 infants), and postimplementation period from May 2015 to June 2016 (44 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0041"> <li> <p>Decrease in mean length of stay (22.4 days to 5.9 days; P &lt; 0.001), postnatal morphine treatment (98% to 14%; P &lt; 0.001), and mean cost (USD 44,824 to USD 10,289; P &lt; 0.001) </p> </li> <li> <p>More infants fed breast milk at discharge following implementation (20% to 45%; P = 0.01) </p> </li> <li> <p>Fewer infants admitted to the NICU (100% to 20%; P &lt; 0.001)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort (quality improvement methodology)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>163 opioid‐exposed newborns</p> <p>Excluded infants with gestational age &lt; 35 weeks, another reason for NICU admission, or who completed treatment at another facility </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2012 to February 2015</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pediatrics unit, postnatal ward, and NICU (New Hampshire, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Staff training, family education (involvement in symptom monitoring and non‐pharmacological treatment), and care in inpatient pediatric unit </p> <p>Baseline period from March 2012 to February 2013 (54 infants), intervention year 1 from March 2013 to February 2014 (61 infants), and intervention year 2 from March 2014 to February 2015 (48 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0042"> <li> <p>Decrease in use of pharmacological treatment (46% to 27%), adjunctive use of phenobarbital (13% to 2%), mean length of hospitalization for pharmacologically treated infants (16.9 days to 12.3 days), mean cost per treated infant (USD 19,737 to USD 8755; P &lt; 0.01), mean cost per at risk patient (USD 11,000 to USD 5300; P &lt; 0.01), and cumulative morphine exposure (13.7 mg to 6.6 mg per treated newborn) </p> </li> <li> <p>No change noted in length of hospitalization for non‐pharmacologically treated infants (4.2 days to 4.4 days; P = 0.33) </p> </li> <li> <p>No change in mean daily Finnegan score; quote: "no significant difference in median score, maximum score, or first score by year (<i>P</i> = 0.53, 0.29, 0.48, respectively)" </p> </li> <li> <p>No change in number of newborns discharged in parental custody (93% to 90%; P = 0.73)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0020" title="KirchnerL , Graf-RohrmeisterK , Klebermass-SchrehofK , WeningerM , JagschR , MetzV , et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: 25062111]">Kirchner 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>131 infants who completed an international multicenter clinical trial ("MOTHER study")</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2005–2008</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (international)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparison by site of enrollment; quote: "the 7 contributing sites were divided into 3 clusters: the <i>European cluster</i> (Vienna site, n=37), the <i>rural US cluster (N=39)</i> : Burlington (University of Vermont, n=26), Nashville (Vanderbilt University, n=13), and the <i>urban US cluster (n=55)</i>: Detroit (Wayne State University, n=12), Providence (Brown University, n=3), Philadelphia (Thomas Jefferson University, n=23), Baltimore (Johns Hopkins University, n=17)" </p> <p>Quote: "A standardized NAS rating and treatment protocol was applied, while non‐pharmacologic care of NAS symptoms differed across sites" </p> <p>Quote: "In Europe, all neonates (also those without treatment requirement) stayed in the hospital accommodated in a room with their mothers for at least 10 days" </p> <p>Quote: "The breastfeeding rate was much higher in Europe and was highest in rural US" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0043"> <li> <p>Quote: "The lowest morphine doses for both medication conditions were administered in Europe where all babies were kept in a rooming‐in situation in hospital for at least 10 days" </p> </li> <li> <p>Pharmacological treatment rates: 18.5% Europe rooming in model vs 29.5% urban USA vs 18.5% rural USA </p> </li> <li> <p>Mean total dose of morphine within the first 28 postpartum days: 5.38 mg Europe rooming in model vs 35.05 mg urban USA vs 8.66 mg rural US </p> </li> <li> <p>Quote: "Urban US neonates had significantly higher NAS scores (p&lt;0.01) compared to rural US and European neonates, and needed significantly higher morphine doses (<i>P</i> &lt; 0.05) with longer treatment duration" </p> </li> <li> <p>Quote: "Urban US neonates exhibited most neurological symptoms (<i>P</i> &lt; 0.001) while in Europe autonomous, respiratory and gastrointestinal symptoms were found significantly more often compared to urban and/or rural US (<i>P</i> &lt; 0.05)" </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "No differences between sites could be found in behavioural symptoms, but interestingly a significant positive influence on these symptoms could be demonstrated by breastfeeding (β = –0.261; P = 0.034), with explaining 6.8% of variance" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0022" title="LoudinS , WerthammerJ , PruntyL , MurrayS , ShapiroJI , DaviesTH . A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic. Journal of Perinatology2017;37(10):1108-11. [DOI: ﻿10.1038/jp.2017.101] [PMID: 28682317]">Loudin 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort (historical controls)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1023; quote: "inborn neonates &gt;35 weeks' gestational age with the diagnosis of NAS (ICD9‐CM 779.5), requiring pharmacologic treatment" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2010–2015</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neonatal abstinence center, NTU, and NICU (West Virginia, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline (number of infants not reported); quote: "managed in the NICU, a 36 bed level III unit with an average of 550 admissions per year" and post‐implementation (number of infants not reported) of a neonatal therapeutic unit (NTU), (quote) "a 15‐bed low‐light, low‐noise unit with a dedicated nursing staff and nursing aids along with community volunteers called 'rockers' who were specially trained to hold and rock the neonates when appropriate and when family members were unavailable. The staff utilized therapeutic handling techniques that further enhanced calming effects on the neonates." Also compared to post‐implementation (78 infants) of an offsite; quote: "neonatal abstinence center with 12 beds and a dedicated staff of nurses, patient care assistants, and volunteers trained in the care of neonates with NAS. In addition, on‐site social service personnel served to transition caretakers (birth parents, foster parents or adopting families) … to a safe home environment. Limited number of patient rooms were available to accommodate rooming in, thus that space was utilized to help prepare caretakers prior to discharge." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0044"> <li> <p>Quote: "The median [length of stay] for NAS medication‐treated patients in the NICU without comorbidities was 24 days (interquartile range 24 to 52). Median [length of stay] in the NTU was 26 days (interquartile range 26 to 42). The median [length of stay] for Lily's Place was 33 days (interquartile range 32 to 60 days), indicative of the transition to home life mission of the facility in addition to extended neonatal withdrawal care" </p> </li> <li> <p>Significantly higher median cost per patient for those managed in the NICU (USD 90,601, IQR USD 64,489 to USD 128,135) compared to the NTU (USD 68,750, IQR USD 44,952 to USD 92,548) and then compared to the offsite neonatal abstinence center (USD 17,688, IQR USD 9933 to USD 20,033); P &lt; 0.0001 </p> </li> <li> <p>Quote: "The percentage of total NAS patients requiring pharmacologic treatment in the NICU fell from 100% prior to the establishment of the NTU to 22% by 2015" </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort (historical controls)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>176 infants of women in a methadone maintenance program</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1991–1994, 1997–2001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward and neonatal medicine unit (UK)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline (78 infants) and postimplementation (98 infants) of a shared care approach in clinical management with a drug liaison midwife service for mothers and infants. Also changed from primary admission to the neonatal medicine unit to primary admission to the maternity ward with transfer to the neonatal medicine unit if pharmacological treatment was required. Additionally, scoring was modified, the threshold for pharmacological treatment adjusted, and treatment choice changed from chlorpromazine to phenobarbitone. Quote: "The [drug liaison midwife] provided specialist advice regarding methadone treatment, care of the newborn, and the advantages of breastfeeding." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0045"> <li> <p>Quote: "Infants spend less time in hospital (median 5 days vs 28 days, <i>P</i> &lt; 0.0002), a smaller proportion had treatment for NAS (14% vs 79%, <i>P</i> = 0.001), and neonatal medicine unit admission was reduced (median 14 days vs 26 days, <i>P</i> &lt; 0.0003 [number of infants 100% vs 40%, <i>P</i> &lt; 0.001])" </p> </li> <li> <p>Quote: "Neonatal convulsions (<i>P</i> = 0.0001) and jaundice (<i>P</i> &lt; 0.001) occurred less frequently, and more infants were breastfed (<i>P</i> = 0.001)" </p> </li> <li> <p>Quote: "About 10% of infants were discharged to a foster family" in both time periods</p> </li> <li> <p>Quote: "None of these children had impairments of vision, hearing, growth, or development" in the first year after leaving the hospital (baseline n = 24, post‐implementation n = 98) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort (quality improvement methodology)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3458 infants pharmacologically treated for NAS. Data were collected through serial cross‐sectional audits of 199 participating centers </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012–2014</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (International)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Participating NICUs shared common interests, worked collaboratively, shared information and ideas, and developed standardized practices." The goal was to facilitate guideline update "for the following: (1) screening for maternal substance use; (2) nonpharmacologic treatment of infants with NAS; (3) scoring signs of NAS; (4) breastfeeding; (5) pharmacologic management; and (6) duration of observation of exposed infants." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0046"> <li> <p>Quote: "(T)he mean number of NAS‐focused guidelines increased from 3.7 to 5.1 of a possible 6 (<i>P</i> &lt; .001), with improvements noted in all measured domains" </p> </li> <li> <p>Quote: "(D)ecreases occurred in median (interquartile range) length of pharmacologic treatment, from 16 days (10 to 27 days) to 15 days (10 to 24 days; <i>P</i> = .02) and [length of stay] from 21 days (14 to 33 days) to 19 days (15 to 28 days; <i>P</i> = .002)" </p> </li> <li> <p>The difference in predicted mean length of treatment for hospitals that implemented policies about non‐pharmacological treatment of NAS was –2.0 days (95% CI –4.4 to 0.5) with a predicted length of stay of –2.5 days (95% CI –5.1 to 1.2) </p> </li> <li> <p>The difference in predicted mean length of treatment for hospitals that implemented policies about breastfeeding or provision of expressed human milk was –0.7 days (95% CI –2.1 to 0.7) with a predicted length of stay of –0.5 days (95% CI –2.1 to 1.1) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort (pre‐/postquality improvement methodology)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>240 opioid‐exposed infants &gt; 36 weeks' gestation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>April 2015 to December 2017</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pediatrics unit and postnatal ward (Massachusetts, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline (101 infants), intervention (54 infants), and postintervention (85 infants). Interventions included (quote): "a non‐pharmacologic care bundle, function‐based assessments consisting of symptom prioritization and then the "Eat, Sleep, Console" (ESC) Tool; and a switch to methadone for pharmacologic treatment." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0047"> <li> <p>Quote: "Pharmacologic treatment decreased from 87.1 to 40.0%; adjunctive agent use from 33.6 to 2.4%; hospitalization length from a mean 17.4 to 11.3 days, and opioid treatment days from 16.2 to 12.7 (<i>P</i> &lt; 0.001 for all). Total hospital charges decreased from $31,825 to $20,668 per infant. Parental presence increased from 55.6 to 75.8% (<i>P</i> &lt; 0.0001). No adverse events were noted." </p> </li> <li> <p>Hospital length of stay for pharmacologically treated infants trended downward (19.1 days to 17.6 days; P = 0.11) </p> </li> <li> <p>Quote: "There were no NICU admissions for management of NAS or its complications, and no seizures" </p> </li> <li> <p>No significant change in NICU admission (23.7% to 21.2%; P = 0.78) or DCF custody status (19.8% to 28.2%; P = 0.18) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Breastfeeding initiation rate did not differ during the two time periods."</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; DCF: Department of Children and Families; ESC: Eat, Sleep, Console Tool; IQR: interquartile range; MOTHER: Maternal Opioid Treatment: Human Experimental Research; NAS: neonatal abstinence syndrome; NICU: neonatal intensive care unit; NTU: neonatal therapeutic unit. </p> </div> </div> </section> <section id="CD013217-sec-0058"> <h4 class="title">Ongoing studies</h4> <p>We identified seven ongoing studies in the search that may qualify for inclusion at review update when complete (<a href="./references#CD013217-sec-0167" title="">Characteristics of ongoing studies</a> table; <a href="./references#CD013217-bbs2-0041" title="NCT02768844. Physiology and therapeutic management of neonatal abstinence syndrome. clinicaltrials.gov/show/NCT02768844 (first received 11 May 2016). ">NCT02768844</a>; <a href="./references#CD013217-bbs2-0042" title="NCT02801331. Efficacy and outcomes of a non-pharmacological intervention for neonatal abstinence syndrome. clinicaltrials.gov/show/NCT02801331 (first received 15 June 2016). ">NCT02801331</a>; <a href="./references#CD013217-bbs2-0043" title="NCT03097484. The effect of aromatherapy on neonatal abstinence syndrome and salivary cortisol levels. clinicaltrials.gov/show/NCT03097484 (first received 31 March 2017). ">NCT03097484</a>; <a href="./references#CD013217-bbs2-0044" title="NCT03113656. Weighted blankets with infants with NAS. clinicaltrials.gov/show/NCT03113656 (first received 13 April 2017). ">NCT03113656</a>; <a href="./references#CD013217-bbs2-0045" title="NCT03533985. Effect of music therapy on Infants with Neonatal Abstinence Syndrome. clinicaltrials.gov/show/NCT03533985 (first received 23 May 2018). ">NCT03533985</a>; <a href="./references#CD013217-bbs2-0046" title="NCT03549936. Role of low lactose infant formula in the management of neonatal abstinence syndrome. clinicaltrials.gov/show/NCT03549936 (first received 8 June 2018). ">NCT03549936</a>; <a href="./references#CD013217-bbs2-0047" title="NCT03987165. The effect of music therapy on newborns. clinicaltrials.gov/show/NCT03987165 (first received 14 June 2019). ">NCT03987165</a>). </p> <p>See <a href="#CD013217-fig-0001">Figure 1</a> for the selection process. </p> </section> <section id="CD013217-sec-0059"> <h4 class="title">Results of the search</h4> <section id="CD013217-sec-0060"> <h5 class="title">Comparison 1</h5> <p>We identified six RCTs comparing single or bundled non‐pharmacological interventions to no non‐pharmacological treatment or different single or bundled non‐pharmacological interventions in infants at risk for, or having early symptoms consistent with, opioid withdrawal as defined above (see <a href="./references#CD013217-sec-0165" title="">Characteristics of included studies</a> table). </p> </section> <section id="CD013217-sec-0061"> <h5 class="title">Comparison 2</h5> <p>We identified no RCTs comparing single or bundled non‐pharmacological interventions to no non‐pharmacological treatment or different single or bundled non‐pharmacological interventions in infants receiving opioid treatment for symptoms consistent with opioid withdrawal as defined above. </p> </section> </section> <section id="CD013217-sec-0062"> <h4 class="title">Included studies</h4> <section id="CD013217-sec-0063"> <h5 class="title">Modifying environmental stimulation</h5> <p><a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a> compared 198 infants randomized to either a study nursery or the regular nursery at a children's hospital in the USA. This study included infants at risk for opioid withdrawal due to maternal opioid exposure (131 clinic infants, 57 non‐clinic infants). Non‐opioid exposure and feeding type were not specified. Infants in the study nursery were placed in incubators; fed every three hours; and maintained in a secluded, quiet, dim room. In comparison, infants in the regular nursery were placed in open bassinets, fed every four hours, and exposed to normal nursery noise and light. As measured by a center‐specific withdrawal rating, there were no significant differences in severity or pattern of withdrawal symptoms or in degree of weight loss. Eleven infants received pharmacological treatment and there was no difference between groups. </p> <p><a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a> compared 49 infants randomized to either non‐oscillating waterbeds or conventional bassinets in a nursery at a hospital in the USA. This study included infants at risk for opioid withdrawal due to prenatal narcotic exposure and heroin or methadone, or both, on urine toxicology results. Twelve narcotic‐exposed and three with coexposure to cocaine or methamphetamine, or both, were chosen from the intervention group and matched to comparable control neonates. Outcomes were not reported for 19 randomized infants. All infants were formula fed. Infants in the intervention group showed less severe central nervous system withdrawal symptoms, improved weight gain, required a lower maximum dose of phenobarbital, and more infants were weaned off from medication prior to discharge. There was no significant difference in overall use of pharmacological treatment. </p> <p><a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a> compared 14 infants randomized to either a rocking bed or a standard bed from 24 hours of life to seven days of life in a nursery at a university hospital in the USA. This study included infants at risk for opioid withdrawal due to prenatal methadone exposure. Non‐opioid exposures included ethanol, heroin, marijuana, and cigarettes, but excluded cocaine. Feeding type was not reported. The rocking bed intervention consisted of a motor‐driven rocking bed set at 75% rocking that started and stopped at randomly determined intervals and was used in combination with maternal intrauterine sounds. Infants in the intervention group showed increased withdrawal symptoms by the seventh day of life and increased sleep disruption. All infants received pharmacotherapy for withdrawal symptoms. </p> <p><a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a> compared 48 infants randomized to either prone sleep positioning or supine sleep positioning in an intensive care nursery at a university hospital in the USA. This study included infants at risk for opioid withdrawal with urine toxicology positive for heroin or methadone, or both. Approximately 60% of infants in each group also had urine toxicology positive for cocaine. All infants were formula fed. All infants were swaddled for sleep. Infants in the intervention group were then placed prone. Infants in the intervention group had lower peak and mean withdrawal scores as well as lower caloric intake. All infants received pharmacotherapy for withdrawal symptoms. </p> </section> <section id="CD013217-sec-0064"> <h5 class="title">Feeding practices</h5> <p><a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> compared 49 infants randomized to either 24 kcal/oz formula or 20 kcal/oz formula from day three to 21 of life at a large, urban hospital in the USA. Site of care was not specified. This study included infants at risk for opioid withdrawal due to maternal methadone treatment. Maternal and infant drug screens at delivery were positive for illicit drugs more often in the control group. Both breastfed and formula‐fed infants were included in the study and breast milk feedings were prioritized over study formula feedings. The main outcome was evaluation of weight parameters. Infants in the high‐calorie intervention group trended toward improved weight parameters as measured by weight nadir, days to return to birth weight, and mean daily weight gain. A similar proportion of infants in each group received pharmacological treatment and there was no significant difference in treatment duration for those who used pharmacological treatment. There was significant crossover between groups. </p> </section> <section id="CD013217-sec-0065"> <h5 class="title">Support of the mother‐infant dyad</h5> <p><a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a> compared 14 mother‐infant dyads randomized to either tailored breastfeeding support or standard Baby‐Friendly Initiative care in a tertiary maternity hospital in Scotland. Infants were admitted to a room with their mothers and transferred to the neonatal unit for pharmacological treatment. This study included infants at risk for opioid withdrawal due to maternal opioid substitution therapy during pregnancy. Mothers with ongoing illicit psychoactive drug or alcohol use were excluded. All mothers intended to breastfeed. Tailored support included a one‐hour session daily for five days with a dedicated support worker. Sessions focused on breastfeeding support, promotion of self‐efficacy, neonatal self‐consolation techniques, and low‐stimuli environment. Infants in the intervention group were less likely to receive pharmacological treatment, and had a shorter length of stay compared to the control group. This effect may have been related to feeding practice since all infants in the intervention group were breastfed on day five compared to four of seven in the control group or to the ability to continue to room in with their mothers. In post hoc analysis of feeding practice, breastfed infants were less likely to be treated with pharmacological therapy and had a shorter length of stay. </p> </section> </section> <section id="CD013217-sec-0066"> <h4 class="title">Excluded studies</h4> <p>We excluded 34 non‐randomized studies in the search. These studies are described in a narrative presentation here. Further details about studies are included in and supplementary tables and the appendix (see <a href="./references#CD013217-sec-0166" title="">Characteristics of excluded studies</a> table; <a href="#CD013217-tbl-0002">Table 1</a>; <a href="#CD013217-tbl-0003">Table 2</a>; <a href="#CD013217-tbl-0004">Table 3</a>; <a href="#CD013217-tbl-0005">Table 4</a>; and <a href="./appendices#CD013217-sec-0130">Appendix 3</a>). </p> <p>We described cohort studies, case‐controlled studies, and cross‐sectional studies with a clear comparison of non‐pharmacological care practices. We did not describe studies without a clear comparison of non‐pharmacological care practices such as case series or case reports. We classified studies as prospective, retrospective, or both prospective and retrospective. We described studies using quality improvement methodology as prospective and retrospective cohorts. We classified studies as either historically or concurrently controlled. </p> <section id="CD013217-sec-0067"> <h5 class="title">Modifying environmental stimulation</h5> <p>(Adjustments of environmental stimulation include low light, low noise, clustered care, containment or swaddling, bedding type, positioning, non‐nutritive sucking, bathing, aromatherapy, music therapy, and massage.) </p> <p>Two prospective feasibility studies explored the effect of modifying environmental stimulation on individual opioid‐exposed newborns. <a href="./references#CD013217-bbs2-0033" title="RadziewiczRM , Wright-EsberS , ZupancicJ , GargiuloD , WoodallP . Safety of reiki therapy for newborns at risk for neonatal abstinence syndrome. Holistic Nursing Practice2018;32(2):63-70. [DOI: 10.1097/HNP.0000000000000251] [PMID: 29315084]">Radziewicz 2018</a> evaluated the effect of a 30‐minute Reiki treatment in a newborn nursery. <a href="./references#CD013217-bbs2-0040" title="ZuzarteI , IndicP , BartonB , PaydarfarD , BednarekF , Bloch-SalisburyE . Vibrotactile stimulation: a nonpharmacological intervention for opioid exposed newborns. PloS One2017;12(4):e0175981. [DOI: ﻿10.1371/journal.pone.0175981] [PMID: 28426726]">Zuzarte 2017</a> evaluated the effect of stochastic vibrotactile stimulation delivered by a specially constructed mattress in 30‐minute intervals in the NICU and a newborn nursery. Both studies were conducted in the USA. Neither study recorded outcomes prespecified for this review. </p> </section> <section id="CD013217-sec-0068"> <h5 class="title">Feeding practices</h5> <p>(Feeding modifications include infant‐led feeding, high caloric feedings, tube feedings, maternal breast milk feedings, non‐maternal breast milk feedings, low‐lactose formula, and breastfeeding.) </p> <p>Fifteen studies assessed the effect of feeding practices on outcomes in opioid‐exposed newborns. Thirteen studies were cohort studies including 11 retrospective (<a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a>; <a href="./references#CD013217-bbs2-0010" title="ArlettazR , KashiwagiM , Das-KunduS , FauchèreJC , LangA , BucherHU . Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstetricia et Gynecologica Scandinavica2005;84(2):145-50. [DOI: ﻿10.1111/j.0001-6349.2005.00510.x] [PMID: 15683374]">Arlettaz 2005</a>; <a href="./references#CD013217-bbs2-0012" title="DrydenC , YoungD , CampbellN , MactierH . Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. Archives of Disease in Childhood. Fetal and Neonatal Edition2012;97(3):F214-6. [DOI: ﻿10.1136/adc.2009.178723] [PMID: 20656717]DrydenC , YoungD , HepburnM , MactierH . Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG2009;116(5):665-71. [DOI: 10.1111/j.1471-0528.2008.02073.x] [PMID: 19220239]">Dryden 2009</a>; <a href="./references#CD013217-bbs2-0014" title="HodgsonZG , AbrahamsRR . A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2012;34(5):475-81. [DOI: 10.1016/s1701-2163(16)35245-8] [PMID: 22555142]">Hodgson 2012</a>; <a href="./references#CD013217-bbs2-0018" title="IsemannB , Meinzen-DerrJ , AkinbiH . Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. Journal of Perinatology2011;31(1):25-9. [DOI: dx.doi.org/10.1038/jp.2010.66] [PMID: 20508596]">Isemann 2011</a>; <a href="./references#CD013217-bbs2-0021" title="LiuA , JuarezJ , NairA , NananR . Feeding modalities and the onset of the neonatal abstinence syndrome. Frontiers in Pediatrics2015;3:14. [DOI: ﻿10.3389/fped.2015.00014] [PMID: 25767791]">Liu 2015</a>; <a href="./references#CD013217-bbs2-0024" title="McQueenKA , Murphy-OikonenJ , GerlachK , MontelpareW . The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Advances in Neonatal Care2011;11(4):282-90. [DOI: ﻿10.1097/ANC.0b013e318225a30c] [PMID: 22123351]">McQueen 2011</a>; <a href="./references#CD013217-bbs2-0026" title="MetzVE , ComerSD , PribasnigA , WuerzlJ , FischerG . Observational study in an outpatient clinic specializing in treating opioid dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine. Heroin Addiction and Related Clinical Problems2015;17(1):5-16. ">Metz 2015</a>; <a href="./references#CD013217-bbs2-0028" title="O'ConnorAB , CollettA , AltoWA , O'BrienLM . Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. Journal of Midwifery and Women's Health2013;58(4):383-8. [DOI: ﻿10.1111/jmwh.12009] [PMID: 23931660]">O'Connor 2013</a>; <a href="./references#CD013217-bbs2-0031" title="PrithamUA , PaulJA , HayesMJ . Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing2012;41(2):180-90. [DOI: 10.1111/j.1552-6909.2011.01330.x] [PMID: 22375882]">Pritham 2012</a>; <a href="./references#CD013217-bbs2-0035" title="ShortVL , GannonM , AbatemarcoDJ . The association between breastfeeding and length of hospital stay among infants diagnosed with neonatal abstinence syndrome: a population-based study of in-hospital births. Breastfeeding Medicine2016;11(7):343-9. [DOI: ﻿10.1089/bfm.2016.0084] [PMID: 27529500]">Short 2016</a>), one retrospective and prospective (<a href="./references#CD013217-bbs2-0039" title="Welle-StrandGK , SkurtveitS , JanssonLM , BakstadB , BjarkoL , RavndalE . Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatrica2013;102(11):1060-6. [DOI: ﻿10.1111/apa.12378] [PMID: 23909865]">Welle‐Strand 2013</a>), and one prospective study (<a href="./references#CD013217-bbs2-0037" title="WachmanEM , HayesMJ , BrownMS , PaulJ , Harvey-WilkesK , TerrinN , et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA2013;309(17):1821-7. [DOI: ﻿10.1001/jama.2013.3411]">Wachman 2013</a>). Two additional studies used case‐control methodology, one with concurrent controls (<a href="./references#CD013217-bbs2-0019" title="JanssonLM , ChooR , VelezML , HarrowC , SchroederJR , ShakleyaDM , et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics2008;121(1):106-14. [DOI: ﻿10.1542/peds.2008-0217] [PMID: 18166563]">Jansson 2008</a>), and one with historical controls (<a href="./references#CD013217-bbs2-0032" title="RadmacherP , AlexanderC , DevlinL . Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15]">Radmacher 2017</a>). Twelve studies assessed infants at risk for, or having, early symptoms consistent with opioid withdrawal (<a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a>; <a href="./references#CD013217-bbs2-0010" title="ArlettazR , KashiwagiM , Das-KunduS , FauchèreJC , LangA , BucherHU . Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstetricia et Gynecologica Scandinavica2005;84(2):145-50. [DOI: ﻿10.1111/j.0001-6349.2005.00510.x] [PMID: 15683374]">Arlettaz 2005</a>; <a href="./references#CD013217-bbs2-0012" title="DrydenC , YoungD , CampbellN , MactierH . Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. Archives of Disease in Childhood. Fetal and Neonatal Edition2012;97(3):F214-6. [DOI: ﻿10.1136/adc.2009.178723] [PMID: 20656717]DrydenC , YoungD , HepburnM , MactierH . Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG2009;116(5):665-71. [DOI: 10.1111/j.1471-0528.2008.02073.x] [PMID: 19220239]">Dryden 2009</a>; <a href="./references#CD013217-bbs2-0014" title="HodgsonZG , AbrahamsRR . A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2012;34(5):475-81. [DOI: 10.1016/s1701-2163(16)35245-8] [PMID: 22555142]">Hodgson 2012</a>; <a href="./references#CD013217-bbs2-0019" title="JanssonLM , ChooR , VelezML , HarrowC , SchroederJR , ShakleyaDM , et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics2008;121(1):106-14. [DOI: ﻿10.1542/peds.2008-0217] [PMID: 18166563]">Jansson 2008</a>; <a href="./references#CD013217-bbs2-0021" title="LiuA , JuarezJ , NairA , NananR . Feeding modalities and the onset of the neonatal abstinence syndrome. Frontiers in Pediatrics2015;3:14. [DOI: ﻿10.3389/fped.2015.00014] [PMID: 25767791]">Liu 2015</a>; <a href="./references#CD013217-bbs2-0024" title="McQueenKA , Murphy-OikonenJ , GerlachK , MontelpareW . The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Advances in Neonatal Care2011;11(4):282-90. [DOI: ﻿10.1097/ANC.0b013e318225a30c] [PMID: 22123351]">McQueen 2011</a>; <a href="./references#CD013217-bbs2-0026" title="MetzVE , ComerSD , PribasnigA , WuerzlJ , FischerG . Observational study in an outpatient clinic specializing in treating opioid dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine. Heroin Addiction and Related Clinical Problems2015;17(1):5-16. ">Metz 2015</a>; <a href="./references#CD013217-bbs2-0028" title="O'ConnorAB , CollettA , AltoWA , O'BrienLM . Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. Journal of Midwifery and Women's Health2013;58(4):383-8. [DOI: ﻿10.1111/jmwh.12009] [PMID: 23931660]">O'Connor 2013</a>; <a href="./references#CD013217-bbs2-0031" title="PrithamUA , PaulJA , HayesMJ . Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing2012;41(2):180-90. [DOI: 10.1111/j.1552-6909.2011.01330.x] [PMID: 22375882]">Pritham 2012</a>; <a href="./references#CD013217-bbs2-0037" title="WachmanEM , HayesMJ , BrownMS , PaulJ , Harvey-WilkesK , TerrinN , et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA2013;309(17):1821-7. [DOI: ﻿10.1001/jama.2013.3411]">Wachman 2013</a>; <a href="./references#CD013217-bbs2-0039" title="Welle-StrandGK , SkurtveitS , JanssonLM , BakstadB , BjarkoL , RavndalE . Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatrica2013;102(11):1060-6. [DOI: ﻿10.1111/apa.12378] [PMID: 23909865]">Welle‐Strand 2013</a>); two studies assessed infants receiving opioid treatment for symptoms consistent with opioid withdrawal (<a href="./references#CD013217-bbs2-0018" title="IsemannB , Meinzen-DerrJ , AkinbiH . Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. Journal of Perinatology2011;31(1):25-9. [DOI: dx.doi.org/10.1038/jp.2010.66] [PMID: 20508596]">Isemann 2011</a>; <a href="./references#CD013217-bbs2-0032" title="RadmacherP , AlexanderC , DevlinL . Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15]">Radmacher 2017</a>); and one study did not collect information about postnatal treatment (<a href="./references#CD013217-bbs2-0035" title="ShortVL , GannonM , AbatemarcoDJ . The association between breastfeeding and length of hospital stay among infants diagnosed with neonatal abstinence syndrome: a population-based study of in-hospital births. Breastfeeding Medicine2016;11(7):343-9. [DOI: ﻿10.1089/bfm.2016.0084] [PMID: 27529500]">Short 2016</a>). Seven studies were conducted in the USA (<a href="./references#CD013217-bbs2-0018" title="IsemannB , Meinzen-DerrJ , AkinbiH . Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. Journal of Perinatology2011;31(1):25-9. [DOI: dx.doi.org/10.1038/jp.2010.66] [PMID: 20508596]">Isemann 2011</a>; <a href="./references#CD013217-bbs2-0019" title="JanssonLM , ChooR , VelezML , HarrowC , SchroederJR , ShakleyaDM , et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics2008;121(1):106-14. [DOI: ﻿10.1542/peds.2008-0217] [PMID: 18166563]">Jansson 2008</a>; <a href="./references#CD013217-bbs2-0028" title="O'ConnorAB , CollettA , AltoWA , O'BrienLM . Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. Journal of Midwifery and Women's Health2013;58(4):383-8. [DOI: ﻿10.1111/jmwh.12009] [PMID: 23931660]">O'Connor 2013</a>; <a href="./references#CD013217-bbs2-0031" title="PrithamUA , PaulJA , HayesMJ . Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing2012;41(2):180-90. [DOI: 10.1111/j.1552-6909.2011.01330.x] [PMID: 22375882]">Pritham 2012</a>; <a href="./references#CD013217-bbs2-0032" title="RadmacherP , AlexanderC , DevlinL . Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15]">Radmacher 2017</a>; <a href="./references#CD013217-bbs2-0035" title="ShortVL , GannonM , AbatemarcoDJ . The association between breastfeeding and length of hospital stay among infants diagnosed with neonatal abstinence syndrome: a population-based study of in-hospital births. Breastfeeding Medicine2016;11(7):343-9. [DOI: ﻿10.1089/bfm.2016.0084] [PMID: 27529500]">Short 2016</a>; <a href="./references#CD013217-bbs2-0037" title="WachmanEM , HayesMJ , BrownMS , PaulJ , Harvey-WilkesK , TerrinN , et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA2013;309(17):1821-7. [DOI: ﻿10.1001/jama.2013.3411]">Wachman 2013</a>); two in Australia (<a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a>; <a href="./references#CD013217-bbs2-0021" title="LiuA , JuarezJ , NairA , NananR . Feeding modalities and the onset of the neonatal abstinence syndrome. Frontiers in Pediatrics2015;3:14. [DOI: ﻿10.3389/fped.2015.00014] [PMID: 25767791]">Liu 2015</a>); two in Canada (<a href="./references#CD013217-bbs2-0014" title="HodgsonZG , AbrahamsRR . A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2012;34(5):475-81. [DOI: 10.1016/s1701-2163(16)35245-8] [PMID: 22555142]">Hodgson 2012</a>; <a href="./references#CD013217-bbs2-0024" title="McQueenKA , Murphy-OikonenJ , GerlachK , MontelpareW . The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Advances in Neonatal Care2011;11(4):282-90. [DOI: ﻿10.1097/ANC.0b013e318225a30c] [PMID: 22123351]">McQueen 2011</a>); and one each in the UK (<a href="./references#CD013217-bbs2-0012" title="DrydenC , YoungD , CampbellN , MactierH . Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. Archives of Disease in Childhood. Fetal and Neonatal Edition2012;97(3):F214-6. [DOI: ﻿10.1136/adc.2009.178723] [PMID: 20656717]DrydenC , YoungD , HepburnM , MactierH . Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG2009;116(5):665-71. [DOI: 10.1111/j.1471-0528.2008.02073.x] [PMID: 19220239]">Dryden 2009</a>), Switzerland (<a href="./references#CD013217-bbs2-0010" title="ArlettazR , KashiwagiM , Das-KunduS , FauchèreJC , LangA , BucherHU . Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstetricia et Gynecologica Scandinavica2005;84(2):145-50. [DOI: ﻿10.1111/j.0001-6349.2005.00510.x] [PMID: 15683374]">Arlettaz 2005</a>), Austria (<a href="./references#CD013217-bbs2-0026" title="MetzVE , ComerSD , PribasnigA , WuerzlJ , FischerG . Observational study in an outpatient clinic specializing in treating opioid dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine. Heroin Addiction and Related Clinical Problems2015;17(1):5-16. ">Metz 2015</a>), and Norway (<a href="./references#CD013217-bbs2-0039" title="Welle-StrandGK , SkurtveitS , JanssonLM , BakstadB , BjarkoL , RavndalE . Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatrica2013;102(11):1060-6. [DOI: ﻿10.1111/apa.12378] [PMID: 23909865]">Welle‐Strand 2013</a>). One study evaluated infants cared for in the postnatal ward for monitoring and pharmacological treatment (<a href="./references#CD013217-bbs2-0014" title="HodgsonZG , AbrahamsRR . A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2012;34(5):475-81. [DOI: 10.1016/s1701-2163(16)35245-8] [PMID: 22555142]">Hodgson 2012</a>), two studies evaluated infants cared for in the postnatal ward with transfer to the NICU for pharmacological treatment (<a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a>; <a href="./references#CD013217-bbs2-0012" title="DrydenC , YoungD , CampbellN , MactierH . Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. Archives of Disease in Childhood. Fetal and Neonatal Edition2012;97(3):F214-6. [DOI: ﻿10.1136/adc.2009.178723] [PMID: 20656717]DrydenC , YoungD , HepburnM , MactierH . Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG2009;116(5):665-71. [DOI: 10.1111/j.1471-0528.2008.02073.x] [PMID: 19220239]">Dryden 2009</a>), three studies evaluated infants cared for in the NICU (<a href="./references#CD013217-bbs2-0018" title="IsemannB , Meinzen-DerrJ , AkinbiH . Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. Journal of Perinatology2011;31(1):25-9. [DOI: dx.doi.org/10.1038/jp.2010.66] [PMID: 20508596]">Isemann 2011</a>; <a href="./references#CD013217-bbs2-0031" title="PrithamUA , PaulJA , HayesMJ . Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing2012;41(2):180-90. [DOI: 10.1111/j.1552-6909.2011.01330.x] [PMID: 22375882]">Pritham 2012</a>; <a href="./references#CD013217-bbs2-0032" title="RadmacherP , AlexanderC , DevlinL . Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15]">Radmacher 2017</a>), and nine studies did not report the site of care (<a href="./references#CD013217-bbs2-0010" title="ArlettazR , KashiwagiM , Das-KunduS , FauchèreJC , LangA , BucherHU . Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstetricia et Gynecologica Scandinavica2005;84(2):145-50. [DOI: ﻿10.1111/j.0001-6349.2005.00510.x] [PMID: 15683374]">Arlettaz 2005</a>; <a href="./references#CD013217-bbs2-0019" title="JanssonLM , ChooR , VelezML , HarrowC , SchroederJR , ShakleyaDM , et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics2008;121(1):106-14. [DOI: ﻿10.1542/peds.2008-0217] [PMID: 18166563]">Jansson 2008</a>; <a href="./references#CD013217-bbs2-0021" title="LiuA , JuarezJ , NairA , NananR . Feeding modalities and the onset of the neonatal abstinence syndrome. Frontiers in Pediatrics2015;3:14. [DOI: ﻿10.3389/fped.2015.00014] [PMID: 25767791]">Liu 2015</a>; <a href="./references#CD013217-bbs2-0024" title="McQueenKA , Murphy-OikonenJ , GerlachK , MontelpareW . The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Advances in Neonatal Care2011;11(4):282-90. [DOI: ﻿10.1097/ANC.0b013e318225a30c] [PMID: 22123351]">McQueen 2011</a>; <a href="./references#CD013217-bbs2-0026" title="MetzVE , ComerSD , PribasnigA , WuerzlJ , FischerG . Observational study in an outpatient clinic specializing in treating opioid dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine. Heroin Addiction and Related Clinical Problems2015;17(1):5-16. ">Metz 2015</a>; <a href="./references#CD013217-bbs2-0028" title="O'ConnorAB , CollettA , AltoWA , O'BrienLM . Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. Journal of Midwifery and Women's Health2013;58(4):383-8. [DOI: ﻿10.1111/jmwh.12009] [PMID: 23931660]">O'Connor 2013</a>; <a href="./references#CD013217-bbs2-0035" title="ShortVL , GannonM , AbatemarcoDJ . The association between breastfeeding and length of hospital stay among infants diagnosed with neonatal abstinence syndrome: a population-based study of in-hospital births. Breastfeeding Medicine2016;11(7):343-9. [DOI: ﻿10.1089/bfm.2016.0084] [PMID: 27529500]">Short 2016</a>; <a href="./references#CD013217-bbs2-0037" title="WachmanEM , HayesMJ , BrownMS , PaulJ , Harvey-WilkesK , TerrinN , et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA2013;309(17):1821-7. [DOI: ﻿10.1001/jama.2013.3411]">Wachman 2013</a>; <a href="./references#CD013217-bbs2-0039" title="Welle-StrandGK , SkurtveitS , JanssonLM , BakstadB , BjarkoL , RavndalE . Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatrica2013;102(11):1060-6. [DOI: ﻿10.1111/apa.12378] [PMID: 23909865]">Welle‐Strand 2013</a>). All studies assessed the impact of breast milk feedings compared to non‐breast milk feedings on outcomes. Intervention definitions varied between studies in terms of timing and 'dose' of breast milk. Only one study assessed the impact of non‐maternal donor breast milk feedings (<a href="./references#CD013217-bbs2-0032" title="RadmacherP , AlexanderC , DevlinL . Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15]">Radmacher 2017</a>). Measured primary outcomes included length of hospitalization (<a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a>; <a href="./references#CD013217-bbs2-0012" title="DrydenC , YoungD , CampbellN , MactierH . Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. Archives of Disease in Childhood. Fetal and Neonatal Edition2012;97(3):F214-6. [DOI: ﻿10.1136/adc.2009.178723] [PMID: 20656717]DrydenC , YoungD , HepburnM , MactierH . Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG2009;116(5):665-71. [DOI: 10.1111/j.1471-0528.2008.02073.x] [PMID: 19220239]">Dryden 2009</a>; <a href="./references#CD013217-bbs2-0018" title="IsemannB , Meinzen-DerrJ , AkinbiH . Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. Journal of Perinatology2011;31(1):25-9. [DOI: dx.doi.org/10.1038/jp.2010.66] [PMID: 20508596]">Isemann 2011</a>; <a href="./references#CD013217-bbs2-0026" title="MetzVE , ComerSD , PribasnigA , WuerzlJ , FischerG . Observational study in an outpatient clinic specializing in treating opioid dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine. Heroin Addiction and Related Clinical Problems2015;17(1):5-16. ">Metz 2015</a>; <a href="./references#CD013217-bbs2-0028" title="O'ConnorAB , CollettA , AltoWA , O'BrienLM . Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. Journal of Midwifery and Women's Health2013;58(4):383-8. [DOI: ﻿10.1111/jmwh.12009] [PMID: 23931660]">O'Connor 2013</a>; <a href="./references#CD013217-bbs2-0031" title="PrithamUA , PaulJA , HayesMJ . Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing2012;41(2):180-90. [DOI: 10.1111/j.1552-6909.2011.01330.x] [PMID: 22375882]">Pritham 2012</a>; <a href="./references#CD013217-bbs2-0032" title="RadmacherP , AlexanderC , DevlinL . Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15]">Radmacher 2017</a>; <a href="./references#CD013217-bbs2-0035" title="ShortVL , GannonM , AbatemarcoDJ . The association between breastfeeding and length of hospital stay among infants diagnosed with neonatal abstinence syndrome: a population-based study of in-hospital births. Breastfeeding Medicine2016;11(7):343-9. [DOI: ﻿10.1089/bfm.2016.0084] [PMID: 27529500]">Short 2016</a>; <a href="./references#CD013217-bbs2-0037" title="WachmanEM , HayesMJ , BrownMS , PaulJ , Harvey-WilkesK , TerrinN , et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA2013;309(17):1821-7. [DOI: ﻿10.1001/jama.2013.3411]">Wachman 2013</a>), use of pharmacological treatment (<a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a>; <a href="./references#CD013217-bbs2-0012" title="DrydenC , YoungD , CampbellN , MactierH . Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. Archives of Disease in Childhood. Fetal and Neonatal Edition2012;97(3):F214-6. [DOI: ﻿10.1136/adc.2009.178723] [PMID: 20656717]DrydenC , YoungD , HepburnM , MactierH . Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG2009;116(5):665-71. [DOI: 10.1111/j.1471-0528.2008.02073.x] [PMID: 19220239]">Dryden 2009</a>; <a href="./references#CD013217-bbs2-0014" title="HodgsonZG , AbrahamsRR . A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2012;34(5):475-81. [DOI: 10.1016/s1701-2163(16)35245-8] [PMID: 22555142]">Hodgson 2012</a>; <a href="./references#CD013217-bbs2-0019" title="JanssonLM , ChooR , VelezML , HarrowC , SchroederJR , ShakleyaDM , et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics2008;121(1):106-14. [DOI: ﻿10.1542/peds.2008-0217] [PMID: 18166563]">Jansson 2008</a>; <a href="./references#CD013217-bbs2-0021" title="LiuA , JuarezJ , NairA , NananR . Feeding modalities and the onset of the neonatal abstinence syndrome. Frontiers in Pediatrics2015;3:14. [DOI: ﻿10.3389/fped.2015.00014] [PMID: 25767791]">Liu 2015</a>; <a href="./references#CD013217-bbs2-0028" title="O'ConnorAB , CollettA , AltoWA , O'BrienLM . Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. Journal of Midwifery and Women's Health2013;58(4):383-8. [DOI: ﻿10.1111/jmwh.12009] [PMID: 23931660]">O'Connor 2013</a>; <a href="./references#CD013217-bbs2-0037" title="WachmanEM , HayesMJ , BrownMS , PaulJ , Harvey-WilkesK , TerrinN , et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA2013;309(17):1821-7. [DOI: ﻿10.1001/jama.2013.3411]">Wachman 2013</a>; <a href="./references#CD013217-bbs2-0039" title="Welle-StrandGK , SkurtveitS , JanssonLM , BakstadB , BjarkoL , RavndalE . Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatrica2013;102(11):1060-6. [DOI: ﻿10.1111/apa.12378] [PMID: 23909865]">Welle‐Strand 2013</a>), length of pharmacological treatment (<a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a>; <a href="./references#CD013217-bbs2-0019" title="JanssonLM , ChooR , VelezML , HarrowC , SchroederJR , ShakleyaDM , et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics2008;121(1):106-14. [DOI: ﻿10.1542/peds.2008-0217] [PMID: 18166563]">Jansson 2008</a>; <a href="./references#CD013217-bbs2-0026" title="MetzVE , ComerSD , PribasnigA , WuerzlJ , FischerG . Observational study in an outpatient clinic specializing in treating opioid dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine. Heroin Addiction and Related Clinical Problems2015;17(1):5-16. ">Metz 2015</a>; <a href="./references#CD013217-bbs2-0032" title="RadmacherP , AlexanderC , DevlinL . Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15]">Radmacher 2017</a>; <a href="./references#CD013217-bbs2-0039" title="Welle-StrandGK , SkurtveitS , JanssonLM , BakstadB , BjarkoL , RavndalE . Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatrica2013;102(11):1060-6. [DOI: ﻿10.1111/apa.12378] [PMID: 23909865]">Welle‐Strand 2013</a>), maximum dose of opioid medication (<a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a>; <a href="./references#CD013217-bbs2-0021" title="LiuA , JuarezJ , NairA , NananR . Feeding modalities and the onset of the neonatal abstinence syndrome. Frontiers in Pediatrics2015;3:14. [DOI: ﻿10.3389/fped.2015.00014] [PMID: 25767791]">Liu 2015</a>), and cumulative dose of opioid medication (<a href="./references#CD013217-bbs2-0026" title="MetzVE , ComerSD , PribasnigA , WuerzlJ , FischerG . Observational study in an outpatient clinic specializing in treating opioid dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine. Heroin Addiction and Related Clinical Problems2015;17(1):5-16. ">Metz 2015</a>). One study evaluated the secondary outcomes of growth rate and days to regain birth weight (<a href="./references#CD013217-bbs2-0032" title="RadmacherP , AlexanderC , DevlinL . Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15]">Radmacher 2017</a>), another evaluated weight nadir (<a href="./references#CD013217-bbs2-0012" title="DrydenC , YoungD , CampbellN , MactierH . Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. Archives of Disease in Childhood. Fetal and Neonatal Edition2012;97(3):F214-6. [DOI: ﻿10.1136/adc.2009.178723] [PMID: 20656717]DrydenC , YoungD , HepburnM , MactierH . Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG2009;116(5):665-71. [DOI: 10.1111/j.1471-0528.2008.02073.x] [PMID: 19220239]">Dryden 2009</a>), and one evaluated custody at discharge (<a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a>). Though no studies assessed the predefined secondary outcome of peak NAS score in the first 72 hours of life, eight studies assessed the severity of NAS using other measures (<a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a>; <a href="./references#CD013217-bbs2-0010" title="ArlettazR , KashiwagiM , Das-KunduS , FauchèreJC , LangA , BucherHU . Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstetricia et Gynecologica Scandinavica2005;84(2):145-50. [DOI: ﻿10.1111/j.0001-6349.2005.00510.x] [PMID: 15683374]">Arlettaz 2005</a>; <a href="./references#CD013217-bbs2-0019" title="JanssonLM , ChooR , VelezML , HarrowC , SchroederJR , ShakleyaDM , et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics2008;121(1):106-14. [DOI: ﻿10.1542/peds.2008-0217] [PMID: 18166563]">Jansson 2008</a>; <a href="./references#CD013217-bbs2-0021" title="LiuA , JuarezJ , NairA , NananR . Feeding modalities and the onset of the neonatal abstinence syndrome. Frontiers in Pediatrics2015;3:14. [DOI: ﻿10.3389/fped.2015.00014] [PMID: 25767791]">Liu 2015</a>; <a href="./references#CD013217-bbs2-0024" title="McQueenKA , Murphy-OikonenJ , GerlachK , MontelpareW . The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Advances in Neonatal Care2011;11(4):282-90. [DOI: ﻿10.1097/ANC.0b013e318225a30c] [PMID: 22123351]">McQueen 2011</a>; <a href="./references#CD013217-bbs2-0026" title="MetzVE , ComerSD , PribasnigA , WuerzlJ , FischerG . Observational study in an outpatient clinic specializing in treating opioid dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine. Heroin Addiction and Related Clinical Problems2015;17(1):5-16. ">Metz 2015</a>; <a href="./references#CD013217-bbs2-0028" title="O'ConnorAB , CollettA , AltoWA , O'BrienLM . Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. Journal of Midwifery and Women's Health2013;58(4):383-8. [DOI: ﻿10.1111/jmwh.12009] [PMID: 23931660]">O'Connor 2013</a>; <a href="./references#CD013217-bbs2-0032" title="RadmacherP , AlexanderC , DevlinL . Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15]">Radmacher 2017</a>). </p> </section> <section id="CD013217-sec-0069"> <h5 class="title">Support of the mother‐infant dyad</h5> <p>(Treatments focused on the mother‐infant dyad include parental presence, rooming in, skin‐to‐skin or 'kangaroo care,' parental respite or 'cuddler' programs, trauma‐informed care, social work support, mental health support, treatment program support, and legal support.) </p> <p>Ten studies evaluated methods of support for the mother‐infant dyad on outcomes in opioid‐exposed newborns. Nine were retrospective cohort studies, seven with concurrent controls (<a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a>; <a href="./references#CD013217-bbs2-0009" title="AbrahamsRR , Mackay-DunnMH , NevmerjitskaiaV , MacraeGS , PayneSP , HodgsonZG . An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2010;32(9):866-71. [DOI: ﻿10.1016/S1701-2163(16)34659-X] [PMID: 21050520]">Abrahams 2010</a>; <a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a>; <a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>; <a href="./references#CD013217-bbs2-0025" title="MetzV , JagschR , EbnerN , WurzlJ , PribasnigA , AschauerC , et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology2011;26(6):412-21. [DOI: ﻿10.1002/hup.1224] [PMID: 21823171]">Metz 2011</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>; <a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a>), and two with historical controls (<a href="./references#CD013217-bbs2-0023" title="McKnightS , CooH , DaviesG , HolmesB , NewmanA , NewtonL , et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology2016;33(5):495-501. [DOI: ﻿10.1055/s-0035-1566295] [PMID: 26588259]NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):e555-61. [PMID: 27035006]">McKnight 2016</a>; <a href="./references#CD013217-bbs2-0034" title="SaikiT , LeeS , HannamS , GreenoughA . Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics2010;169(1):95-8. [DOI: ﻿10.1007/s00431-009-0994-0] [PMID: 19440732]">Saiki 2010</a>). One study was a retrospective and prospective cohort utilizing quality improvement methodology (<a href="./references#CD013217-bbs2-0011" title="CrookK , BrandonD . Prenatal breastfeeding education: impact on infants with neonatal abstinence syndrome. Advances in Neonatal Care2017;17(4):299-305. [DOI: 10.1097/ANC.0000000000000392] [PMID: 28244941]">Crook 2017</a>). Nine studies assessed infants at risk for, or having, early symptoms consistent with opioid withdrawal (<a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a>; <a href="./references#CD013217-bbs2-0009" title="AbrahamsRR , Mackay-DunnMH , NevmerjitskaiaV , MacraeGS , PayneSP , HodgsonZG . An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2010;32(9):866-71. [DOI: ﻿10.1016/S1701-2163(16)34659-X] [PMID: 21050520]">Abrahams 2010</a>; <a href="./references#CD013217-bbs2-0011" title="CrookK , BrandonD . Prenatal breastfeeding education: impact on infants with neonatal abstinence syndrome. Advances in Neonatal Care2017;17(4):299-305. [DOI: 10.1097/ANC.0000000000000392] [PMID: 28244941]">Crook 2017</a>; <a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>; <a href="./references#CD013217-bbs2-0023" title="McKnightS , CooH , DaviesG , HolmesB , NewmanA , NewtonL , et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology2016;33(5):495-501. [DOI: ﻿10.1055/s-0035-1566295] [PMID: 26588259]NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):e555-61. [PMID: 27035006]">McKnight 2016</a>; <a href="./references#CD013217-bbs2-0025" title="MetzV , JagschR , EbnerN , WurzlJ , PribasnigA , AschauerC , et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology2011;26(6):412-21. [DOI: ﻿10.1002/hup.1224] [PMID: 21823171]">Metz 2011</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>; <a href="./references#CD013217-bbs2-0034" title="SaikiT , LeeS , HannamS , GreenoughA . Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics2010;169(1):95-8. [DOI: ﻿10.1007/s00431-009-0994-0] [PMID: 19440732]">Saiki 2010</a>; <a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a>), and one study assessed infants receiving opioid treatment for symptoms consistent with opioid withdrawal (<a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a>). Four studies were conducted in Canada (<a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a>; <a href="./references#CD013217-bbs2-0009" title="AbrahamsRR , Mackay-DunnMH , NevmerjitskaiaV , MacraeGS , PayneSP , HodgsonZG . An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2010;32(9):866-71. [DOI: ﻿10.1016/S1701-2163(16)34659-X] [PMID: 21050520]">Abrahams 2010</a>; <a href="./references#CD013217-bbs2-0023" title="McKnightS , CooH , DaviesG , HolmesB , NewmanA , NewtonL , et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology2016;33(5):495-501. [DOI: ﻿10.1055/s-0035-1566295] [PMID: 26588259]NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):e555-61. [PMID: 27035006]">McKnight 2016</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>); three in the USA (<a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>; <a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a>); and one each in the UK (<a href="./references#CD013217-bbs2-0034" title="SaikiT , LeeS , HannamS , GreenoughA . Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics2010;169(1):95-8. [DOI: ﻿10.1007/s00431-009-0994-0] [PMID: 19440732]">Saiki 2010</a>), Austria (<a href="./references#CD013217-bbs2-0025" title="MetzV , JagschR , EbnerN , WurzlJ , PribasnigA , AschauerC , et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology2011;26(6):412-21. [DOI: ﻿10.1002/hup.1224] [PMID: 21823171]">Metz 2011</a>), and Germany (<a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>). Four studies evaluated infants cared for in the postnatal ward compared to a NICU setting (<a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a>; <a href="./references#CD013217-bbs2-0009" title="AbrahamsRR , Mackay-DunnMH , NevmerjitskaiaV , MacraeGS , PayneSP , HodgsonZG . An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2010;32(9):866-71. [DOI: ﻿10.1016/S1701-2163(16)34659-X] [PMID: 21050520]">Abrahams 2010</a>; <a href="./references#CD013217-bbs2-0034" title="SaikiT , LeeS , HannamS , GreenoughA . Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics2010;169(1):95-8. [DOI: ﻿10.1007/s00431-009-0994-0] [PMID: 19440732]">Saiki 2010</a>; <a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a>), two studies evaluated infants cared for in a pediatrics ward (<a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a>; <a href="./references#CD013217-bbs2-0023" title="McKnightS , CooH , DaviesG , HolmesB , NewmanA , NewtonL , et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology2016;33(5):495-501. [DOI: ﻿10.1055/s-0035-1566295] [PMID: 26588259]NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):e555-61. [PMID: 27035006]">McKnight 2016</a>), two studies evaluated infants cared for in the NICU (<a href="./references#CD013217-bbs2-0011" title="CrookK , BrandonD . Prenatal breastfeeding education: impact on infants with neonatal abstinence syndrome. Advances in Neonatal Care2017;17(4):299-305. [DOI: 10.1097/ANC.0000000000000392] [PMID: 28244941]">Crook 2017</a>; <a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>), and two studies did not report the site of care (<a href="./references#CD013217-bbs2-0025" title="MetzV , JagschR , EbnerN , WurzlJ , PribasnigA , AschauerC , et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology2011;26(6):412-21. [DOI: ﻿10.1002/hup.1224] [PMID: 21823171]">Metz 2011</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>). Eight studies assessed the impact of rooming in, five as the primary intervention (<a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a>; <a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>; <a href="./references#CD013217-bbs2-0023" title="McKnightS , CooH , DaviesG , HolmesB , NewmanA , NewtonL , et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology2016;33(5):495-501. [DOI: ﻿10.1055/s-0035-1566295] [PMID: 26588259]NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):e555-61. [PMID: 27035006]">McKnight 2016</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>; <a href="./references#CD013217-bbs2-0034" title="SaikiT , LeeS , HannamS , GreenoughA . Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics2010;169(1):95-8. [DOI: ﻿10.1007/s00431-009-0994-0] [PMID: 19440732]">Saiki 2010</a>), and three in combination with additional support and education (<a href="./references#CD013217-bbs2-0009" title="AbrahamsRR , Mackay-DunnMH , NevmerjitskaiaV , MacraeGS , PayneSP , HodgsonZG . An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2010;32(9):866-71. [DOI: ﻿10.1016/S1701-2163(16)34659-X] [PMID: 21050520]">Abrahams 2010</a>; <a href="./references#CD013217-bbs2-0025" title="MetzV , JagschR , EbnerN , WurzlJ , PribasnigA , AschauerC , et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology2011;26(6):412-21. [DOI: ﻿10.1002/hup.1224] [PMID: 21823171]">Metz 2011</a>; <a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a>). One study examined a breastfeeding education program (<a href="./references#CD013217-bbs2-0011" title="CrookK , BrandonD . Prenatal breastfeeding education: impact on infants with neonatal abstinence syndrome. Advances in Neonatal Care2017;17(4):299-305. [DOI: 10.1097/ANC.0000000000000392] [PMID: 28244941]">Crook 2017</a>), and another examined the impact of parental presence (<a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a>). Measured primary outcomes included length of hospitalization (<a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a>; <a href="./references#CD013217-bbs2-0009" title="AbrahamsRR , Mackay-DunnMH , NevmerjitskaiaV , MacraeGS , PayneSP , HodgsonZG . An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2010;32(9):866-71. [DOI: ﻿10.1016/S1701-2163(16)34659-X] [PMID: 21050520]">Abrahams 2010</a>; <a href="./references#CD013217-bbs2-0011" title="CrookK , BrandonD . Prenatal breastfeeding education: impact on infants with neonatal abstinence syndrome. Advances in Neonatal Care2017;17(4):299-305. [DOI: 10.1097/ANC.0000000000000392] [PMID: 28244941]">Crook 2017</a>; <a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a>; <a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>; <a href="./references#CD013217-bbs2-0023" title="McKnightS , CooH , DaviesG , HolmesB , NewmanA , NewtonL , et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology2016;33(5):495-501. [DOI: ﻿10.1055/s-0035-1566295] [PMID: 26588259]NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):e555-61. [PMID: 27035006]">McKnight 2016</a>; <a href="./references#CD013217-bbs2-0025" title="MetzV , JagschR , EbnerN , WurzlJ , PribasnigA , AschauerC , et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology2011;26(6):412-21. [DOI: ﻿10.1002/hup.1224] [PMID: 21823171]">Metz 2011</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>; <a href="./references#CD013217-bbs2-0034" title="SaikiT , LeeS , HannamS , GreenoughA . Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics2010;169(1):95-8. [DOI: ﻿10.1007/s00431-009-0994-0] [PMID: 19440732]">Saiki 2010</a>; <a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a>), use of pharmacological treatment (<a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a>; <a href="./references#CD013217-bbs2-0011" title="CrookK , BrandonD . Prenatal breastfeeding education: impact on infants with neonatal abstinence syndrome. Advances in Neonatal Care2017;17(4):299-305. [DOI: 10.1097/ANC.0000000000000392] [PMID: 28244941]">Crook 2017</a>, <a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>, <a href="./references#CD013217-bbs2-0023" title="McKnightS , CooH , DaviesG , HolmesB , NewmanA , NewtonL , et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology2016;33(5):495-501. [DOI: ﻿10.1055/s-0035-1566295] [PMID: 26588259]NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):e555-61. [PMID: 27035006]">McKnight 2016</a>; <a href="./references#CD013217-bbs2-0025" title="MetzV , JagschR , EbnerN , WurzlJ , PribasnigA , AschauerC , et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology2011;26(6):412-21. [DOI: ﻿10.1002/hup.1224] [PMID: 21823171]">Metz 2011</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>; <a href="./references#CD013217-bbs2-0034" title="SaikiT , LeeS , HannamS , GreenoughA . Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics2010;169(1):95-8. [DOI: ﻿10.1007/s00431-009-0994-0] [PMID: 19440732]">Saiki 2010</a>), length of pharmacological treatment (<a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a>; <a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a>; <a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>; <a href="./references#CD013217-bbs2-0023" title="McKnightS , CooH , DaviesG , HolmesB , NewmanA , NewtonL , et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology2016;33(5):495-501. [DOI: ﻿10.1055/s-0035-1566295] [PMID: 26588259]NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):e555-61. [PMID: 27035006]">McKnight 2016</a>; <a href="./references#CD013217-bbs2-0025" title="MetzV , JagschR , EbnerN , WurzlJ , PribasnigA , AschauerC , et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology2011;26(6):412-21. [DOI: ﻿10.1002/hup.1224] [PMID: 21823171]">Metz 2011</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>; <a href="./references#CD013217-bbs2-0034" title="SaikiT , LeeS , HannamS , GreenoughA . Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics2010;169(1):95-8. [DOI: ﻿10.1007/s00431-009-0994-0] [PMID: 19440732]">Saiki 2010</a>), maximum dose of opioid medication (<a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>; <a href="./references#CD013217-bbs2-0023" title="McKnightS , CooH , DaviesG , HolmesB , NewmanA , NewtonL , et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology2016;33(5):495-501. [DOI: ﻿10.1055/s-0035-1566295] [PMID: 26588259]NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):e555-61. [PMID: 27035006]">McKnight 2016</a>), and cumulative dose of opioid medication (<a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a>; <a href="./references#CD013217-bbs2-0025" title="MetzV , JagschR , EbnerN , WurzlJ , PribasnigA , AschauerC , et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology2011;26(6):412-21. [DOI: ﻿10.1002/hup.1224] [PMID: 21823171]">Metz 2011</a>). Secondary outcomes assessed included NICU admission (<a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a>; <a href="./references#CD013217-bbs2-0009" title="AbrahamsRR , Mackay-DunnMH , NevmerjitskaiaV , MacraeGS , PayneSP , HodgsonZG . An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2010;32(9):866-71. [DOI: ﻿10.1016/S1701-2163(16)34659-X] [PMID: 21050520]">Abrahams 2010</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>; <a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a>), length of NICU stay (<a href="./references#CD013217-bbs2-0009" title="AbrahamsRR , Mackay-DunnMH , NevmerjitskaiaV , MacraeGS , PayneSP , HodgsonZG . An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2010;32(9):866-71. [DOI: ﻿10.1016/S1701-2163(16)34659-X] [PMID: 21050520]">Abrahams 2010</a>), weight nadir (<a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>; <a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a>), seizure (<a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a>), custody at discharge (<a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a>; <a href="./references#CD013217-bbs2-0009" title="AbrahamsRR , Mackay-DunnMH , NevmerjitskaiaV , MacraeGS , PayneSP , HodgsonZG . An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2010;32(9):866-71. [DOI: ﻿10.1016/S1701-2163(16)34659-X] [PMID: 21050520]">Abrahams 2010</a>; <a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a>; <a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>; <a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a>; <a href="./references#CD013217-bbs2-0034" title="SaikiT , LeeS , HannamS , GreenoughA . Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics2010;169(1):95-8. [DOI: ﻿10.1007/s00431-009-0994-0] [PMID: 19440732]">Saiki 2010</a>; <a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a>), and cost of care (<a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>; <a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a>). Though no studies assessed the predefined secondary outcome of peak NAS score in first 72 hours of life, two studies assessed the severity of NAS using other measures (<a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a>; <a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a>). </p> </section> <section id="CD013217-sec-0070"> <h5 class="title">Multiple non‐pharmacological care practices</h5> <p>(Any combination of the above non‐pharmacological interventions.)</p> <p>Seven studies examined multiple non‐pharmacological care practices in combination with other non‐pharmacological and pharmacological treatments. Four studies were retrospective and prospective cohorts utilizing quality improvement methodology (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>; <a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a>). Three studies were retrospective cohort studies, one with concurrent controls (<a href="./references#CD013217-bbs2-0020" title="KirchnerL , Graf-RohrmeisterK , Klebermass-SchrehofK , WeningerM , JagschR , MetzV , et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: 25062111]">Kirchner 2014</a>), and two with historical controls (<a href="./references#CD013217-bbs2-0022" title="LoudinS , WerthammerJ , PruntyL , MurrayS , ShapiroJI , DaviesTH . A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic. Journal of Perinatology2017;37(10):1108-11. [DOI: ﻿10.1038/jp.2017.101] [PMID: 28682317]">Loudin 2017</a>; <a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a>). Five studies assessed infants at risk for, or having, early symptoms consistent with opioid withdrawal (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0020" title="KirchnerL , Graf-RohrmeisterK , Klebermass-SchrehofK , WeningerM , JagschR , MetzV , et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: 25062111]">Kirchner 2014</a>; <a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a>; <a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a>), and two studies assessed infants receiving opioid treatment for symptoms consistent with opioid withdrawal (<a href="./references#CD013217-bbs2-0022" title="LoudinS , WerthammerJ , PruntyL , MurrayS , ShapiroJI , DaviesTH . A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic. Journal of Perinatology2017;37(10):1108-11. [DOI: ﻿10.1038/jp.2017.101] [PMID: 28682317]">Loudin 2017</a>; <a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>). Four studies were conducted in the USA (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0022" title="LoudinS , WerthammerJ , PruntyL , MurrayS , ShapiroJI , DaviesTH . A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic. Journal of Perinatology2017;37(10):1108-11. [DOI: ﻿10.1038/jp.2017.101] [PMID: 28682317]">Loudin 2017</a>; <a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a>), two at multiple international sites (<a href="./references#CD013217-bbs2-0020" title="KirchnerL , Graf-RohrmeisterK , Klebermass-SchrehofK , WeningerM , JagschR , MetzV , et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: 25062111]">Kirchner 2014</a>; <a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>), and one in the UK (<a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a>). Two studies evaluated infants cared for in the postnatal ward, pediatrics unit, and NICU settings (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>); one study evaluated infants cared for in the postnatal ward and the pediatrics unit (<a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a>); one study evaluated infants cared for in the postnatal ward and the NICU (<a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a>); and two studies did not report the site of care (<a href="./references#CD013217-bbs2-0020" title="KirchnerL , Graf-RohrmeisterK , Klebermass-SchrehofK , WeningerM , JagschR , MetzV , et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: 25062111]">Kirchner 2014</a>; <a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>). Three studies assessed a combination of standardized non‐pharmacological care, education, and rooming in among other interventions (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a>). Two studies compared different care environments (<a href="./references#CD013217-bbs2-0020" title="KirchnerL , Graf-RohrmeisterK , Klebermass-SchrehofK , WeningerM , JagschR , MetzV , et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: 25062111]">Kirchner 2014</a>; <a href="./references#CD013217-bbs2-0022" title="LoudinS , WerthammerJ , PruntyL , MurrayS , ShapiroJI , DaviesTH . A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic. Journal of Perinatology2017;37(10):1108-11. [DOI: ﻿10.1038/jp.2017.101] [PMID: 28682317]">Loudin 2017</a>). One study examined the combination of rooming in, maternal support, and changes in pharmacological care practices in combination (<a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a>). One study evaluated the impact of a multicenter effort to standardize care and guidelines affecting both non‐pharmacological and pharmacological care practices (<a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>). Measured primary outcomes included length of hospitalization (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0022" title="LoudinS , WerthammerJ , PruntyL , MurrayS , ShapiroJI , DaviesTH . A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic. Journal of Perinatology2017;37(10):1108-11. [DOI: ﻿10.1038/jp.2017.101] [PMID: 28682317]">Loudin 2017</a>; <a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a>; <a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>; <a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a>), use of pharmacological treatment (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0020" title="KirchnerL , Graf-RohrmeisterK , Klebermass-SchrehofK , WeningerM , JagschR , MetzV , et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: 25062111]">Kirchner 2014</a>; <a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a>; <a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a>), length of pharmacological treatment (<a href="./references#CD013217-bbs2-0020" title="KirchnerL , Graf-RohrmeisterK , Klebermass-SchrehofK , WeningerM , JagschR , MetzV , et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: 25062111]">Kirchner 2014</a>; <a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a>; <a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a>), and cumulative dose of opioid medication (<a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0020" title="KirchnerL , Graf-RohrmeisterK , Klebermass-SchrehofK , WeningerM , JagschR , MetzV , et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: 25062111]">Kirchner 2014</a>). Secondary outcomes evaluated include NICU admission (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0022" title="LoudinS , WerthammerJ , PruntyL , MurrayS , ShapiroJI , DaviesTH . A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic. Journal of Perinatology2017;37(10):1108-11. [DOI: ﻿10.1038/jp.2017.101] [PMID: 28682317]">Loudin 2017</a>; <a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a>; <a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a>), seizures (<a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a>; <a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a>), custody at discharge (<a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a>), and cost of care (<a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a>; <a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0022" title="LoudinS , WerthammerJ , PruntyL , MurrayS , ShapiroJI , DaviesTH . A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic. Journal of Perinatology2017;37(10):1108-11. [DOI: ﻿10.1038/jp.2017.101] [PMID: 28682317]">Loudin 2017</a>). Though no studies assessed the predefined secondary outcome of peak NAS score in first 72 hours of life, two studies assessed the severity of NAS using other measures (<a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a>; <a href="./references#CD013217-bbs2-0020" title="KirchnerL , Graf-RohrmeisterK , Klebermass-SchrehofK , WeningerM , JagschR , MetzV , et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: 25062111]">Kirchner 2014</a>). No studies assessed neurodevelopmental outcome as prespecified in the protocol at two years; however, one study assessed neurodevelopmental outcome in the first year of life (<a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a>). </p> </section> </section> </section> <section id="CD013217-sec-0071"> <h3 class="title">Risk of bias in included studies</h3> <p>Six RCTs are included in a risk of bias assessment (<a href="#CD013217-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD013217-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD013217-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> </div> <p> <ol id="CD013217-list-0048"> <li> <p><b>Modifying environmental stimulation</b> (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>; <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>). </p> </li> <li> <p><b>Feeding practices</b> (<a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a>). </p> </li> <li> <p><b>Support of the mother‐infant dyad</b> (<a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a>). </p> </li> </ol> </p> <p>The six studies demonstrated a generally high risk of bias. <a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> exhibited low risk of bias in several categories; however, sensitivity analysis was not performed because it was the only study in the category. </p> <section id="CD013217-sec-0072"> <h4 class="title">Allocation</h4> <p><b>Modifying environmental stimulation:</b> we judged <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a> to have high risk of sequence generation bias due to randomization of infants based on hospital record numbers. Three studies did not describe the randomization process and we judged risk of bias due to sequence generation as unclear (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>). None of the four studies report blinded allocation and we judged risk of selection bias as unclear. </p> <p><b>Feeding practices:</b> we judged <a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> to have low risk of sequence generation and selection bias due to randomization of infants with blinded computer‐based sequence generation. </p> <p><b>Support of the mother‐infant dyad:</b> we judged <a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a> to have low risk sequence generation bias due to randomization of infants with computer‐based sequence generation. Blinded allocation was not reported, and we judged risk of selection bias as unclear. </p> </section> <section id="CD013217-sec-0073"> <h4 class="title">Blinding</h4> <p><b>Modifying environmental stimulation:</b> four studies did not blind caregivers or evaluators to the intervention due to inability to conceal the interventions during routine care. We judged the risk of performance and detection bias as high (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>; <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>). </p> <p><b>Feeding practices:</b><a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> blinded all caregivers and evaluators to the intervention. We judged the risk of performance and detection bias as low. </p> <p><b>Support of the mother‐infant dyad:</b><a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a> did not blind caregivers or evaluators to the intervention due to inability to conceal the interventions during routine care. We judged the risk of performance and detection bias as high. </p> </section> <section id="CD013217-sec-0074"> <h4 class="title">Incomplete outcome data</h4> <p><b>Modifying environmental stimulation:</b> we judged <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a> to have a high risk of attrition bias due to the exclusion of randomized infants who were unable to be matched to controls (approximately 39% of randomized infants). Three studies reported outcomes for all enrolled infants, and we judged the risk of attrition bias as low (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>). </p> <p><b>Feeding practices:</b> we judged <a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> to have a high risk of attrition bias due to the proportion of infants lost to follow‐up before reaching birth weight or the end of the study intervention on day 21 (18%). </p> <p><b>Support of the mother‐infant dyad:</b> we judged <a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a> to have a high risk of attrition bias due to the proportion of infants stopping the intervention early (approximately 43%), and the loss to follow‐up posthospitalization (approximately 21%). </p> </section> <section id="CD013217-sec-0075"> <h4 class="title">Selective reporting</h4> <p><b>Modifying environmental stimulation:</b> all four studies were not preregistered (study predated the mandatory requirement for preregistration) and there was no clear evidence of selective reporting (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>; <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>). We judged the risk of reporting bias as unclear. </p> <p><b>Feeding practices:</b><a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> was preregistered; however, several prespecified outcomes were not reported in the publication raising the possibility of selective reporting. We judged the risk of reporting bias as high. </p> <p><b>Support of the mother‐infant dyad:</b><a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a> was not preregistered (expected for the publication year) and there was no clear evidence of selective reporting. We judged the risk of reporting bias as unclear. </p> </section> <section id="CD013217-sec-0076"> <h4 class="title">Other potential sources of bias</h4> <p><b>Modifying environmental stimulation:</b><a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a> and <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a> noted differences in the number of infants with fetal distress. <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a> and <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a> did not report differences between treatment groups. None of the studies reported the number of eligible infants not enrolled and we could not assess the risk for differential enrollment affecting generalizability of study results. We judged the risk of other potential sources of bias in these studies as unclear. </p> <p><b>Feeding practices:</b><a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> noted crossover and protocol deviation between groups that could have biased the results toward the null. Six infants assigned to standard‐calorie formula and one assigned to high‐calorie formula changed to open‐label high‐calorie formula due to slow weight gain. The change was made per protocol for two infants, and determined by non‐study physicians for four infants. Three infants assigned to high‐calorie formula switched to soy formula based on physician or family preference. Primary analysis was performed based on original intention‐to‐treat analysis. Post hoc analysis was performed based on feeding type. <a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> also noted baseline differences between the intervention and control groups. Six infants had positive screens at delivery for drugs other than methadone in the intervention group with no exposure in the control group. <a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> did not enroll 35% of infants whose mothers enrolled during pregnancy, largely due to need for prolonged NICU care not related to NAS and low birth weight. This may affect generalizability of study results. We judged the risk of other potential sources of bias as high. </p> <p><b>Support of the mother‐infant dyad:</b><a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a> noted baseline differences between the intervention and control groups. There were more multiparous women and women with experience breastfeeding in the intervention group compared to the control group, and this difference could have a significant effect on a mother's initial comfort with newborn care. <a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a> did not enroll 74% of mothers approached, suggesting the study group may be a non‐representative population and likely a self‐selected population with intent to breastfeed. This may affect generalizability of study results. We judged the risk of other potential sources of bias as high. </p> </section> </section> <section id="CD013217-sec-0077"> <h3 class="title" id="CD013217-sec-0077">Effects of interventions</h3> <p>See: <a href="./full#CD013217-tbl-0001"><b>Summary of findings 1</b> Non‐pharmacological treatment compared to placebo for infants at risk for, or having early symptoms consistent with, opioid withdrawal</a> </p> <section id="CD013217-sec-0078"> <h4 class="title">Comparison 1. Infants at risk for, or having early symptoms consistent with, opioid withdrawal </h4> <p>See <a href="./full#CD013217-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD013217-sec-0079"> <h5 class="title">Modifying environmental stimulation</h5> <p>Four studies reported modifying environmental stimulation (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>; <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>). </p> <p>The studies compared a study nursery to a regular nursery (<a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>), non‐oscillating waterbeds to conventional bassinets (<a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>), rocking beds to standard beds (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>), and prone sleep positioning to supine sleep positioning (<a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>). </p> <section id="CD013217-sec-0080"> <h6 class="title">Primary outcomes</h6> <section id="CD013217-sec-0081"> <p><b>Length of hospitalization (days) (outcome 1.1.1)</b></p> <p><a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a> reported a mean reduction in length of hospitalization by 1 day with a wide 95% CI ranging from a reduction of 2.82 days to an increase of 0.82 days (30 infants) (<a href="./references#CD013217-fig-0003" title="">Analysis 1.1</a>). We judged the certainty of evidence as very low and downgraded three levels for very serious concerns about risk of bias (due to unblinded study, concern for performance, detection, and attrition bias) and serious concern for imprecision (due to wide 95% CI). </p> </section> <section id="CD013217-sec-0082"> <p><b>Pharmacological treatment with one or more doses of opioid or sedative medication (outcome 1.2.1)</b></p> <p>Three studies of modifying environmental stimulation reported no difference in the use of pharmacological treatment with one or more doses of opioid or sedative medication (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>). Meta‐analysis of the three studies found no evidence of a difference in the use of pharmacological treatment (typical RR 1.00, 95% CI 0.86 to 1.16; I<sup>2</sup> = 0; 92 infants; <a href="./references#CD013217-fig-0004" title="">Analysis 1.2</a>). We judged the certainty of evidence as low and downgraded two levels for very serious concerns about risk of bias (due to unblinded study, concern for performance, detection, and attrition bias). </p> </section> </section> <section id="CD013217-sec-0083"> <h6 class="title">Secondary outcomes</h6> <section id="CD013217-sec-0084"> <p><b>Peak neonatal abstinence syndrome score in first 72 hours of life (outcome 1.3.1)</b></p> <p>None of the studies of modifying environmental stimulation reported the peak NAS score in the first 72 hours of life as prespecified in the protocol. Post hoc we decided to evaluate 'peak' score at any time or any score reported in the first 72 hours as measured by a standardized withdrawal assessment tool (<a href="./references#CD013217-fig-0005" title="">Analysis 1.3</a>). </p> <p><a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a> studied infant positioning during sleep and reported a mean reduction of peak neonatal abstinence score at any time of 2.65 (95% CI –3.81 to –1.49; 48 infants). <a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a> and <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a> studied bed type. <a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a> reported the mean score in the first 72 hours of life (MD 1.60, 95% CI –1.11 to 4.31; 14 infants) and <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a> reported peak neonatal abstinence score at any time (MD –0.20, 95% CI –0.82 to 0.42; 30 infants). Neither demonstrated a reduction of score. Meta‐analysis of the three studies of peak NAS score demonstrated extremely high heterogeneity and are not reported. </p> </section> <section id="CD013217-sec-0085"> <p><b>Neonatal intensive care unit admission (outcome 1.4.1)</b></p> <p>None of the studies reported the effect of modifying environmental stimulation on NICU admission. </p> </section> <section id="CD013217-sec-0086"> <p><b>Days to regain birth weight (outcome 1.5.1)</b></p> <p>None of the studies reported the effect of modifying environmental stimulation on days to regain birth weight. </p> </section> <section id="CD013217-sec-0087"> <p><b>Weight nadir (outcome 1.6.1)</b></p> <p><a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a> reported a mean reduction in weight nadir by 0.28% with a wide 95% CI ranging from a reduction of 1.15% to an increase of 0.59% (194 infants) (<a href="./references#CD013217-fig-0008" title="">Analysis 1.6</a>). We judged the certainty of evidence as very low and downgraded three levels for very serious concerns about risk of bias (due to unblinded study, concern for performance and detection bias) and serious concern for imprecision (due to wide 95% CI). </p> </section> </section> </section> <section id="CD013217-sec-0088"> <h5 class="title">Feeding practices</h5> <p>One study reported feeding practices (<a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a>). </p> <p>The study compared 24 kcal/oz formula to 20 kcal/oz formula.</p> <section id="CD013217-sec-0089"> <h6 class="title">Primary outcomes</h6> <section id="CD013217-sec-0090"> <p><b>Length of hospitalization (days) (outcome 1.1.2)</b></p> <p>The study did not report the effect of feeding practices on length of hospitalization.</p> </section> <section id="CD013217-sec-0091"> <p><b>Pharmacological treatment with one or more doses of opioid or sedative medication (outcome 1.2.2)</b></p> <p><a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> reported a reduced use of pharmacological treatment with an RR of 0.92 and a wide 95% CI ranging from 0.63 to 1.33 (49 infants) (<a href="./references#CD013217-fig-0004" title="">Analysis 1.2</a>). We judged the certainty of evidence as very low and downgraded three levels for very serious concerns about risk of bias (due to concern for attrition and reporting bias), serious concern about imprecision (due to wide 95% CI), and plausible confounding that would reduce demonstrated effect. </p> </section> </section> <section id="CD013217-sec-0092"> <h6 class="title">Secondary outcomes</h6> <section id="CD013217-sec-0093"> <p><b>Peak neonatal abstinence syndrome (NAS) score in first 72 hours of life (outcome 1.3.2)</b></p> <p>The study did not report the effect of feeding practices on peak NAS.</p> </section> <section id="CD013217-sec-0094"> <p><b>Neonatal intensive care unit admission (outcome 1.4.2)</b></p> <p>The study did not report the effect of feeding practices on NICU admission.</p> </section> <section id="CD013217-sec-0095"> <p><b>Days to regain birth weight (outcome 1.5.2)</b></p> <p><a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> reported a reduction in the mean number of days to regain birth weight by 1.1 days with a wide 95% CI ranging from a reduction of 2.76 days to an increase of 0.56 days (46 infants) (<a href="./references#CD013217-fig-0007" title="">Analysis 1.5</a>). We judged the certainty of evidence as very low and downgraded three levels for very serious concerns about risk of bias (due to concern for attrition and reporting bias), very serious concern about imprecision (due to very wide 95% CI), and plausible confounding that would reduce demonstrated effect. </p> </section> <section id="CD013217-sec-0096"> <p><b>Weight nadir (outcome 1.6.2)</b></p> <p><a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a> reported a mean reduction in weight nadir by 0.80% with a wide 95% CI ranging from a reduction of 2.24% to an increase of 0.64% (46 infants) (<a href="./references#CD013217-fig-0008" title="">Analysis 1.6</a>). We judged the certainty of evidence as very low and downgraded three levels for very serious concerns about risk of bias (due to concern for attrition and reporting bias), serious concern about imprecision (due to wide 95% CI), and plausible confounding that would reduce demonstrated effect. </p> </section> </section> </section> <section id="CD013217-sec-0097"> <h5 class="title">Support of the mother‐infant dyad</h5> <p>One study reported support of the mother‐infant dyad (<a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a>). </p> <p>The study compared tailored breastfeeding support to standard Baby‐Friendly Initiative care. </p> <section id="CD013217-sec-0098"> <h6 class="title">Primary outcomes</h6> <section id="CD013217-sec-0099"> <p><b>Length of hospitalization (days) (outcome 1.1.3)</b></p> <p><a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a> reported a mean reduction in length of hospitalization by 8.9 days with a wide 95% CI ranging from a reduction of 19.84 days to an increase of 2.04 days (14 infants) (<a href="./references#CD013217-fig-0003" title="">Analysis 1.1</a>). We judged the certainty of evidence as very low and downgraded three levels for very serious concerns about risk of bias (due to unblinded study, concern for performance, detection, and attrition bias) and very serious concern for imprecision (due to very wide 95% CI). </p> </section> <section id="CD013217-sec-0100"> <p><b>Pharmacological treatment with one or more doses of opioid or sedative medication (outcome 1.2.3)</b></p> <p><a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a> reported a reduced use of pharmacological treatment with an RR of 0.50 and a wide 95% CI ranging from 0.13 to 1.90 (14 infants) (<a href="./references#CD013217-fig-0004" title="">Analysis 1.2</a>). We judged the certainty of evidence as very low and downgraded three levels for very serious concerns about risk of bias (due to unblinded study, concern for performance, detection, and attrition bias) and very serious concern for imprecision (due to very wide 95% CI). </p> </section> </section> <section id="CD013217-sec-0101"> <h6 class="title">Secondary outcomes</h6> <section id="CD013217-sec-0102"> <p><b>Peak neonatal abstinence syndrome (NAS) score in first 72 hours of life (outcome 1.3.3)</b></p> <p>The study did not report the effect of support of the mother‐infant dyad on peak NAS.</p> </section> <section id="CD013217-sec-0103"> <p><b>Neonatal intensive care unit admission (outcome 1.4.3)</b></p> <p><a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a> reported a reduced need for NICU admission with an RR of 0.50 and a wide 95% CI ranging from 0.13 to 1.90 (14 infants) (<a href="./references#CD013217-fig-0006" title="">Analysis 1.4</a>). We judged the certainty of evidence as very low and downgraded three levels for very serious concerns about risk of bias (due to unblinded study, concern for performance, detection, and attrition bias) and very serious concern for imprecision (due to very wide 95% CI). </p> </section> <section id="CD013217-sec-0104"> <p><b>Days to regain birth weight (outcome 1.5.3)</b></p> <p>The study did not report the effect of support of the mother‐infant dyad on days to regain birth weight. </p> </section> <section id="CD013217-sec-0105"> <p><b>Weight nadir (outcome 1.6.3)</b></p> <p>The study did not report the effect of support of the mother‐infant dyad on weight nadir. </p> </section> </section> <section id="CD013217-sec-0106"> <h6 class="title">Other secondary outcomes for studies of infants at risk for, or having early symptoms consistent with, opioid withdrawal </h6> <p>None of the studies reported on length of NICU stay, neonatal seizure requiring anticonvulsant therapy, neonatal and infant all‐cause mortality, cerebral palsy, neurodevelopmental outcome at approximately two years' corrected age (cerebral palsy, developmental delay [Bayley or Griffith assessment more than two SD below mean] or intellectual impairment [IQ more than two SD below mean], blindness [vision less than 6/60 in both eyes], sensorineural deafness requiring amplification), complications of therapy, measures of maternal mood and bonding including Edinburgh Postpartum Depression Scale, Patient Health Questionnaire (2 or 9), Maternal Attachment Inventory, Maternal Postpartum Attachment Scale, Mother‐Infant Bonding Scale, or Postpartum Bonding Questionnaire (<a href="./references#CD013217-bbs2-0053" title="BrockingtonI , FraserC , WilsonD . The Postpartum Bonding Questionnaire: a validation. Archives of Women's Mental Health2006;9(5):233-42. [DOI: 10.1007/s00737-006-0132-1] [PMID: 16673041]">Brockington 2006</a>; <a href="./references#CD013217-bbs2-0060" title="CondonJ , CorkindaleCJ . The assessment of parent-to-infant attachment: development of a self-report questionnaire instrument. Journal of Reproductive and Infant Psychology1998;16(1):57-76. [DOI: 10.1080/02646839808404558]">Condon 1998</a>; <a href="./references#CD013217-bbs2-0062" title="CoxJ , HoldenJ , SagovskyR . Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry1987;150(6):782-6. [DOI: 10.1192/bjp.150.6.782] [PMID: 3651732]">Cox 1987</a>; <a href="./references#CD013217-bbs2-0092" title="KroenkeK , SpitzerR , WilliamsJ . The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine2001;16(9):606-13. [DOI: 10.1046/j.1525-1497.2001.016009606.x] [PMID: 11556941]">Kroenke 2001</a>; <a href="./references#CD013217-bbs2-0110" title="MullerME . A questionnaire to measure mother-to-infant attachment. Journal of Nursing Measurement1994;2(2):129-41. [PMID: 7780768]">Muller 1994</a>; <a href="./references#CD013217-bbs2-0137" title="TaylorA , AtkinsR , KumarR , AdamsD , GloverV . A new mother-to-infant bonding scale: links with early maternal mood. Archives of Women's Mental Health2005;8(1):45-51. [DOI: 10.1007/s00737-005-0074-z] [PMID: 15868385]">Taylor 2005</a>; <a href="./references#CD013217-bbs2-0145" title="WhooleyMA , AvinsAL , MirandaJ , BrownerWS . Case-finding instruments for depression. Two questions are as good as many. Journal of General Internal Medicine1997;12(7):439-45. [DOI: 10.1046/j.1525-1497.1997.00076.x] [PMID: 9229283]">Whooley 1997</a>), custody status at discharge, or cost of care. </p> </section> </section> </section> <section id="CD013217-sec-0107"> <h4 class="title">Comparison 2. infants receiving opioid treatment for <i>symptoms consistent with opioid</i> withdrawal </h4> <p>We identified no studies.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013217-sec-0108" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013217-sec-0108"></div> <section id="CD013217-sec-0109"> <h3 class="title" id="CD013217-sec-0109">Summary of main results</h3> <p>We identified six RCTs evaluating 353 infants for inclusion in the analysis. The RCTs were published between 1975 and 2018 (six for comparison one, and none for comparison two). We identified and excluded 34 non‐randomized studies published between 2005 and 2018. We identified and excluded seven preregistered interventional clinical trials. These studies may qualify for inclusion at review update when complete. The certainty of evidence for the outcomes in the RCTs was very low to low. This was due to risk of bias inherent in the intervention, imprecision related to study size, and heterogeneity in study design. </p> <p>Four studies evaluated modifying environmental stimulation by comparing a study nursery to a regular nursery (<a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>), non‐oscillating waterbeds to conventional bassinets (<a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>), rocking beds to standard beds (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>), and prone sleep positioning to supine sleep positioning (<a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>). We are uncertain whether modifying environmental stimulation is associated with length of hospitalization based on one study with 30 infants (<a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>). Modifying environmental stimulation may be associated with little or no difference in use of pharmacological treatment based on three studies with 92 infants (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>). We are uncertain whether modifying environmental stimulation is associated with peak NAS score at any time based on three studies with 92 infants (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>). We are uncertain whether modifying environmental stimulation is associated with weight nadir based on one study with 194 infants (<a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>). </p> <p>One study evaluated feeding practices by comparing 24 kcal/oz formula to 20 kcal/oz formula (<a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a>). We are uncertain whether feeding practices are associated with use of pharmacological treatment, days to regain birth weight, or weight nadir based on one study with 46 infants (<a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a>). </p> <p>One study evaluated support of the mother‐infant dyad by comparing tailored breastfeeding support to standard Baby‐Friendly Initiative care (<a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a>). We are uncertain whether support of the mother‐infant dyad is associated with length of hospitalization, use of pharmacological treatment, or NICU admission based on one study with 14 infants (<a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a>). </p> <p>Many prespecified outcomes were not reported. None of the studies reported length of NICU stay, neonatal seizures requiring anticonvulsant therapy, neonatal and infant all‐cause mortality, cerebral palsy, neurodevelopmental outcome at approximately two years' corrected age (cerebral palsy, developmental delay [Bayley or Griffith assessment more than two SD below mean] or intellectual impairment [IQ more than two SD below mean], blindness [vision less than 6/60 in both eyes], sensorineural deafness requiring amplification), complications of therapy, measures of maternal mood and bonding including Edinburgh Postpartum Depression Scale, Patient Health Questionnaire (2 or 9), Maternal Attachment Inventory, Maternal Postpartum Attachment Scale, Mother‐Infant Bonding Scale, or Postpartum Bonding Questionnaire (<a href="./references#CD013217-bbs2-0053" title="BrockingtonI , FraserC , WilsonD . The Postpartum Bonding Questionnaire: a validation. Archives of Women's Mental Health2006;9(5):233-42. [DOI: 10.1007/s00737-006-0132-1] [PMID: 16673041]">Brockington 2006</a>; <a href="./references#CD013217-bbs2-0060" title="CondonJ , CorkindaleCJ . The assessment of parent-to-infant attachment: development of a self-report questionnaire instrument. Journal of Reproductive and Infant Psychology1998;16(1):57-76. [DOI: 10.1080/02646839808404558]">Condon 1998</a>; <a href="./references#CD013217-bbs2-0062" title="CoxJ , HoldenJ , SagovskyR . Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry1987;150(6):782-6. [DOI: 10.1192/bjp.150.6.782] [PMID: 3651732]">Cox 1987</a>; <a href="./references#CD013217-bbs2-0092" title="KroenkeK , SpitzerR , WilliamsJ . The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine2001;16(9):606-13. [DOI: 10.1046/j.1525-1497.2001.016009606.x] [PMID: 11556941]">Kroenke 2001</a>; <a href="./references#CD013217-bbs2-0110" title="MullerME . A questionnaire to measure mother-to-infant attachment. Journal of Nursing Measurement1994;2(2):129-41. [PMID: 7780768]">Muller 1994</a>; <a href="./references#CD013217-bbs2-0137" title="TaylorA , AtkinsR , KumarR , AdamsD , GloverV . A new mother-to-infant bonding scale: links with early maternal mood. Archives of Women's Mental Health2005;8(1):45-51. [DOI: 10.1007/s00737-005-0074-z] [PMID: 15868385]">Taylor 2005</a>; <a href="./references#CD013217-bbs2-0145" title="WhooleyMA , AvinsAL , MirandaJ , BrownerWS . Case-finding instruments for depression. Two questions are as good as many. Journal of General Internal Medicine1997;12(7):439-45. [DOI: 10.1046/j.1525-1497.1997.00076.x] [PMID: 9229283]">Whooley 1997</a>), custody status at discharge, or cost of care. No studies evaluating modifying environmental stimulation looked at NICU admission or days to regain birth weight. No studies evaluating feeding practices looked at length of hospitalization, peak NAS score at any time, or NICU admission. No studies evaluating support of the mother‐infant dyad looked at peak NAS score at any time, days to regain birth weight, or weight nadir. </p> <p>In summary, we identified few small studies of low quality and many prespecified outcomes were not reported. We are uncertain whether non‐pharmacological care for opioid withdrawal in newborns affects the prespecified outcomes. Given the low‐ or very low‐certainty evidence for all outcomes, the included studies do not support a specific non‐pharmacological intervention or combination of interventions over others. </p> </section> <section id="CD013217-sec-0110"> <h3 class="title" id="CD013217-sec-0110">Overall completeness and applicability of evidence</h3> <p>We identified six RCTs with heterogeneous study population, interventions, and outcome measures. The heterogeneity limits our ability to address the initial research question as well as generalizability of the results to other sites of care. Baseline outcome measures varied between studies suggesting that there are significant undefined differences between study sites. There is also lack of standardization in outcome measures and important measures are not measured in all studies (<a href="./references#CD013217-bbs2-0088" title="KellyL , ShanF , MacVicarS , CzaplinkskiE , MoulsdaleW , SimpsonS , et al. A core outcome set for neonatal opioid withdrawal syndrome. Pediatrics2020;146(1):e20200018. [DOI: ﻿10.1542/peds.2020-0018] [PMID: 32493710]">Kelly 2020</a>). </p> <p>The population studied is heterogeneous due to the presence of variable non‐opioid exposures. There is also high risk for differential enrollment not representative of the general population in this vulnerable population (<a href="./references#CD013217-bbs2-0136" title="StineSM , HeilSH , KaltenbachK , MartinPR , CoyleMG , FischerG , et al. Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study. American Journal of Drug and Alcohol Abuse2009;35(6):429-33. [DOI: 10.3109/00952990903374080]">Stine 2009</a>). Study publications ranged from 1975 to 2018, and both substance exposures and treatments have changed over time. Many of the older studies were conducted when single drug exposure was common (e.g. heroin), and the model of care was more restrictive with fewer opportunities for parent contact, breastfeeding, or other aspects of non‐pharmacological care (<a href="./references#CD013217-bbs2-0090" title="KocherlakotaP , QianE , PatelVC , MandruC , VilarRE , AlpanG , et al. A new scoring system for the assessment of neonatal abstinence syndrome. American Journal of Perinatology2020;37(3):333-40. [DOI: ﻿10.1055/s-0039-3400310] [PMID: 31777045]">Kocherlakota 2020</a>). All but one of the RCTs was conducted in the USA, potentially limiting generalizability to other countries. Important demographic information such as, exact substance exposures, coexposures, and maternal medical and psychiatric history was not consistently collected. </p> <p>We identified few studies in each category of non‐pharmacological intervention and heterogeneity of interventions within categories. In many of the included studies, there is lack of clarity in the 'dose', both in quality and quantity, of the intended intervention. The small number of studies and heterogeneity limited our ability to combine and compare studies directly. The identified studies lacked sufficient similarity for meta‐analysis for all outcomes except for the effect of modifying environmental stimulation on the use of pharmacotherapy. Though combined, these meta‐analyses include different interventions categorized as modifying environmental stimulation, including a waterbed, a rocking bed, and prone positioning. </p> <p>The included studies showed differences in baseline outcome values between studies with no clear pattern. Due to lack of detail, we were unable to explore this source of heterogeneity between studies fully. The differences may be due to undefined cointerventions, which could include pharmacological treatment thresholds, non‐pharmacological interventions, and other multifactorial differences between study sites. Baseline and co‐occurring non‐pharmacological interventions were poorly defined in the studies. Clinically, cointerventions are common and some non‐pharmacological care practices are typically accompanied by other non‐pharmacological care practices. For example, breastfeeding is often accompanied by increases in clustered care, holding, skin‐to‐skin or 'kangaroo care', rocking, parental presence, and potentially additional support from staff (<a href="./references#CD013217-bbs2-0052" title="BogenDL , WhalenBL . Breastmilk feeding for mothers and infants with opioid exposure: What is best?Seminars in Fetal &amp; Neonatal Medicine2019;24(2):95-104. [DOI: 10.1016/j.siny.2019.01.001]">Bogen 2019</a>). The practice of rooming in is often associated with increased rates of breastfeeding and may be associated with differences in environmental stimulation (<a href="./references#CD013217-bbs2-0144" title="WhalenBL , HolmesAV , BlytheS . Models of care for neonatal abstinence syndrome: what works?Seminars in Fetal &amp; Neonatal Medicine2019;24(2):121-32. [DOI: 10.1016/j.siny.2019.01.004]">Whalen 2019</a>). These cointerventions, or bundles of non‐pharmacological interventions, are not always clearly defined or measured. Within the hospital, nursing ratios and site of care are likely significant unmeasured confounders that affect the ability to deliver non‐pharmacological interventions (<a href="./references#CD013217-bbs2-0133" title="SmithJG , RogowskiJA , SchoenauerKM , LakeET . Infants in drug withdrawal: a national description of nurse workload, infant acuity, and parental needs. Journal of Perinatal &amp; Neonatal Nursing2018;32(1):72-9. [DOI: 10.1097/JPN.0000000000000309] [ 29373422]">Smith 2018</a>). A specific site of care may be the most effective and efficient way to deliver certain non‐pharmacological interventions or combinations of non‐pharmacological interventions because site of care is highly interrelated with the ability to deliver non‐pharmacological care (<a href="./references#CD013217-bbs2-0144" title="WhalenBL , HolmesAV , BlytheS . Models of care for neonatal abstinence syndrome: what works?Seminars in Fetal &amp; Neonatal Medicine2019;24(2):121-32. [DOI: 10.1016/j.siny.2019.01.004]">Whalen 2019</a>). For example, one intensive care unit may be unable to offer rooming in and have limited ability to decrease environmental stimulation. However, these limitations are not universal, and another intensive care unit may offer private rooms, intensive lactation and social support, and specific non‐pharmacological therapies. For this review, we chose to incorporate these differences between sites by assessing and comparing the specific interventions offered in each site studied. Limited data on cointerventions, site of care, and baseline confounding affect the generalizability of the study results. </p> <p>While these studies assessed many predefined short‐term outcomes, they were not addressed consistently and important outcomes, such as NICU admission, were often missing. Heterogeneity of outcome measures in studies of neonates experiencing opioid withdrawal is common (<a href="./references#CD013217-bbs2-0132" title="ShanF , MacVicarS , AllegaertK , OffringaM , JanssonLM , SimpsonS , et al. Outcome reporting in neonates experiencing withdrawal following opioid exposure in pregnancy: a systematic review. Trials2020;21:262. [DOI: 10.1186/s13063-020-4183-9]">Shan 2020</a>). The largest and oldest study only contributed one prespecified secondary outcome of limited clinical importance. No studies addressed neonatal seizures requiring anticonvulsant therapy, all‐cause mortality, neurodevelopmental outcome, complications of therapy, measures of maternal mood and bonding, and custody at discharge. </p> <p>Overall, based on six small RCTs, the completeness of evidence and applicability to the study question were limited by study heterogeneity, unmeasured baseline confounders and cointerventions, and unmeasured outcomes. </p> <p>We also identified and excluded 34 non‐randomized studies published between 2005 and 2018 (29 for comparison 1, and five for comparison 2). The evidence is at baseline very low‐certainty based on the non‐randomized study design. The non‐randomized studies were identified using the standardized search strategies for randomized trials with additional studies identified when cross‐referencing for additional randomized studies. The search strategies and criteria for description of non‐randomized studies are less rigorous than those of RCTs. For this reason, we consider there is high likelihood that all eligible non‐randomized studies were not identified in the search process. </p> <p>While the non‐randomized evidence is not methodologically strong, the 34 studies variably suggest improved outcomes with non‐pharmacological care practices when implemented singly or in combination. The majority of the non‐randomized studies showed either a decrease or no change in length of hospitalization, use of pharmacological treatment, and length of treatment when non‐pharmacological interventions were systematically implemented. The most widely studied non‐pharmacological care practices included breastfeeding, rooming in, and multiple non‐pharmacological practices implemented as part of a quality improvement initiative. Similar to the identified RCTs, the baseline outcome values and differences between groups varied significantly between sites for all interventions. This suggests that there are many unmeasured variables that impact care. The differences are likely partially related to unmeasured baseline differences in non‐pharmacological cointerventions and other multifactorial differences at each study site. There is also variability in quality and quantity of non‐pharmacological interventions. Heterogeneity in study design and size contribute to further variability. </p> <p>Similar to the identified RCTs, the completeness of evidence and applicability to the study question based on non‐randomized studies are limited by study heterogeneity, unmeasured baseline confounders and cointerventions, and unmeasured outcomes. </p> </section> <section id="CD013217-sec-0111"> <h3 class="title" id="CD013217-sec-0111">Quality of the evidence</h3> <p>We judged the certainty of evidence for all outcomes in the six included RCTs as very low to low. Risk of bias was very serious for all studies secondary to the high risk of performance and detection bias related to lack of blinding (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>; <a href="./references#CD013217-bbs2-0006" title="OstreaEM , ChavezCJ , StraussME . A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases1975;2(1-2):187-99. [PMID: 1163362]">Ostrea 1975</a>), concern for attrition bias (<a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a>; <a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a>; <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>), concern for reporting bias (<a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a>), concern for other bias related to differential enrollment (<a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a>; <a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a>), as well as many areas of unclear bias. Many outcomes were also downgraded for imprecision due to small study sizes with wide CIs. Though three studies reported the outcome of peak NAS score or NAS score in first 72 hours of life, meta‐analysis was not performed, and the outcome was downgraded due to serious inconsistency with marked heterogeneity and serious indirectness of the outcome measure. All outcomes for feeding measures were further downgraded for plausible confounding that would bias the results toward the null due to the significant number of participants who switched intervention groups in <a href="./references#CD013217-bbs2-0001" title="BogenDL , HanusaBH , BakerR , Medoff-CooperB , CohlanB . Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: 29263124]">Bogen 2018</a>. </p> </section> <section id="CD013217-sec-0112"> <h3 class="title" id="CD013217-sec-0112">Potential biases in the review process</h3> <p>Non‐pharmacological care for opioid withdrawal in newborns encompasses a group of interventions that are not well defined in the literature. The lack of standard terminology or definitions is a significant source of bias in the review process. For this review, we utilized a categorization of non‐pharmacological interventions based on common interventions reported in treatment of opioid withdrawal in newborns (<a href="./references#CD013217-bbs2-0103" title="MangatAK , SchmolzerGM , KraftWK . Pharmacological and non-pharmacological treatments for the neonatal abstinence syndrome (NAS). Seminars in Fetal and Neonatal Medicine2019;24(2):133-41. [DOI: ﻿10.1016/j.siny.2019.01.009] [PMID: 30745219]">Mangat 2019</a>). There is no established standard research classification of non‐pharmacological care for opioid withdrawal in newborns and we established search terms based on our knowledge of the literature. Studies may categorize similar interventions in different ways such that the search terms did not identify all eligible studies. Additionally, some interventions such as breastfeeding or breast milk feedings are often examined as a subanalysis of a larger study that may not have been captured in the initial search. We included studies in categories of individual or combined non‐pharmacological interventions based on the study description and may have categorized studies incorrectly if the study description lacked detail. Within a category, we assumed the class and intensity of intervention was similar in the studies. When not described, we assumed a constant dose of each non‐pharmacological intervention. </p> <p>The literature search using this categorization may not have captured all studies of the heterogeneous and historically not well‐defined group of non‐pharmacological interventions. Despite our best efforts, incomplete identification of studies for this review is possible. We reviewed 171 full‐text studies, many abstracts were advanced to full‐text review due to lack of clarity in study abstract about intervention and study design. We identified 28 of the full‐text studies outside of the search, largely in the references of other studies. The number of studies that were not captured by the search terms supports our suspicion for incomplete identification of studies. The majority of the full‐text studies reviewed were excluded due to study design, and it is likely that missed studies were a non‐randomized study design and would not qualify for inclusion. Importantly, the last search was performed in October 2019 and there may be more recent studies that qualify for inclusion. </p> </section> <section id="CD013217-sec-0113"> <h3 class="title" id="CD013217-sec-0113">Agreements and disagreements with other studies or reviews</h3> <p>While a number of reviews have assessed the impact of non‐pharmacological care practices together or as subgroups, we found no combined systematic review and meta‐analysis that evaluate non‐pharmacological care practices. Unlike many reviews of non‐pharmacological care practices, we chose to exclude studies of acupuncture and acupressure. A separate Cochrane Review is currently planned to address acupuncture and acupressure for opioid withdrawal in newborns, the protocol is not yet published. Similar to other recent reviews, we identified few RCTs and a larger literature of non‐randomized studies (<a href="./references#CD013217-bbs2-0100" title="MacMillanKD , RendonCP , VermaK , RibletN , WasherDB , Volpe HolmesA . Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis. JAMA Pediatrics2018;172(4):345-51. [DOI: dx.doi.org/10.1001/jamapediatrics.2017.5195]">MacMillan 2018</a>; <a href="./references#CD013217-bbs2-0101" title="MacVicarS , KellyLE . Systematic mixed-study review of nonpharmacological management of neonatal abstinence syndrome. Birth2019;46(3):428-38. [DOI: 10.1111/birt.12427]">MacVicar 2019</a>; <a href="./references#CD013217-bbs2-0103" title="MangatAK , SchmolzerGM , KraftWK . Pharmacological and non-pharmacological treatments for the neonatal abstinence syndrome (NAS). Seminars in Fetal and Neonatal Medicine2019;24(2):133-41. [DOI: ﻿10.1016/j.siny.2019.01.009] [PMID: 30745219]">Mangat 2019</a>; <a href="./references#CD013217-bbs2-0104" title="McQueenK , TaylorC , Murphy-OikonenJ . Systematic review of newborn feeding method and outcomes related to neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing2019;48(4):398-407. [DOI: 10.1016/j.jogn.2019.03.004]">McQueen 2019</a>; <a href="./references#CD013217-bbs2-0114" title="OostlanderSA , FallaJA , DowK , FucileS . Occupational therapy management strategies for infants with neonatal abstinence syndrome: scoping review. Occupational Therapy in Health Care2019;33(2):197-226. [DOI: 10.1080/07380577.2019.1594485]">Oostlander 2019</a>; <a href="./references#CD013217-bbs2-0127" title="RyanG , DooleyJ , Gerber FinnL , KellyL . Nonpharmacological management of neonatal abstinence syndrome: a review of the literature. Journal of Maternal-fetal &amp; Neonatal Medicine2019;32(10):1735-40. [DOI: 10.1080/14767058.2017.1414180]">Ryan 2019</a>). Unlike these reviews, we excluded non‐randomized studies. Our conclusion based on six RCTs was that we are uncertain whether non‐pharmacological care for opioid withdrawal in newborns affects the prespecified outcomes. </p> <p>Other reviews that included non‐randomized studies discussed a trend toward improved outcomes when non‐pharmacological care practices were purposefully implemented. <a href="./references#CD013217-bbs2-0100" title="MacMillanKD , RendonCP , VermaK , RibletN , WasherDB , Volpe HolmesA . Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis. JAMA Pediatrics2018;172(4):345-51. [DOI: dx.doi.org/10.1001/jamapediatrics.2017.5195]">MacMillan 2018</a> noted reduced use of pharmacotherapy, length of stay, and cost of care in a systematic review and meta‐analysis of six non‐randomized studies evaluating rooming in. <a href="./references#CD013217-bbs2-0104" title="McQueenK , TaylorC , Murphy-OikonenJ . Systematic review of newborn feeding method and outcomes related to neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing2019;48(4):398-407. [DOI: 10.1016/j.jogn.2019.03.004]">McQueen 2019</a> noted reduced incidence and duration of pharmacological treatment, shorter hospital length of stay, and decreased severity of NAS in methadone‐exposed infants in one randomized study (<a href="./references#CD013217-bbs2-0003" title="MacVicarS , HumphreyT , Forbes-McKayKE . Breastfeeding and the substance-exposed mother and baby. Birth2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: 29411890]">MacVicar 2018</a>), and seven non‐randomized studies evaluating newborn feeding methods, the effect in buprenorphine‐exposed infants was unclear. <a href="./references#CD013217-bbs2-0101" title="MacVicarS , KellyLE . Systematic mixed-study review of nonpharmacological management of neonatal abstinence syndrome. Birth2019;46(3):428-38. [DOI: 10.1111/birt.12427]">MacVicar 2019</a> noted reduced use of pharmacotherapy in 10 studies and reduced length of stay in nine studies in a narrative review of non‐pharmacological care including 14 studies of heterogeneous non‐pharmacological interventions (13 non‐randomized, 1 RCT evaluating acupuncture; 2 studies included changes to pharmacotherapy protocols). Other studies, such as <a href="./references#CD013217-bbs2-0114" title="OostlanderSA , FallaJA , DowK , FucileS . Occupational therapy management strategies for infants with neonatal abstinence syndrome: scoping review. Occupational Therapy in Health Care2019;33(2):197-226. [DOI: 10.1080/07380577.2019.1594485]">Oostlander 2019</a>, <a href="./references#CD013217-bbs2-0103" title="MangatAK , SchmolzerGM , KraftWK . Pharmacological and non-pharmacological treatments for the neonatal abstinence syndrome (NAS). Seminars in Fetal and Neonatal Medicine2019;24(2):133-41. [DOI: ﻿10.1016/j.siny.2019.01.009] [PMID: 30745219]">Mangat 2019</a>, and <a href="./references#CD013217-bbs2-0127" title="RyanG , DooleyJ , Gerber FinnL , KellyL . Nonpharmacological management of neonatal abstinence syndrome: a review of the literature. Journal of Maternal-fetal &amp; Neonatal Medicine2019;32(10):1735-40. [DOI: 10.1080/14767058.2017.1414180]">Ryan 2019</a> described randomized studies of environmental changes (<a href="./references#CD013217-bbs2-0002" title="D'ApolitoK . Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: 10326317]">D'Apolito 1999</a>; <a href="./references#CD013217-bbs2-0004" title="MaichukGT , ZahorodnyW , MarshallR . Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: 10685301]">Maichuk 1999</a>; <a href="./references#CD013217-bbs2-0005" title="OroAS , DixonSD . Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: 3341322]">Oro 1988</a>), and acupuncture (<a href="./references#CD013217-bbs2-0125" title="RaithW , SchmölzerGM , ReschB , ReitererF , AvianA , KoestenbergerM , et al. Laser acupuncture for neonatal abstinence syndrome: a randomized controlled trial. Pediatrics2015;136(5):876-84. [DOI: 10.1542/peds.2015-0676]">Raith 2015</a>), in combination with a larger body of non‐randomized evidence. Based on this combination of evidence, <a href="./references#CD013217-bbs2-0103" title="MangatAK , SchmolzerGM , KraftWK . Pharmacological and non-pharmacological treatments for the neonatal abstinence syndrome (NAS). Seminars in Fetal and Neonatal Medicine2019;24(2):133-41. [DOI: ﻿10.1016/j.siny.2019.01.009] [PMID: 30745219]">Mangat 2019</a> concluded "most non‐pharmacological treatments (exception of rocking and outpatient therapy) are safe, effective and easy to be implemented as adjunct therapies to pharmacological treatments." </p> <p>In summary, recent reviews of non‐pharmacological care for opioid withdrawal in newborns described the potential benefits based largely on non‐randomized evidence. In the current review of RCTs, we concluded that the evidence was uncertain. There is a need for further high‐quality studies to identify the most efficacious interventions and guide clinical care teams to choose safe, cost‐effective, and impactful non‐pharmacological care practices. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013217-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/urn:x-wiley:14651858:media:CD013217:CD013217-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013217-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_t/tCD013217-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013217-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/urn:x-wiley:14651858:media:CD013217:CD013217-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD013217-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_t/tCD013217-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013217-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/urn:x-wiley:14651858:media:CD013217:CD013217-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 1: Length of hospitalization (days)" data-id="CD013217-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_t/tCD013217-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 1: Length of hospitalization (days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/references#CD013217-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013217-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/urn:x-wiley:14651858:media:CD013217:CD013217-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 2: Pharmacological treatment with ≥ 1 doses of opioid or sedative medication" data-id="CD013217-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_t/tCD013217-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 2: Pharmacological treatment with ≥ 1 doses of opioid or sedative medication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/references#CD013217-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013217-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/urn:x-wiley:14651858:media:CD013217:CD013217-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 3: Peak neonatal abstinence syndrome (NAS) score in first 72 hours of life" data-id="CD013217-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_t/tCD013217-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 3: Peak neonatal abstinence syndrome (NAS) score in first 72 hours of life </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/references#CD013217-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013217-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/urn:x-wiley:14651858:media:CD013217:CD013217-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 4: Neonatal intensive care unit admission" data-id="CD013217-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_t/tCD013217-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 4: Neonatal intensive care unit admission </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/references#CD013217-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013217-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/urn:x-wiley:14651858:media:CD013217:CD013217-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 5: Days to regain birth weight" data-id="CD013217-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_t/tCD013217-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 5: Days to regain birth weight </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/references#CD013217-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013217-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/urn:x-wiley:14651858:media:CD013217:CD013217-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 6: Weight nadir (% weight loss)" data-id="CD013217-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_t/tCD013217-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 6: Weight nadir (% weight loss) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/references#CD013217-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/media/CDSR/CD013217/image_n/nCD013217-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013217-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Non‐pharmacological treatment compared to placebo for infants at risk for, or having early symptoms consistent with, opioid withdrawal</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Non‐pharmacological treatment compared to placebo for infants at risk for, or having early symptoms consistent with, opioid withdrawal</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> infants at risk for, or having early symptoms consistent with, opioid withdrawal </p> <p><b>Setting:</b> newborn or neonatal unit, USA and UK </p> <p><b>Intervention:</b> non‐pharmacological treatment </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with non‐pharmacological treatment</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Primary outcome measures</i> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Length of hospitalization (days)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Modifying environmental stimulation</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean was 11.5 days (SD 3.4)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 1 lower</b><br/>(2.82 lower to 0.82 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Feeding practices</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Support of the mother‐infant dyad</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean was 19.4 days (SD 13)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 8.9 lower</b><br/>(19.84 lower to 2.04 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Pharmacological treatment with</b> ≥ 1<b>doses of opioid or sedative medication</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>– <i>Modifying environmental stimulation</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.00</b><br/>(0.86 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>92<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>844 per 1000</p> <p>(533 to 1000)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>851 per 1000<br/>(533 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>– <i>Feeding practices</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.92</b><br/>(0.63 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>49<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>727 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>667 per 1000</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>– <i>Support of the mother‐infant dyad</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.50</b><br/>(0.13 to 1.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>571 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1000</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Secondary outcome measures**</i> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>NICU admission</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>– <i>Support of the mother‐infant dyad</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.50</b><br/>(0.13 to 1.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>571 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1000</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Days to regain birth</b> <b>weight</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Feeding practices</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean was 14.7 days (SD 2.84)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.1 lower</b><br/>(2.76 lower to 0.56 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>e</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Weight nadir (% weight loss)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Modifying environmental stimulation</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean was 5.5% weight loss</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.28 lower</b><br/>(1.15 lower to 0.59 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>f</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>– <i>Feeding practices</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean was 9.4% weight loss</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.8 lower</b><br/>(2.24 lower to 0.64 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p>**Only interventions that reported on secondary outcomes are included in the 'Summary of findings' table. </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>NICU:</b> neonatal intensive care unit; <b>RCT:</b> randomized controlled trial; <b>SD:</b> standard deviation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded three levels for very serious concerns about risk of bias (due to unblinded study, concern for performance, detection, and attrition bias) and serious concern for imprecision (due to wide CIs).<br/><sup>b</sup>Downgraded three levels for very serious concerns about risk of bias (due to unblinded study, concern for performance, detection, and attrition bias) and very serious concern for imprecision (due to very wide CIs).<br/><sup>c</sup>Downgraded two levels for very serious concerns about risk of bias (due to unblinded study, concern for performance, detection, and attrition bias).<br/><sup>d</sup>Downgraded three levels for very serious concerns about risk of bias (due to concern for attrition and reporting bias), serious concern about imprecision (due to wide CIs), and plausible confounding that would reduce demonstrated effect.<br/><sup>e</sup>Downgraded three levels for very serious concerns about risk of bias (due to concern for attrition and reporting bias), very serious concern about imprecision (due to very wide CIs), and plausible confounding that would reduce demonstrated effect.<br/><sup>f</sup>Downgraded three levels for very serious concerns about risk of bias (due to unblinded study, concern for performance and detection bias) and serious concern for imprecision (due to wide CIs). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Non‐pharmacological treatment compared to placebo for infants at risk for, or having early symptoms consistent with, opioid withdrawal</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013217-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Excluded studies of modifying environmental stimulation</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Details</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0033" title="RadziewiczRM , Wright-EsberS , ZupancicJ , GargiuloD , WoodallP . Safety of reiki therapy for newborns at risk for neonatal abstinence syndrome. Holistic Nursing Practice2018;32(2):63-70. [DOI: 10.1097/HNP.0000000000000251] [PMID: 29315084]">Radziewicz 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 newborns at risk for withdrawal in a newborn nursery</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newborn nursery (Ohio, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Each subject received one thirty‐minute treatment of Reiki in a private room."</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0015"> <li> <p>Slight decrease in heart rate and withdrawal scores following treatment</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0040" title="ZuzarteI , IndicP , BartonB , PaydarfarD , BednarekF , Bloch-SalisburyE . Vibrotactile stimulation: a nonpharmacological intervention for opioid exposed newborns. PloS One2017;12(4):e0175981. [DOI: ﻿10.1371/journal.pone.0175981] [PMID: 28426726]">Zuzarte 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective cohort (within‐subjects)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 opioid‐exposed newborns (&gt; 37 weeks' gestation) treated pharmacologically for NAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neonatal intensive care unit and newborn nursery (Massachusetts, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "A specially‐constructed mattress delivered low‐level SVS (30–60Hz, 10–12μm RMS [root‐mean‐square]), alternated in 30‐min intervals between continuous vibration (ON) and no vibration (OFF) over a 6–8 hr session." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0016"> <li> <p>35% reduction in movement activity with SVS</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>NAS: neonatal abstinence syndrome; SVS: stochastic vibrotactile stimulation.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Excluded studies of modifying environmental stimulation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013217-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Excluded studies of feeding practices</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Details</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0007" title="Abdel-LatifME , PinnerJ , ClewsS , CookeF , LuiK , OeiJ . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics2006;117(6):e1163-9. [DOI: ﻿10.1542/peds.2005-1561] [PMID: 16740817]">Abdel‐Latif 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>190 consecutive drug‐dependent mother‐infant pairs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1998–2004</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward with mother unless medical or social contraindications (New South Wales, Australia) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Predominant feed on day 5 of life: ≤ 2 feeds daily of formula (85 infants) or &gt; 2 feeds daily of formula (105 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≤ 2 feeds daily of formula vs &gt; 2 feeds daily of formula</p> <p> <ol id="CD013217-list-0017"> <li> <p>Shorter length of hospitalization (mean: 14.7 days, SD 14.9 vs 19.1 days, SD 15.0; P = 0.049) </p> </li> <li> <p>Significant decrease in need for treatment (52.9% vs 79.0%; P &lt; 0.001)</p> </li> <li> <p>Non‐significant decrease in treatment duration (mean: 85.4 days, SD 71.7 vs 108.2 days, SD 81.8; P = 0.185) </p> </li> <li> <p>Non‐significant decrease in maximum dose of morphine (mean: 0.57 mg/kg/day, SD 0.22 vs 0.59 mg/kg/day, SD 0.22; P = 0.526) </p> </li> <li> <p>Fewer infants in foster care (9.4% vs 29.5%; P = 0.001)</p> </li> <li> <p>Fewer infants designated; quote: "child at risk" (31.8% vs 68.6%; P &lt; 0.001)</p> </li> <li> <p>Lower mean Finnegan scores (numeric values not provided in text)</p> </li> <li> <p>Later median time to withdrawal (10 days vs 3 days; P &lt; 0.001)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More heroin, non‐opioid, and polydrug use in formula group</p> <p>Emailed authors to clarify data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0010" title="ArlettazR , KashiwagiM , Das-KunduS , FauchèreJC , LangA , BucherHU . Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstetricia et Gynecologica Scandinavica2005;84(2):145-50. [DOI: ﻿10.1111/j.0001-6349.2005.00510.x] [PMID: 15683374]">Arlettaz 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 infants of women enrolled in a methadone maintenance program</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1996–2001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified, 77% transferred to the neonatal unit for medical reasons or pharmacological treatment (Switzerland) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infants who received more than half of total amount of milk during hospital stay as human milk (27 infants) vs infants who received less than half (59 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Twenty‐six percent of breast‐fed babies (7/27) and 78% of formula‐fed babies (42/54) developed NAS (P &lt; 0.01)." </p> <p>Pharmacological treatment rate and custody not reported by feeding status</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0012" title="DrydenC , YoungD , CampbellN , MactierH . Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. Archives of Disease in Childhood. Fetal and Neonatal Edition2012;97(3):F214-6. [DOI: ﻿10.1136/adc.2009.178723] [PMID: 20656717]DrydenC , YoungD , HepburnM , MactierH . Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG2009;116(5):665-71. [DOI: 10.1111/j.1471-0528.2008.02073.x] [PMID: 19220239]">Dryden 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>450 singleton pregnancies of drug misusing women prescribed substitute methadone for pregnancy </p> <p>354 term substitute methadone‐exposed infants included in subgroup published in 2012</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2004 to December 2006</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward with mother unless any specific indication for admission to the neonatal unit (UK) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received maternal breast milk ≥ 72 hours (99 infants) vs formula fed or received maternal breast milk &lt; 72 hours (351 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Received maternal breast milk ≥ 72 hours vs formula fed or received maternal breast milk &lt; 72 hours </p> <p> <ol id="CD013217-list-0018"> <li> <p>Breastfeeding associated with reduced odds of requiring treatment for NAS (OR 0.55, 95% CI 0.34 to 0.88; P = 0.013) </p> </li> <li> <p>Follow‐up analysis of 354 infants with complete data (breastfed 72 infants, non‐breastfed 282 infants) showed higher median maximal weight loss in breastfed group (10.2% vs 8.5%; P = 0.003) </p> </li> <li> <p>The group of 22 exclusively breastfed infants had a median maximal weight loss of 9.3% </p> </li> <li> <p>Quote: "For infants who were not admitted to the [neonatal unit] (n=208), median age at discharge was 7 days; this did not differ between breast and formula feeders" </p> </li> <li> <p>More breastfed infants were classified as "non‐admitted" and did not require admission to the neonatal unit (52/72 [72%] vs 155/282 [55%]) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emailed authors to clarify the relationship between the 2 publications, 2009 study is the primary study as fewer infants were included in 2012 study due to missing data. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0014" title="HodgsonZG , AbrahamsRR . A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2012;34(5):475-81. [DOI: 10.1016/s1701-2163(16)35245-8] [PMID: 22555142]">Hodgson 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>295 singleton mother‐infant dyads who received care in combined care for maternal substance use in a rooming in program </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2003 to December 2006</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal; quote: "combined care nursery" with mother including those receiving pharmacotherapy (British Columbia, Canada) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed (196 infants) vs not breastfed (99 infants)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0019"> <li> <p>Significant decrease in probability of an infant receiving morphine (12% of breastfed infants vs 37% of non‐breastfed infants; OR 0.21, SD 1.43, 95% CI 0.10 to 0.42; P &lt; 0.001) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0018" title="IsemannB , Meinzen-DerrJ , AkinbiH . Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. Journal of Perinatology2011;31(1):25-9. [DOI: dx.doi.org/10.1038/jp.2010.66] [PMID: 20508596]">Isemann 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>128 infants that received pharmacotherapy for opiate withdrawal in the newborn intensive care unit (92 infants &gt; 37 weeks, 36 infants &lt; 37 weeks) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2002 to December 2007</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NICU (Ohio, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mother's breast milk ingested vs formula fed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0020"> <li> <p>Inverse correlation between the percentage of mother's breast milk ingested and length of stay (β = –0.03; P = 0.02) </p> </li> <li> <p>Median: 12.5 days, range 3–51 days for infants who ingested maternal breast milk vs 18.5 days, range 9̫–43 days for formula‐fed infant </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0019" title="JanssonLM , ChooR , VelezML , HarrowC , SchroederJR , ShakleyaDM , et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics2008;121(1):106-14. [DOI: ﻿10.1542/peds.2008-0217] [PMID: 18166563]">Jansson 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective case control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 breastfed methadone‐exposed infants and 8 matched formula‐feeding infants</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2001 to September 2005</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (Maryland, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed (8 infants) vs formula fed (8 infants)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs formula fed</p> <p> <ol id="CD013217-list-0021"> <li> <p>Decrease in use of pharmacological treatment (12.5% vs 50%; P = 0.28)</p> </li> <li> <p>Shorter time of treatment (median: 6 days, IQR not reported vs 13.5 days, IQR 10.5)</p> </li> <li> <p>Lower day 3 NAS score (median: 4.5, IQR 3.9 vs 6.8, IQR 1.2; P non‐significant)</p> </li> <li> <p>Lower peak NAS score (median: 6.5, IQR 4.5 vs 11.0, IQR 5.0; P non‐significant)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More medical comorbidities in breastfed group</p> <p>3 breastfeeding infants not included due to failure to provide complete study specimens</p> <p>1 breastfeeding infants not included due to inability to find match</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0021" title="LiuA , JuarezJ , NairA , NananR . Feeding modalities and the onset of the neonatal abstinence syndrome. Frontiers in Pediatrics2015;3:14. [DOI: ﻿10.3389/fped.2015.00014] [PMID: 25767791]">Liu 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194 methadone‐maintained mother‐infant dyads &gt; 30 weeks' gestation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2000–2006</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified; quote: "two birthing units" (New South Wales, Australia)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorized in the 1st 2 days of life as predominantly breastfed (≥ 50% of feeds, 32 infants), fed expressed breast milk (≥ 15 mL expressed breast milk and breastfed &lt; 3 times daily, 12 infants), or formula fed (≥ 50% of feeds and &lt; 15 ml/day breast milk ingestion, 150 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs fed expressed breast milk vs formula fed</p> <p> <ol id="CD013217-list-0022"> <li> <p>No difference in percent requiring treatment for NAS (72% vs 100% vs 81%; P = 0.11)</p> </li> <li> <p>No difference in maximum dose of morphine required (median: 0.5 mg/kg/day, IQR 0.5 to 0.7 vs 0.7, IQR 0.53 to 9.84 vs 0.5, IQR 0.5 to 0.7; P = 0.20) </p> </li> <li> <p>No difference in mean NAS score (5.1, SD 1.3 vs 5.7, SD 0.9 vs 5.4, SD 1.1; P = 0.47)</p> </li> <li> <p>Quote: "Breastfeeding during the first 2 days of life was associated with a delayed onset of NAS (P = .04)" </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0024" title="McQueenKA , Murphy-OikonenJ , GerlachK , MontelpareW . The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Advances in Neonatal Care2011;11(4):282-90. [DOI: ﻿10.1097/ANC.0b013e318225a30c] [PMID: 22123351]">McQueen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 term infants exposed to methadone with symptoms of NAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2007 to March 2008</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (Ontario, Canada)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfeeding (&gt; 75% breast milk, 8 infants) vs combination feeds (25% to 75% breast milk, 11 infants) vs formula fed (&lt; 25% breast milk, 9 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs combination feed vs formula fed</p> <p> <ol id="CD013217-list-0023"> <li> <p>Fewer mean NAS scores on Modified Finnegan Scoring Tool (25, SD 23.5 vs 56.2, SD 39.1 vs 95.6, SD 34.6) </p> </li> <li> <p>Lower mean NAS scores on Modified Finnegan Scoring Tool (4.9, SD 2.9 vs 6.5, SD 3.7 vs 6.9, SD 4.2) </p> </li> <li> <p>Fewer infants scored &gt; 8 (17% vs 38.8% vs 40.2%)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More regular prenatal care in the breastfed group</p> <p>Emailed with authors to clarify data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0026" title="MetzVE , ComerSD , PribasnigA , WuerzlJ , FischerG . Observational study in an outpatient clinic specializing in treating opioid dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine. Heroin Addiction and Related Clinical Problems2015;17(1):5-16. ">Metz 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>390 infants born to opioid‐dependent women undergoing comprehensive treatment during pregnancy (184 methadone, 77 buprenorphine, 129 slow‐release oral morphine) </p> <p>50 infants excluded due to incomplete data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1994 to January 2009</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (Austria)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed infants (100 infants; methadone group 48 infants, slow‐release oral morphine group 21 infants, buprenorphine group 31 infants) vs non‐breastfed infants (250 infants; methadone group 118 infants, slow‐release oral morphine group 91 infants, buprenorphine group 41 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs non‐breastfed</p> <p> <ol id="CD013217-list-0024"> <li> <p>Decreased mean modified Finnegan score in methadone group (6.52, SD 2.50 vs 7.94, SD 2.87; P = 0.004) and slow‐release oral morphine group (6.97, SD 2.77 vs 9.07, SD 3.11; P = 0.007) with no difference in buprenorphine group (4.89, SD 2.03 vs 5.77, SD 2.49; P = 0.110) </p> </li> <li> <p>Decreased peak modified Finnegan score in methadone group (mean: 12.60, SD 5.16 vs 17.00, SD 5.65; P &lt; 0.001) and slow‐release oral morphine group (mean 15.24, SD 6.66 vs 18.93, SD 5.56; P = 0.009) with no difference in buprenorphine group (mean: 11.19, SD 5.11 vs 12.29, SD 4.78; P = 0.352) </p> </li> <li> <p>Decreased total morphine dose in methadone group (mean: 4.35 mg, SD 9.03 vs 12.65 mg, SD 18.64; P &lt; 0.001) with no difference in slow‐release oral morphine group (mean: 5.23 mg, SD 7.00 vs 8.75 mg, SD 11.54; P = 0.193) and buprenorphine group (mean: 1.90 mg, SD 3.32 vs 2.77 mg, SD 5.78; P = 0.457) </p> </li> <li> <p>Decreased duration of treatment in methadone group (mean: 8.10 days, SD 12.64 vs 16.94 days, SD 16.75; P &lt; 0.001) and slow‐release oral morphine group (mean: 10.20 days, SD 12.53 vs 18.07, SD 13.67; P = 0.020) with no difference in buprenorphine group (mean: 4.74 days, SD 5.58 vs 5.76 days, SD 7.37; P = 0.524) </p> </li> <li> <p>Decreased length of stay in methadone group (mean: 17.17 days, SD 10.28 vs 29.36 days, SD 15.07; P &lt; 0.001) and slow‐release oral morphine group (mean: 19.71 days, SD 12.37 vs 31.03 days, SD 13.81; P = 0.001) with no difference in buprenorphine group (mean: 12.26 days, SD 5.35 vs 14.71 days, SD 9.60; P = 0.174) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes reported as subgroups only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0028" title="O'ConnorAB , CollettA , AltoWA , O'BrienLM . Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. Journal of Midwifery and Women's Health2013;58(4):383-8. [DOI: ﻿10.1111/jmwh.12009] [PMID: 23931660]">O'Connor 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 mother‐infant dyads in buprenorphine treatment program, infants &gt; 35 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>December 2007 to August 2012</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (Maine, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfeeding (65 infants) vs non‐breastfed infants (20 infants)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs non‐breastfed</p> <p> <ol id="CD013217-list-0025"> <li> <p>Non‐significant increase in length of hospital stay (mean: 7.08 days, SD 4.39 vs 6.60 days, SD 1.70; P = 0.35) </p> </li> <li> <p>Non‐significant decrease in peak modified Finnegan NAS score (mean: 8.83, SD 3.56 vs 9.65, SD 2.58; P = 0.17) </p> </li> <li> <p>Non‐significant decrease in pharmacological treatment (23.1% vs 30.0%; P = 0.56)</p> </li> <li> <p>Non‐significant decrease in time to first and last peak modified Finnegan NAS score (first: mean: 66.5 hours, SD 43.80 vs 73.5 hours, SD 41.82; P =.32; last: mean: 76.1 hours, SD 43.95 vs 78.3 hours, SD 38.54; P = 0.67) </p> </li> <li> <p>Decreased likelihood of higher modified Finnegan NAS scores (≥ 8: 65% vs 75%; ≥ 12: 17% vs 30%) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed infants were significantly less likely to have exposure to illicit substances in the 3rd trimester (41.4% vs 80.0%; P = 0.004) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0031" title="PrithamUA , PaulJA , HayesMJ . Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing2012;41(2):180-90. [DOI: 10.1111/j.1552-6909.2011.01330.x] [PMID: 22375882]">Pritham 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152 opioid‐dependent pregnant women in treatment (136 methadone, 16 buprenorphine) and their infants </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2005 to December 2007</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of Care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NICU (Maine, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed (17 infants, methadone group 14, buprenorphine group 3) vs both formula and breast (26 infants, methadone group 22, buprenorphine group 4) vs formula fed (105 infants, methadone group 96, buprenorphine group 9) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0026"> <li> <p>Length of stay was shorter in breastfed neonates than formula‐fed neonates or neonates that fed both formula and breast in regression model of methadone group (β = –0.176; P = 0.05) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0032" title="RadmacherP , AlexanderC , DevlinL . Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15]">Radmacher 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective cohort (historically controlled feasibility study)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 term formula‐fed infants receiving oral morphine for opioid withdrawal matched to historical controls </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2014–2017</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NICU (Kentucky, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exclusive donor milk for up to 2 weeks (12 infants) vs formula‐fed historical controls (12 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Donor milk vs formula fed</p> <p> <ol id="CD013217-list-0027"> <li> <p>No significant difference in length of stay (mean: 41 days, SD 16 vs 33 days, SD 9; P non‐significant) </p> </li> <li> <p>No significant difference in length of treatment (mean: 37 days, SD 16 vs 29 days, SD 9; P non‐significant) </p> </li> <li> <p>No significant difference in median total Finnegan Neonatal Abstinence Score (values not reported) </p> </li> <li> <p>Significant decrease in gastrointestinal subscore &gt; 2 (39% vs 61%; P = 0.001)</p> </li> <li> <p>No significant difference in return to birth weight (mean: 17 days, SD 7 vs 16 days, SD 4; P non‐significant) </p> </li> <li> <p>No significant difference in weight gain during study period (mean: 19.1 g/day, SD 13.1 vs 20.5 g/day, SD 3.0; P non‐significant) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Benzodiazepine exposure in the donor milk group but not the control group</p> <p>Significant deviation from intended intervention noted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0035" title="ShortVL , GannonM , AbatemarcoDJ . The association between breastfeeding and length of hospital stay among infants diagnosed with neonatal abstinence syndrome: a population-based study of in-hospital births. Breastfeeding Medicine2016;11(7):343-9. [DOI: ﻿10.1089/bfm.2016.0084] [PMID: 27529500]">Short 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3725 singleton in‐hospital births &gt; 35 weeks' gestation diagnosed with NAS based on discharge diagnosis codes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012–2014</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified, though mentions benefits of rooming in and 40% admission to NICU (Pennsylvania, USA) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfeeding at discharge (1576 infants) vs not breastfeeding (1968 infants) as reported on birth certificate </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0028"> <li> <p>Length of stay was 9.4% shorter in infants breastfed at discharge than infants not breastfed at discharge in regression model (β = –0.060; P = 005) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information about in‐utero exposure or postnatal treatment for NAS</p> <p>Breastfed infants were more likely to have a higher birthweight and gestational age; less likely to be insured by Medicaid; and more likely to be born to mothers who completed high school, were married, had adequate prenatal care, and who did not smoke </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0037" title="WachmanEM , HayesMJ , BrownMS , PaulJ , Harvey-WilkesK , TerrinN , et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA2013;309(17):1821-7. [DOI: ﻿10.1001/jama.2013.3411]">Wachman 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 infants &gt; 36 weeks' gestation exposed to methadone or buprenorphine in utero</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>July 2011 to July 2012</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified, 5 tertiary care centers and community hospitals (Massachusetts and Maine, USA) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessed breastfeeding as a potential covariate related to NAS severity; breastfeeding (38 infants) vs no breastfeeding (48 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs non‐breastfed</p> <p> <ol id="CD013217-list-0029"> <li> <p>Shorter length of stay (mean: 15.8 days, 95% CI 11.5 to 20.1 vs 27.4 days, 95% CI 22.5 to 32.3; P &lt; 0.001) </p> </li> <li> <p>Decrease in pharmacological treatment (50% vs 77%; P = 0.009)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Objective: to determine whether single nucleotide polymorphisms in the μ‐opioid receptor (OPRM1), multiple‐drug resistance (ABCB1), and catechol‐O‐methyltransferase (COMT) genes are associated with length of hospital stay and the need for treatment of NAS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0039" title="Welle-StrandGK , SkurtveitS , JanssonLM , BakstadB , BjarkoL , RavndalE . Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatrica2013;102(11):1060-6. [DOI: ﻿10.1111/apa.12378] [PMID: 23909865]">Welle‐Strand 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>124 infants of women on opioid maintenance therapy (78 methadone, 46 muprenorphine)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1999–2003 (36 infants, retrospective), 2005–2007 (36 infants, prospective), 2007–2009 (52 infants, retrospective) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified, national cohort (Norway)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed (95 infants; methadone exposed 58, buprenorphine exposed 37) vs not breastfed (29 infants; methadone exposed 20, buprenorphine exposed 9) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfed vs not breastfed</p> <p> <ol id="CD013217-list-0030"> <li> <p>Non‐significant decrease in NAS use of pharmacological treatment overall (overall: 57% vs 69%, not significant; methadone exposed: 53% vs 80%; P &lt; 0.05; buprenorphine exposed: 64% vs 44%; P not significant) </p> </li> <li> <p>Significant decrease in NAS treatment duration overall (overall: mean: 28.6 days, SD 19.1 vs 46.7 days, SD 26.3; P &lt; 0.05; methadone‐exposed mean: 31.0 days, SD 21.4 vs 48.9 days, SD 27.2; P &lt; 0.05; buprenorphine‐exposed mean: 25.7 days, SD 16.0 vs 38.8 days, SD 24.0; P not significant) </p> </li> <li> <p>Length of NAS treatment was shorter in breastfed infants vs not breastfed infants in regression model (overall: β = –19.7; P = 0.00; methadone exposed: β = –20.7; P = 0.00; buprenorphine exposed: β = –6.62; P = 0.59) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More preterm birth and delivery by cesarean in non‐breastfed group</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>CI: confidence interval; NAS: neonatal abstinence syndrome; IQR: interquartile range; NICU: neonatal intensive care unit; OR: odds ratio; SD: standard deviation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Excluded studies of feeding practices</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013217-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Excluded studies of support of the mother‐infant dyad</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Details</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0008" title="AbrahamsRR , KellySA , PayneS , ThiessenPN , MackintoshJ , JanssenPA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien2007;53(10):1722-30. [DOI: ﻿53/10/1722 [pii]] [PMID: 17934036]">Abrahams 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106 infants of mothers with known heroin or methadone use during pregnancy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2001 to December 2002</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward and intensive care nursery (BC, Canada)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in infants in study hospital (32 infants) compared to historical comparisons in study hospital (38 infants) and comparisons at a neighboring hospital without rooming in (36 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in vs historical comparisons in study hospital vs neighboring hospital without rooming in </p> <p> <ol id="CD013217-list-0031"> <li> <p>Shorter length of hospital stay (mean: 11.8 days, SD 9.1 vs 23.5 days, SD 24.6 vs 25.9 days, SD 19.7) </p> </li> <li> <p>Statistically significant decrease in use of pharmacological treatment (25.0% vs 55.3% [RR 0.45, 95% CI 0.23 to 0.87] vs 52.8% [RR 0.47, 95% CI 0.24 to 0.93]) </p> </li> <li> <p>Statistically significant decrease in pharmacological treatment duration (mean: 5.9 days, SD 14.2 in study hospital vs 18.6 days, SD 23.4 vs 18.6 days, SD 20.1) </p> </li> <li> <p>Statistically significant increase in likelihood of discharge with mothers (discharged in custody of mothers: 71.9% vs 31.6% [RR 2.28, 95% CI 1.36 to 3.81] vs 42.5% [RR 1.52, 95% CI 1.01 to 2.29]) </p> </li> <li> <p>Trend toward decreased prevalence of NAS symptoms</p> </li> <li> <p>Increased prevalence of weight loss &gt; 10% in the first week of life (16.6% vs 5.2% [RR 2.96, 95% CI 0.62 to 14.28] vs 5.3% [RR 2.81, 95% CI 0.59 to 13.5]) </p> </li> <li> <p>Statistically significant decrease in admission to a level II nursery (37.5% vs 89.5% [RR 0.42, 95% CI 0.26 to 0.66] and 83.3% ]RR 0.45, 95% CI 0.28 to 0.72]) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Several baseline differences between groups and hospitals with significant difference in feeding practices between groups (62.5% of the rooming in group breastfeeding compared to 7.9% of the historical cohort and 11.1% of the concurrent cohort) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0009" title="AbrahamsRR , Mackay-DunnMH , NevmerjitskaiaV , MacraeGS , PayneSP , HodgsonZG . An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2010;32(9):866-71. [DOI: ﻿10.1016/S1701-2163(16)34659-X] [PMID: 21050520]">Abrahams 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>952 singleton infants of mothers with documented substance use</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2003 to December 2006</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal; quote: "combined care nursery" and intensive care nursery (British Columbia, Canada) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in with comprehensive education in study hospital (355 infants, term 255 infants) vs standard nursery care at all other hospitals (597 infants, term 434 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in vs standard nursery care</p> <p> <ol id="CD013217-list-0032"> <li> <p>Longer hospital length of stay (all infants: mean: 20.7 days, SD 20.5 vs 10.7 days, SD 19.4; term infants: mean 17.6 days, SD 11.3 vs 8.1 days, SD 12.6) </p> </li> <li> <p>Decreased admissions to NICU (all infants: 38.9% vs 45.0%; OR 0.68, 95% CI 0.51 to 0.92; P &lt; 0.001; term infants: 23.5% vs 38.5%; OR 47, 95% CI 0.324 to 0.67; P &lt; 0.001) </p> </li> <li> <p>Shorter NICU length of stay in term infants (all infants: mean: 5.0 days, SD 19.2 vs 5.0 days, SD 12.6; term infants: mean: 1.1 days, SD 3.1 vs 3.1 days, SD 8.3) </p> </li> <li> <p>Increased receipt of breast milk (all infants: 63.7% vs 45.4%; OR 2.11, 95% CI 1.61 to 2.77; P &lt; 0.001) </p> </li> <li> <p>No difference in breastfeeding status at discharge (all infants: 34% vs 35.1%; OR 0.953, 95% CI 0.67 to 1.35; P = 0.79) </p> </li> <li> <p>Increased discharge home with mother (69.9% vs 58.7%)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline differences between groups and hospitals. Newborns in rooming in group had increased odds of receiving breast milk during hospital stay. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0011" title="CrookK , BrandonD . Prenatal breastfeeding education: impact on infants with neonatal abstinence syndrome. Advances in Neonatal Care2017;17(4):299-305. [DOI: 10.1097/ANC.0000000000000392] [PMID: 28244941]">Crook 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort (quality improvement methodology)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 infants evaluated for NAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2014 to July 2015</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NICU, small percentage on pediatric unit if high NICU census (North Carolina, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baby friendly status</p> <p>Breastfeeding initiative (3 class curriculum)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0033"> <li> <p>Decrease in length of stay from a mean of 18.80 days, SD 14.71 to 10.41 days, SD 10.54 (P &lt; 0.001) </p> </li> <li> <p>Decrease in pharmacological treatment from 67.3% to 34.8% (P &lt; 0.001)</p> </li> <li> <p>Increase in exclusive breastfeeding from 20.0% to 31.9% (P not reported)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Infants who received more than 50% human milk had a predicted [length of stay] 2.78 days shorter than infants who received more than 50% formula during hospitalization (P = .08)." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0016" title="HowardMB , SchiffDM , PenwillN , SiW , RaiA , WolfgangT , et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: 28137920]">Howard 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 mother‐infant dyads in a single center rooming in cohort of infants treated pharmacologically for NAS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2015 to April 2016</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pediatric inpatient unit for pharmacological treatment (Massachusetts, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Parental presence (percent of time)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0034"> <li> <p>Maximum (100%) parental presence was associated with a 9‐day shorter length of stay (r = –0.31, 95% CI –0.48 to –0.10; P = 0.01), 8 fewer days of infant opioid therapy (r = –0.34, 95% CI –0.52 to –0.15; P = 0.001), and 1 point lower mean Finnegan score (r = –0.35, 95% CI –0.52 to –0.15; P = 0.01) </p> </li> <li> <p>Quote: "There was a 5.3 mg decrease in the total morphine equivalent dose with increased parental presence (r = –0.20; 95% CI, –0.39 to 0.02; P = .06)" </p> </li> <li> <p>Quote: "The mean NAS score when a parent was present was significantly lower compared with when a parent was not present (5.1 [95% CI, 4.9–5.3] versus 6.0 [95% CI, 5.8–6.2]; P &lt; .0001)" </p> </li> <li> <p>Quote: "Parental presence was higher for infants who were breastfed (65.2% vs 44.5%; P &lt; .001)" </p> </li> <li> <p>Quote: "Parental presence was lower for infants in Department of Children and Families (DCF) custody (36.6% vs 59.7%; P &lt; .001)" </p> </li> <li> <p>Quote: "After adjusting for breastfeeding, parental presence remained significantly associated with reduced NAS score and opioid treatment days" </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "In unadjusted analyses, any amount of breastfeeding was associated with a decreased [length of stay] (16.5 vs 21.2 days; P &lt; .01) as was clinical trial participation (15.8 vs 20.0 days; P &lt; .01). Similarly, breastfeeding and clinical trial participation were also significantly associated with decreased duration of opioid therapy and decreased total morphine equivalent dose." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0017" title="HünselerC , BrückleM , RothB , KribsA . Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie2013;225(5):247-51. [DOI: ﻿10.1055/s-0033-1347190] [PMID: 23966227]">Hünseler 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 infants with NAS transferred from the maternity ward to the neonatal ward for potential pharmacological treatment </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2004–2011</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neonatal ward (Germany)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in within the neonatal ward (24 infants) vs not rooming in within the neonatal ward (53 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in vs no rooming in</p> <p> <ol id="CD013217-list-0035"> <li> <p>Shorter length of hospital stay (mean: 36.6, SD 10.2 vs 42.8, SD 15.3; P = 0.077)</p> </li> <li> <p>No difference in use of pharmacological treatment (79% vs 88.7%; P = 0.14)</p> </li> <li> <p>Shorter duration of pharmacological treatment (mean: 29.5, SD 11.5 vs 35.8, SD 15.3; P = 0.043) </p> </li> <li> <p>Lower maximum dose of opioid (mean: 132 μg/kg/day diluted tincture of opium, SD 56 vs 145 μg/kg/day diluted tincture of opium, SD 60; P = 0.84) </p> </li> <li> <p>No difference in the frequency of Finnegan Scores ≥ 12 (6.4% vs 6.3%; P = 0.98). No difference in maximum Finnegan score (19 points in both groups). </p> </li> <li> <p>Lower costs (mean EUR 10,620, SD 5306 vs EUR 14,331, SD 6028; P = 0.014)</p> </li> <li> <p>More infants discharged home with families (79.2% vs 69.8%; P = 0.046)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 2 infants were breastfed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0023" title="McKnightS , CooH , DaviesG , HolmesB , NewmanA , NewtonL , et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology2016;33(5):495-501. [DOI: ﻿10.1055/s-0035-1566295] [PMID: 26588259]NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):e555-61. [PMID: 27035006]">McKnight 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort (historical controls)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44 singleton infants &gt; 36 weeks' gestation of women taking chronic opioid therapy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>May 2012 to September 2014 (excluding June to August 2013)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pediatrics unit with transfer to NICU for pharmacological treatment (Ontario, Canada)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline (24 infants) and postimplementation (20 infants) of initial observation while rooming in with mother in a private room in the pediatrics unit. Infants transferred to the NICU if pharmacological treatment was required </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0036"> <li> <p>Shorter length of hospitalization (median: 5.0, IQR 3 vs 24.0, IQR 34; P &lt; 0.001)</p> </li> <li> <p>Reduced use of pharmacological treatment of NAS (15.0% vs 83.3%; P &lt; 0.001)</p> </li> <li> <p>No difference in duration of treatment with morphine (median: 24.0, IQR could not be calculated vs 29.5, IQR 23; P = 0.83) </p> </li> <li> <p>No difference in maximum daily dose of morphine (median: 0.48 mg/kg/day, IQR could not be calculated vs 0.48 mg/kg/day, IQR 0.48; P = 0.90) </p> </li> <li> <p>Fewer treated with adjunct pharmacotherapy (0% vs 30.0%; P = 0.54)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "While not significant, a higher proportion of infants in the rooming‐in group were breastfed exclusively or in combination with formula." </p> <p>Emailed authors to clarify data and the relationship between the 2 publications, 1 additional participant included in earlier publication (<a href="./references#CD013217-bbs2-0111" title="NewmanA , DaviesGA , DowK , HolmesB , MacdonaldJ , McKnightS , et al. Rooming-in care for infants of opioid-dependent mothers: implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien2015;61(12):555-61. [PMID: 27035006]">Newman 2015</a>) who was different from the usual population </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0025" title="MetzV , JagschR , EbnerN , WurzlJ , PribasnigA , AschauerC , et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology2011;26(6):412-21. [DOI: ﻿10.1002/hup.1224] [PMID: 21823171]">Metz 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114 opioid‐exposed newborns of mothers maintained on methadone (70 infants) or buprenorphine (44 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>June 2005 to December 2009</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (Austria)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participation in a randomized double‐blind double‐dummy clinical trial ("MOTHER study", 37 infants) vs standard care (77 infants) </p> <p>Clinical trial included daily maternal contact with study staff and mandatory rooming in with mother for ≥ 10 days after delivery </p> <p>Standard care neonates were treated in a separate ward and mothers were discharged when medically cleared </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical trial vs standard protocol</p> <p> <ol id="CD013217-list-0037"> <li> <p>Shorter length of stay (days) in the clinical trial group (methadone‐exposed mean: 16.74, SD 6.78 vs 29.36, SD 17.94; buprenorphine‐exposed mean: 13.67, SD 2.63 vs 13.92, SD 7.33) </p> </li> <li> <p>More infants used pharmacological treatment in the clinical trial group (76% vs 60%)</p> </li> <li> <p>Lower total medication dose in the clinical trial group (methadone‐exposed mean: 5.18 mg, SD 6.94 vs 21.61 mg, SD 26.64; buprenorphine‐exposed mean: 2.02 mg, SD 1.71 vs 4.30 mg, SD 7.30) </p> </li> <li> <p>Shorter length of pharmacological treatment in the clinical trial group (methadone‐exposed mean: 9.53 days, SD 9.14 vs 21.25 days, SD 21.22; buprenorphine‐exposed mean: 7.33 days, SD 4.46 vs 6.62 days, SD 8.07) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modified Finnegan used for clinical trial vs traditional Finnegan for standard care</p> <p>Likely fundamentally different group self‐selected for clinical trial</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0029" title="OrdeanA , KahanM , GravesL , AbrahamsR , KimT . Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(3):252-7. [DOI: ﻿10.1016/S1701-2163(15)30311-X] [PMID: 26001872]">Ordean 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94 pregnant methadone‐maintained women attending integrated care programs and their children </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1997–2009</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified for rooming in cohort, NICU (Ontario, British Columbia, and Quebec, Canada) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in approach (36 infants) vs 2 neighboring hospitals that admit infants to the neonatal intensive care unit for NAS scoring (36 and 22 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rooming in vs hospital 1 (no rooming in) vs hospital 2 (no rooming in)</p> <p> <ol id="CD013217-list-0038"> <li> <p>Longer hospital stay (mean: 26 days, SD 16 vs 14 days, SD 15 vs 16 days, SD 14)</p> </li> <li> <p>No difference in use of pharmacological treatment (29% vs 31% vs 18%; P = 0.564)</p> </li> <li> <p>No difference in duration of NAS treatment (mean: 13 days, SD 6 vs 25 days, SD 17 vs 30 days, SD 27; P = 0.086) </p> </li> <li> <p>Decreased NICU admission (42% vs 94% vs 91%; P = 0.003)</p> </li> <li> <p>No difference in weight loss (7.4% vs 7.0% vs 8.7%; P = 0.204)</p> </li> <li> <p>No difference in days to weight gain (mean: 4.3, SD 1.9 vs 4.2, SD 2.5 vs 5.6, SD 2.8; P = 0.093) </p> </li> <li> <p>Increase in discharge with mother (41% vs 69% vs 68%; P = 0.115)</p> </li> <li> <p>No difference in breastfeeding (14% vs 17% vs 22%; P = 0.767)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Minimal difference in breastfeeding between groups.</p> <p>Significant intersite differences were found in ethnicity and marital status.</p> <p>Emailed authors to clarify data.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0034" title="SaikiT , LeeS , HannamS , GreenoughA . Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics2010;169(1):95-8. [DOI: ﻿10.1007/s00431-009-0994-0] [PMID: 19440732]">Saiki 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort (historical controls)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 infants with NAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time Period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2002–2007</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of Care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward for monitoring and pharmacological treatment and neonatal unit (UK)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline (42 infants) and postimplementation (18 infants) of a system of pharmacological treatment of the infant in the postnatal ward instead of transferring from the postnatal ward to the neonatal unit if escalating symptoms </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline vs postimplementation</p> <p> <ol id="CD013217-list-0039"> <li> <p>Shorter hospital stay (mean: 19.8 days vs 15.9 days; P = 0.012)</p> </li> <li> <p>Fewer infants required treatment (45% vs 11%; P = 0.012)</p> </li> <li> <p>Shorter duration of treatment (mean: 12.7 days vs 7.3 days; P = 0.05)</p> </li> <li> <p>No difference in discharge with mother (60% vs 67%; P = 0.264)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0036" title="SummeyJ , ChenL , MayoR , CharronE , HudsonJA , SherrillWW , et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources2018;44(6):312-20. [DOI: ﻿10.1016/j.jcjq.2017.12.004] [PMID: 29793880]">Summey 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>466 infants receiving care for NAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2006–2014</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward for monitoring and pharmacological treatment and Neonatal unit (South Carolina, USA) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infants enrolled in the Managing Abstinence in Newborns (MAiN) intervention (110 infants) vs infants who were potentially eligible but did not receive the intervention (356 infants) </p> <p>MAiN; quote: "provides multidisciplinary, coordinated, community‐based care for infants at risk for opioid withdrawal and their families within a mother/baby unit. MAiN's three essential elements are early treatment (methadone administered within 48 hours of birth), the option to room in with the mother for the entire hospitalization, and a combined inpatient/outpatient wean." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MAiN vs no MAiN</p> <p> <ol id="CD013217-list-0040"> <li> <p>Non‐significant decrease in length of stay (median: 8 days, IQR 6 to 10 vs 9 days, IQR 4 to 18; P = 0.14) </p> </li> <li> <p>Significantly higher involvement of child protective services in the MAiN cohort (32.7% vs 23.3%; P = 0.048) </p> </li> <li> <p>All infants received level 1 care, 68.8% of comparison babies received level 2 to 3 care </p> </li> <li> <p>Lower total cost (median: USD 10,058, IQR USD 7935 to USD 11,518 vs USD 18,262, IQR USD 5816 to USD 40,922; P &lt; 0.001) </p> </li> <li> <p>'Convulsions' were reported in 1 intervention infant and no comparison infants</p> </li> <li> <p>Diagnosed with 'abnormal loss of weight' more often (3.6% vs 0.8%; P = 0.04)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference in breastfeeding between groups (43.6% vs 48.9%; P = 0.57)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>CI: confidence interval; DCF: Department of Children and Families; IQR: interquartile range; MAiN: Managing Abstinence in Newborns; MOTHER: Maternal Opioid Treatment: Human Experimental Research; NAS: neonatal abstinence syndrome; NICU: neonatal intensive care unit; OR: odds ratio; r: Pearson's correlation coefficient; RR: risk ratio; SD: standard deviation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Excluded studies of support of the mother‐infant dyad</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013217-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Excluded studies of multiple non‐pharmacological care practices</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Details</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0013" title="GrossmanMR , BerkwittAK , OsbornRR , XuY , EssermanD , ShapiroE , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: 28562267]">Grossman 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort (quality improvement methodology)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>287 infants diagnosed with NAS. Excluded infants not exposed to methadone and with serious comorbid conditions </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January 2008 to June 2016</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pediatrics unit, postnatal ward, and NICU (Connecticut, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Standardization of nonpharmacologic care coupled with an empowering message to parents, development of a novel approach to assessment, administration of morphine on an as‐needed basis, and transfer of infants directly to the inpatient unit." </p> <p>Baseline period from January 2008 to February 2010 (55 infants), intervention period (188 infants), and postimplementation period from May 2015 to June 2016 (44 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0041"> <li> <p>Decrease in mean length of stay (22.4 days to 5.9 days; P &lt; 0.001), postnatal morphine treatment (98% to 14%; P &lt; 0.001), and mean cost (USD 44,824 to USD 10,289; P &lt; 0.001) </p> </li> <li> <p>More infants fed breast milk at discharge following implementation (20% to 45%; P = 0.01) </p> </li> <li> <p>Fewer infants admitted to the NICU (100% to 20%; P &lt; 0.001)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0015" title="HolmesAV , AtwoodEC , WhalenB , BeliveauJ , JarvisJD , MatulisJC , et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics2016;137(6):e1-e9. [DOI: ﻿10.1542/peds.2015-2929] [PMID: 27194629]">Holmes 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort (quality improvement methodology)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>163 opioid‐exposed newborns</p> <p>Excluded infants with gestational age &lt; 35 weeks, another reason for NICU admission, or who completed treatment at another facility </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2012 to February 2015</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pediatrics unit, postnatal ward, and NICU (New Hampshire, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Staff training, family education (involvement in symptom monitoring and non‐pharmacological treatment), and care in inpatient pediatric unit </p> <p>Baseline period from March 2012 to February 2013 (54 infants), intervention year 1 from March 2013 to February 2014 (61 infants), and intervention year 2 from March 2014 to February 2015 (48 infants) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0042"> <li> <p>Decrease in use of pharmacological treatment (46% to 27%), adjunctive use of phenobarbital (13% to 2%), mean length of hospitalization for pharmacologically treated infants (16.9 days to 12.3 days), mean cost per treated infant (USD 19,737 to USD 8755; P &lt; 0.01), mean cost per at risk patient (USD 11,000 to USD 5300; P &lt; 0.01), and cumulative morphine exposure (13.7 mg to 6.6 mg per treated newborn) </p> </li> <li> <p>No change noted in length of hospitalization for non‐pharmacologically treated infants (4.2 days to 4.4 days; P = 0.33) </p> </li> <li> <p>No change in mean daily Finnegan score; quote: "no significant difference in median score, maximum score, or first score by year (<i>P</i> = 0.53, 0.29, 0.48, respectively)" </p> </li> <li> <p>No change in number of newborns discharged in parental custody (93% to 90%; P = 0.73)</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0020" title="KirchnerL , Graf-RohrmeisterK , Klebermass-SchrehofK , WeningerM , JagschR , MetzV , et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: 25062111]">Kirchner 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>131 infants who completed an international multicenter clinical trial ("MOTHER study")</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2005–2008</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (international)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparison by site of enrollment; quote: "the 7 contributing sites were divided into 3 clusters: the <i>European cluster</i> (Vienna site, n=37), the <i>rural US cluster (N=39)</i> : Burlington (University of Vermont, n=26), Nashville (Vanderbilt University, n=13), and the <i>urban US cluster (n=55)</i>: Detroit (Wayne State University, n=12), Providence (Brown University, n=3), Philadelphia (Thomas Jefferson University, n=23), Baltimore (Johns Hopkins University, n=17)" </p> <p>Quote: "A standardized NAS rating and treatment protocol was applied, while non‐pharmacologic care of NAS symptoms differed across sites" </p> <p>Quote: "In Europe, all neonates (also those without treatment requirement) stayed in the hospital accommodated in a room with their mothers for at least 10 days" </p> <p>Quote: "The breastfeeding rate was much higher in Europe and was highest in rural US" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0043"> <li> <p>Quote: "The lowest morphine doses for both medication conditions were administered in Europe where all babies were kept in a rooming‐in situation in hospital for at least 10 days" </p> </li> <li> <p>Pharmacological treatment rates: 18.5% Europe rooming in model vs 29.5% urban USA vs 18.5% rural USA </p> </li> <li> <p>Mean total dose of morphine within the first 28 postpartum days: 5.38 mg Europe rooming in model vs 35.05 mg urban USA vs 8.66 mg rural US </p> </li> <li> <p>Quote: "Urban US neonates had significantly higher NAS scores (p&lt;0.01) compared to rural US and European neonates, and needed significantly higher morphine doses (<i>P</i> &lt; 0.05) with longer treatment duration" </p> </li> <li> <p>Quote: "Urban US neonates exhibited most neurological symptoms (<i>P</i> &lt; 0.001) while in Europe autonomous, respiratory and gastrointestinal symptoms were found significantly more often compared to urban and/or rural US (<i>P</i> &lt; 0.05)" </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "No differences between sites could be found in behavioural symptoms, but interestingly a significant positive influence on these symptoms could be demonstrated by breastfeeding (β = –0.261; P = 0.034), with explaining 6.8% of variance" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0022" title="LoudinS , WerthammerJ , PruntyL , MurrayS , ShapiroJI , DaviesTH . A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic. Journal of Perinatology2017;37(10):1108-11. [DOI: ﻿10.1038/jp.2017.101] [PMID: 28682317]">Loudin 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort (historical controls)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1023; quote: "inborn neonates &gt;35 weeks' gestational age with the diagnosis of NAS (ICD9‐CM 779.5), requiring pharmacologic treatment" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2010–2015</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neonatal abstinence center, NTU, and NICU (West Virginia, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline (number of infants not reported); quote: "managed in the NICU, a 36 bed level III unit with an average of 550 admissions per year" and post‐implementation (number of infants not reported) of a neonatal therapeutic unit (NTU), (quote) "a 15‐bed low‐light, low‐noise unit with a dedicated nursing staff and nursing aids along with community volunteers called 'rockers' who were specially trained to hold and rock the neonates when appropriate and when family members were unavailable. The staff utilized therapeutic handling techniques that further enhanced calming effects on the neonates." Also compared to post‐implementation (78 infants) of an offsite; quote: "neonatal abstinence center with 12 beds and a dedicated staff of nurses, patient care assistants, and volunteers trained in the care of neonates with NAS. In addition, on‐site social service personnel served to transition caretakers (birth parents, foster parents or adopting families) … to a safe home environment. Limited number of patient rooms were available to accommodate rooming in, thus that space was utilized to help prepare caretakers prior to discharge." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0044"> <li> <p>Quote: "The median [length of stay] for NAS medication‐treated patients in the NICU without comorbidities was 24 days (interquartile range 24 to 52). Median [length of stay] in the NTU was 26 days (interquartile range 26 to 42). The median [length of stay] for Lily's Place was 33 days (interquartile range 32 to 60 days), indicative of the transition to home life mission of the facility in addition to extended neonatal withdrawal care" </p> </li> <li> <p>Significantly higher median cost per patient for those managed in the NICU (USD 90,601, IQR USD 64,489 to USD 128,135) compared to the NTU (USD 68,750, IQR USD 44,952 to USD 92,548) and then compared to the offsite neonatal abstinence center (USD 17,688, IQR USD 9933 to USD 20,033); P &lt; 0.0001 </p> </li> <li> <p>Quote: "The percentage of total NAS patients requiring pharmacologic treatment in the NICU fell from 100% prior to the establishment of the NTU to 22% by 2015" </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0027" title="MilesJ , SugumarK , MacroryF , SimsDG , D'SouzaSW . Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development2007;33(2):206-12. [DOI: ﻿10.1111/j.1365-2214.2006.00635.x] [PMID: 17291325]">Miles 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort (historical controls)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>176 infants of women in a methadone maintenance program</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1991–1994, 1997–2001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal ward and neonatal medicine unit (UK)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline (78 infants) and postimplementation (98 infants) of a shared care approach in clinical management with a drug liaison midwife service for mothers and infants. Also changed from primary admission to the neonatal medicine unit to primary admission to the maternity ward with transfer to the neonatal medicine unit if pharmacological treatment was required. Additionally, scoring was modified, the threshold for pharmacological treatment adjusted, and treatment choice changed from chlorpromazine to phenobarbitone. Quote: "The [drug liaison midwife] provided specialist advice regarding methadone treatment, care of the newborn, and the advantages of breastfeeding." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0045"> <li> <p>Quote: "Infants spend less time in hospital (median 5 days vs 28 days, <i>P</i> &lt; 0.0002), a smaller proportion had treatment for NAS (14% vs 79%, <i>P</i> = 0.001), and neonatal medicine unit admission was reduced (median 14 days vs 26 days, <i>P</i> &lt; 0.0003 [number of infants 100% vs 40%, <i>P</i> &lt; 0.001])" </p> </li> <li> <p>Quote: "Neonatal convulsions (<i>P</i> = 0.0001) and jaundice (<i>P</i> &lt; 0.001) occurred less frequently, and more infants were breastfed (<i>P</i> = 0.001)" </p> </li> <li> <p>Quote: "About 10% of infants were discharged to a foster family" in both time periods</p> </li> <li> <p>Quote: "None of these children had impairments of vision, hearing, growth, or development" in the first year after leaving the hospital (baseline n = 24, post‐implementation n = 98) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0030" title="PatrickSW , SchumacherRE , HorbarJD , Buus-FrankM , EdwardsE , MorrowK , et al. Improving care for neonatal abstinence syndrome. Pediatrics2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: 27244809]">Patrick 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort (quality improvement methodology)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3458 infants pharmacologically treated for NAS. Data were collected through serial cross‐sectional audits of 199 participating centers </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012–2014</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit not specified (International)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Participating NICUs shared common interests, worked collaboratively, shared information and ideas, and developed standardized practices." The goal was to facilitate guideline update "for the following: (1) screening for maternal substance use; (2) nonpharmacologic treatment of infants with NAS; (3) scoring signs of NAS; (4) breastfeeding; (5) pharmacologic management; and (6) duration of observation of exposed infants." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0046"> <li> <p>Quote: "(T)he mean number of NAS‐focused guidelines increased from 3.7 to 5.1 of a possible 6 (<i>P</i> &lt; .001), with improvements noted in all measured domains" </p> </li> <li> <p>Quote: "(D)ecreases occurred in median (interquartile range) length of pharmacologic treatment, from 16 days (10 to 27 days) to 15 days (10 to 24 days; <i>P</i> = .02) and [length of stay] from 21 days (14 to 33 days) to 19 days (15 to 28 days; <i>P</i> = .002)" </p> </li> <li> <p>The difference in predicted mean length of treatment for hospitals that implemented policies about non‐pharmacological treatment of NAS was –2.0 days (95% CI –4.4 to 0.5) with a predicted length of stay of –2.5 days (95% CI –5.1 to 1.2) </p> </li> <li> <p>The difference in predicted mean length of treatment for hospitals that implemented policies about breastfeeding or provision of expressed human milk was –0.7 days (95% CI –2.1 to 0.7) with a predicted length of stay of –0.5 days (95% CI –2.1 to 1.1) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD013217-bbs2-0038" title="WachmanEM , GrossmanM , SchiffDM , PhilippB , MinearS , HuttonE , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology2018;38(8):1114-22. [DOI: ﻿10.1038/s41372-018-0109-8] [PMID: 29740196]">Wachman 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective and prospective cohort (pre‐/postquality improvement methodology)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>240 opioid‐exposed infants &gt; 36 weeks' gestation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>April 2015 to December 2017</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Site of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pediatrics unit and postnatal ward (Massachusetts, USA)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline (101 infants), intervention (54 infants), and postintervention (85 infants). Interventions included (quote): "a non‐pharmacologic care bundle, function‐based assessments consisting of symptom prioritization and then the "Eat, Sleep, Console" (ESC) Tool; and a switch to methadone for pharmacologic treatment." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD013217-list-0047"> <li> <p>Quote: "Pharmacologic treatment decreased from 87.1 to 40.0%; adjunctive agent use from 33.6 to 2.4%; hospitalization length from a mean 17.4 to 11.3 days, and opioid treatment days from 16.2 to 12.7 (<i>P</i> &lt; 0.001 for all). Total hospital charges decreased from $31,825 to $20,668 per infant. Parental presence increased from 55.6 to 75.8% (<i>P</i> &lt; 0.0001). No adverse events were noted." </p> </li> <li> <p>Hospital length of stay for pharmacologically treated infants trended downward (19.1 days to 17.6 days; P = 0.11) </p> </li> <li> <p>Quote: "There were no NICU admissions for management of NAS or its complications, and no seizures" </p> </li> <li> <p>No significant change in NICU admission (23.7% to 21.2%; P = 0.78) or DCF custody status (19.8% to 28.2%; P = 0.18) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Breastfeeding initiation rate did not differ during the two time periods."</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>CI: confidence interval; DCF: Department of Children and Families; ESC: Eat, Sleep, Console Tool; IQR: interquartile range; MOTHER: Maternal Opioid Treatment: Human Experimental Research; NAS: neonatal abstinence syndrome; NICU: neonatal intensive care unit; NTU: neonatal therapeutic unit. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Excluded studies of multiple non‐pharmacological care practices</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/full#CD013217-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013217-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Infants at risk for, or having early symptoms consistent with, opioid withdrawal</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Length of hospitalization (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Modifying environmental stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐2.82, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Feeding practices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Support of the mother‐infant dyad</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.90 [‐19.84, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Pharmacological treatment with ≥ 1 doses of opioid or sedative medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Modifying environmental stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.86, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Feeding practices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.63, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 Support of the mother‐infant dyad</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.13, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Peak neonatal abstinence syndrome (NAS) score in first 72 hours of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Modifying environmental stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Feeding practices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.3 Support of the mother‐infant dyad</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.13, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Modifying environmental stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Feeding practices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.3 Support of the mother‐infant dyad</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.13, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Days to regain birth weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐2.76, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Modifying environmental stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Feeding practices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐2.76, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.3 Support of the mother‐infant dyad</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Weight nadir (% weight loss) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Modifying environmental stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐1.15, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Feeding practices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐2.24, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.3 Support of the mother‐infant dyad</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Infants at risk for, or having early symptoms consistent with, opioid withdrawal</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013217.pub2/references#CD013217-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013217.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013217-note-0016">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013217-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013217-note-0014">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD013217-note-0012">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD013217-note-0010">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013217-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013217-note-0015">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD013217-note-0009">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013217-note-0008">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013217\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013217\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013217\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013217\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013217\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=JmNqPX1V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013217.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013217.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013217.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013217.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013217.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716057610"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013217.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716057614"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013217.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d96341f19f409',t:'MTc0MDcxNjA1Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 